Effect of microencapsulation on functional and technological features of probiotic and starter cultures by De Prisco, Annachiara
	
 
 
 
 
 
 
 
EFFECT OF MICROENCAPSULATION 
ON FUNCTIONAL AND TECHNOLOGICAL 
FEATURES OF PROBIOTIC AND STARTER 
CULTURES 
 
 
 
 	 		
Annachiara De Prisco 				 	
	2	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thesis committee  
 
Thesis supervisor  
Prof. Gianluigi Mauriello  
Professor at the Dept. of Agricultural Sciences, Portici-  
Division of Microbiology 
University of Naples Federico II, Naples, Italy  
Thesis co- supervisor  
Dr. Duncan Ongeng  
Assoc. Prof. at the Dept. of Food Science and Postharvest Technology  
Faculty of Agriculture and Environment,  
Gulu University, Gulu, Uganda 
 
PhD program coordinator  
Prof. Guido D’Urso  
Professor at the Dept. of Agricultural Sciences, Portici- 
University of Naples Federico II, Naples, Italy  		
	 3	
 
 
 
EFFECT OF MICROENCAPSULATION 
ON FUNCTIONAL AND TECHNOLOGICAL 
FEATURES OF PROBIOTIC AND STARTER 
CULTURES 
 
 
 
 
 	 		
Annachiara De Prisco 											
Thesis 
submitted in fulfilment of the requirements for the degree of doctor 
in Food Science Technology and Biotechnology 
(XXIX cycle) at Federico II- University of Naples 
TABLE OF CONTENTS 
 
Table of contents 4 
List of tables 7 
List of figures  8 
List of abbreviations 12 
  
 
CHAPTER 1                                                                 Brief thesis presentation  
Short overview of the thesis 
 
13 
 
 13 
Aims and thesis outline 14 
  
 
CHAPTER 2                                                                         Literature Review  
2.1 General introduction 
 
  16 
 
 16 
2.2 Generalities on microencapsulation technologies  18 
2.2.1 Encapsulation techniques: a focus on vibrational nozzle technology  20 
2.2.2 Microencapsulating and coating agents: alginate and chitosan   23 
2.3 Microencapsulation of microbial cells                 25 
2.3.1 Probiotics  26 
2.3.1.1 Probiotic foods, health claims and labels  26 
2.3.1.2 Microencapsulation: a possible tool to overcome technological 
hurdles 28 
2.3.2 Starter Cultures 31 
2.4 Market availability of microencapsulated cells for industrial application 32 
  
 
CHAPTER 3                                                    Validation of vibrating technology  
Validation of microencapsulation of living cells by vibrating technology 34 
3.1 Introduction 34 
3.2 Methodologies and Materials  35 
3.3 Results 38 
3.4 Discussion 
3.5 Conclusion 
48 
50 
Notes 50 
  
 
CHAPTER 4                                          Thermoresistance of encapsulated bacteria  
Enhancement of probiotic stability via entrapment in alginate-based 
microcapsules during exposure to high temperature 52 
4.1 Introduction 52 
4.2 Methodologies and Materials  53 
4.3 Results 56 
4.4 Discussion 61 
	 5	
4.5 Conclusion 63 
Notes 63 
  
 
CHAPTER 5                                                         Encapsulation for GI delivery  
Endurance of new isolated and potentially probiotic Lactobacillus strains to 
simulated gastrointestinal conditions through encapsulation in alginate-
based capsules  64 
5.1 Introduction 64 
5.2 Methodologies and Materials  65 
5.3 Results 66 
5.4 Discussion 79 
5.5 Conclusion 71 
Notes 71 
  
 
CHAPTER 6                                       Encapsulated probiotics in real food systems  
Food functionalization by microencapsulated probiotics: three case studies 73 
6.1 Introduction 74 
6.2 First case study. Probiotication of Water- Buffalo Mozzarella cheese 
with microencapsulated Lactobacillus plantarum LMG P-21021 74 
6.2.1 Methodological plan  74 
6.2.2 Results and discussion 76 
6.3 Second case study. Probiotication of almond milk syrup with 
microencapsulated Lactobacillus plantarum LMG P-21021and Lactobacillus 
reuteri DSM 17988 77 
6.3.1 Methodological plan  78 
6.3.2 Results and discussion 78 
6.4 Third case study. Probiotication of blueberry juice with 
microencapsulated Lactobacillus reuteri DSM 17988 79 
6.4.1 Methodological plan  80 
6.4.2 Results and discussion 81 
6.5 Conclusion 82 
  
 
CHAPTER 7                                                 Microencapsulation of starter culture  
Behaviour of microencapsulated starter culture during yoghurt 
manufacturing 
 
84 
7.1 Introduction 84 
7.2 Methodologies and Materials  85 
7.3 Results 88 
7.4 Discussion 94 
7.5 Conclusion 97 
Notes 97 
  
	6	
	 		 											
 
  
 
CHAPTER 8                                                  Proteomics on encapsulated bacteria 
Proteomics tool for the investigation of encapsulated probiotic Lactobacillus 
reuteri DSM 17938 physiology under simulated gastro-intestinal conditions 99 
8.1 Introduction 99 
8.2 Methodologies and Materials  100 
8.3 Results 104 
8.4 Discussion 107 
8.5 Conclusion 109 
Notes 109 
  
 
CHAPTER 9                                                                        General discussion  110 
References 115 
About the Author 133 
List of publications 134 
Scientific curriculum 135 
	 7	
LIST OF TABLES  
 
Table 2.1 Applications and purposes of immobilized/encapsulated microbial cells in 
different technological processes. 
17 
Table 2.2 Food products functionalized by the addition of probiotic microcapsules 
within several food categories. 
31 
Table 3.1 Bacterial load (Log CFU/ml) of microcapsules before (AA and AM) and 
after (FAA and FAM) freeze-drying obtained by using a cell/alginate suspension of 
9.40±0.10 Log CFU/ml and parameters of microencapsulation yield. 
39 
Table 4.1 Working parameters in the production of chitosan coated alginate (AM) 
and alginate-xanthan (XM) matrix microcapsules and chitosan coated alginate  (CAM) 
and alginate-xanthan (CXM) core-shell microcapsules filled with Lactobacillus reuteri 
cells.  
54 
Table 5.1 Bacterial load (Log CFU/ml or g) of chitosan coated alginate and alginate-
xanthan matrix microcapsules (AM and XM) and chitosan coated alginate and alginate-
xanthan core-shell microcapsules (CAM and CXM) obtained by using a cell suspension 
of BR35, BR7 and BM4 strains of 8.15± 0.20 Log CFU/ml. 
67 
Tab. 6.2.1 Viable counts of not inoculated curd and Mozzarella, curds with free and 
encapsulated probiotic cells and resulting probiotic Mozzarella cheese with free and 
encapsulated Lactobacillus plantarum 
77 
Table 7.1 Bacterial load (Log CFU/ml) of intact and disrupted matrix (AM) and core-
shell (CAM) microcapsules. 
88 
Table 7.2 Concentration, expressed in log10 of absolute peak area, of each compound 
detected by GC/MS analysis of unfermented milk and yoghurt obtained with free and 
encapsulated starter culture in matrix (AM) microcapsules. 
91 
Table 8.1 Abbreviations for samples of free and encapsulated Lactobacillus reuteri cells 
before (untreated) and after incubation in simulated gastric (GSS) and intestinal (ISS) 
solution for 2.0 and 3.0h, respectively. 
99 
  
  
  
  
  
  
  
 
 
 
 
 
	8	
LIST OF FIGURES 
Fig. 2.1 Types of cell immobilization techniques. 18 
Fig. 2.2 Capsule size ranges for main techniques used in cell encapsulation for food and 
pharmaceutical application. 
19 
Fig. 2.3 Different types of microcapsules used in food industry. 19 
Fig. 2.4 Controlled break-up of a laminar liquid jet into droplets of equal size. 21 
Fig 2.6 Functional principle of vibrating technology using Buchi Encapsulator B-395. 
Pro 
23 
Fig 2.7 Steps for alginate cell-microcapsules milti-coating with poly-L-lysin and alginate. 24 
Fig. 2.8 Chemical structure of alginate. 25 
Fig. 2.9 Chemical structure of chitosan. 26 
Fig. 2.10 General mechanisms of action of probiotic lactobacilli. 28 
Fig. 2.11 Main factors affecting viability of probiotic bacteria in cheese. 30 
Fig. 3.1 Fluorescence microscopy images at x 400 magnification of stained Lactobacillus 
reuteri DSM 17938 in alginate, AA (a) and chitosan-alginate, AM microcapsules (b). 
39 
Fig. 3.2 Optical microscopy images of alginate microcapsules, AA at x 200 
magnification (a) and of chitosan coated alginate microcapsules, AM at x 320 
magnification (b). 
40 
Fig. 3.3 SEM images of alginate microcapsules (AA). a) AA with a characteristic 
morphology at x 1600 magnification; b) collapsed AA at x 4300 magnification; c) 
particular of AA surface at x 15000 magnification. 
42 
Fig. 3.4 SEM images of chitosan-alginate microcapsules (AM). a) AM with a 
characteristic morphology at x 240 magnification; b) particular of AM surface at x 15000 
magnification. 
43 
Fig 3.5 SEM images of freeze dried alginate microcapsules (FAA). a) FAA with a 
characteristic morphology at x 2400 magnification; b) particular of FAA surface at x 
15000 magnification. 
44 
Fig. 3.6 SEM images of freeze dried chitosan-alginate microcapsules (FAM). a) FAM 
with a characteristic morphology at x 2400 magnification; b) particular of FAM surface 
at x 15000 magnifications. 
45 
Fig. 3.7 Survival kinetics of free and microencapsulated Lactobacillus reuteri DSM 17938 
in alginate capsules (AA) stored in Ringer (R), NaCl (P) and CaCl2 (C) at 20°C (a) and 
4°C (b) along 28 days. Differences between mean values were analysed by two-way 
ANOVA. Significance was declared at p≤0.05. The error bars represent standard 
deviations. 
46 
	 9	
Fig. 3.8 Viable counts and survival percentage of free and microencapsulated 
Lactobacillus reuteri DSM 17938 before and after incubation in GSS for 3h and in ISS for 
4h. The error bars represent standard deviations. Different letters labeling bar graphs of 
the the sample categories indicate that mean values are significantly different (p≤0.05) as 
determined by t-test. 
47 
Fig. 3.9 Fluorescence microscopy images at x 400 magnification of viable staining of 
microencapsulated Lactobacillus reuteri DSM 17938 after treatment in gastrointestinal 
conditions. Alginate microcapsules, AA (a) and chitosan coated alginate microcapsules, 
AM (b) after 3 h in GSS, AA (c) and AM (d) after 4 h in ISS. 
48 
Fig. 3.10 Viable counts of free and microencapsulated Lactobacillus reuteri DSM 17938 
before and after incubation at 4°C in apricot jam for 0 (T0) and 3 (T3) hours. The error 
bars represent standard deviations. Different letters labelling bar graph of the same 
sample category indicate that mean values are significantly different (p≤0.05) as 
determined by t-tes.t. 
48 
Fig 4.1 Optical images of chitosan coated alginate, AM (a) and alginate-xanthan, XM (b) 
matrix microcapsules at x 40 magnification. 
55 
Fig 4.2 Optical images of chitosan coated alginate, CAM (a) and alginate xanthan, CXM 
(b) core-shell microcapsules at x 10 magnification. 
57 
Fig. 4.3 Survival kinetics of free and microencapsulated Lactobacillus reuteri DSM 17938 
in chitosan coated alginate (CAM) and alginate-xanthan core-shell microcapsules (CXM) 
during 28 days in Ringer at 4°C. Differences between mean values were attested by t-
test. Significance was declared at P < 0.05. The error bars represent standard deviations. 
57 
Fig. 4.4 Survival kinetics of free and microencapsulated Lactobacillus reuteri DSM 17938 
in chitosan coated alginate (AM) and alginate-xanthan (XM) matrix capsules and in 
chitosan coated alginate (CAM) and alginate-xanthan (CXM) core-shell microcapsules 
during exposure at 65 (a) and 70°C (b) for 3, 5, and 10 min. in whole fat milk. 
Differences between mean values were attested by t-test. Significance was declared at P 
< 0.05. The error bars represent standard deviation. 
59 
Fig. 4.5 Survival kinetics of free and microencapsulated Lactobacillus reuteri DSM 17938 
in chitosan coated alginate (AM) and alginate-xanthan (XM) matrix capsules and in 
chitosan coated alginate (CAM) and alginate-xanthan (CXM) core-shell microcapsules 
during exposure at 65 (a) and 70°C (b) for 3, 5, and 10 min. in skimmed milk. 
Differences between mean values were attested by t-test. Significance was declared at P 
< 0.05. The error bars represent standard deviation. 
60 
Fig. 4.6 Fluorescence microscopy images at x 40 magnification of stained Lactobacillus 
reuteri DSM 17938 in chitosan alginate (panel a) and chitosan-alginate-xanthan matrix 
microcapsules (panel b) during thermal exposure at 70°C in whole fat milk for 3 (I), 5 
(II) and 10 (III) min. 
61 
Fig. 5.1 Viable counts of three newly isolated and potentially probiotic Lactobacillus 
strain tested during subsequent incubation in saliva (I), gastric (II) and intestinal (III) 
simulating solutions in free form and microencapsulated in chitosan-coated alginate 
(AM) and chitosan-coated alginate xanthan matrix (XM) capsules. Data are expressed as 68 
	10	
mean vales of three independent replicas of experiment and the error bars represent 
standard deviations. Different letters labeling bar graphs of the different sample 
categories (free, AM and XM) in the same conditions (I, II and III) indicate that mean 
values are significantly different (P<0.05) as determined by t-test. 
Fig. 5.2 Viable counts of three newly isolated and potentially probiotic Lactobacillus 
strain tested during subsequent incubation in saliva (I), gastric (II) and intestinal (III) 
simulating solutions in free form and microencapsulated in chitosan-coated alginate 
(CAM) and chitosan-coated alginate xanthan (CXM) core-shell capsules. Data are 
expressed as mean vales of three independent replicas of experiment and the error bars 
represent standard deviations. Different letters labeling bar graphs of the different 
sample categories (free, AM and XM) in the same conditions (I, II and III) indicate that 
mean values are significantly different (P<0.05) as determined by t-test. 69 
Fig. 5.3 Fluorescence microscopy images of viable staining of free BR7 (X 100 
magnification) and encapsulated in chitosan coated alginate (AM) and alginate-xanthan 
matrix microcapsules ((X 40 magnification) during incubation in gastrointestinal 
conditions (GSS for 2h and ISS for 2h). White spots indicate the braking up of the 
alginate network. 70 
Fig. 6.2.1 Stretched curd and Mozzarella cheese inoculated with core-shell 
microcapsules of Lactobacillus plantarum LMG P-2102. 77 
Fig. 6.3.1 Viable counts of free and encapsulated Lb. reuteri and Lb. plantarum inoculated 
in almond milk syrup. Results are expressed as averaged values of three independent 
experiments carried out in duplicate. Standard deviations were always <0.15. 78 
Fig. 6.4.1 Viable counts of Lb. reuteri cells in free form and encapsulated in alginate and 
chitosan coated alginate matrix microcapsules during growth (t=20h) in blueberry juice 
at 37°C and further storage for 20 days at 4°C. Results are expressed as average values 
from three experiments carried out in duplicate ± standard deviations. Differences 
between mean values were attested by t-test and different letters among the same 
sample indicate significant differences at a level of P < 0.05. 81 
Fig. 6.4.2 Alginate (a) and chitosan coated alginate capsules of Lb. reuteri after 7 days of 
inoculum in blueberry juice. 81 
Fig. 7.1 Matrix (AM, panel a and c) and core-shell (CAM, panel b and d) capsules after 
the inoculum in milk (a and b, 40X magnification) and after 6 hours of fermentation (c 
and d, 10X magnification). 87 
Fig. 7.2 Growth and pH kinetics during milk fermentation by yoghurt starter cultures in 
free form (a) and entrapped in matrix, AM (b) and core-shell, CAM (c) microcapsules. 
Bacterial loads are the sum of values separately acquired for Lactobacillus delbrueckii and 
Streptococcus thermophilus. Results are mean values of three different replicas of 
experiments carried out in duplicate, bars represent standard deviations. 89 
Fig. 7.3 Bacterial loads enumerated on intact and disrupted matrix (AM) and core-shell 
microcapsules (CAM) during milk fermentation. 89 
Fig. 7.4 Proteolytic activity of free and encapsulated S. thermophilus and L. delbrueckii in 
matrix (AM) and core-shell (CAM) microcapsules during skimmed milk fermentation at 90 
	 11	
 
 
 
 
 
 
 
 
 
42°C. Values are averaged from three independent trials carried out in duplicate ± 
standard deviations. 
Fig. 7.5 Viable counts of free and encapsulated untreated L. delbrueckii and S. 
thermophilus and after incubation in saliva simulated solution (SSS) for 10 min, gastric 
simulated solution (GSS) for 2 h and intestinal simulated solution (ISS) for 1.5 h (A) or 
3 h (B). The error bars represent standard deviations. AM: matrix microcapsules. 92 
Fig. 7.6 Images (40X) of matrix (AM) microcapsules in yoghurt after exposure to saliva 
simulated solution (SSS) for 10 min, gastric simulated solution (GSS) for 2 h and 
intestinal simulated solution (ISS) for 1.5 h (a) or 3 h (b).  Arrows indicate points of 
swelling and resulting cell leakage. 92 
Fig. 8.1 Viable counts and survival percentages of free and microencapsulated Lb. reuteri 
cells before (untreated) and after incubation in gastric (GSS) and gastric plus intestinal 
simulated solutions (GSS+ISS). Data are expressed as mean values of three independent 
replicas of the experiment and standard deviations were always <0.1.  Different letters 
labelling bar graphs of the sample categories indicate that mean values are significantly 
different (P≤0.05) as determined by t-test. 101 
Fig 8.2 Brilliant Blue Comassie-stained 2DE gels of total cell proteins extracted from 
free untreated Lb. reuteri DSM17938 (L0, panel a) and treated under gastrointestinal 
simulated passage in free (Lg+i, panel b) and encapsulated form (Mg+i, panel c). The 
figure shows one representative gel for each sample. 102 
Fig. 8.3 Spot identification by Progenesis SameSpots image analysis in protein profiles 
of untreated free Lactobacillus reuteri DSM17938 cells (L0) and of free (Lg+i, panel b) and 
encapsulated Lb. reuteri (Mg+i, panel c) after incubation in gastrointestinal simulated 
conditions. 2DE protein pattern of L0 was used as reference gel. 103 
Fig 9.1 Percentage distribution in the current literature of papers dealing with probiotic 
microcapsules application in different food categories. 108 
	12	
LIST OF ABBREVIATIONS 
GI; gastrointestinal  
LAB; Lactic Acid Bacteria  
AA; alginate matrix microcapsules  
AM; chitosan coated alginate matrix microcapsules   
FAA; freeze-dried alginate matrix microcapsules  
FAA; freeze-dried chitosan coated alginate matrix microcapsules  
EE; entrapment efficiency  
XM; chitosan coated alginate-xanthan matrix microcapsules  
CAM; chitosan coated alginate core-shell microcapsules  
CXM; chitosan coated alginate-xanthan core-shell microcapsules  
SSS; simulated saliva solution  
GSS; simulated gastric solution  
ISS; simulated intestinal solution  
  																									
	 13	
Chapter 1                                                                                                     Brief thesis presentation 
    
 
CHAPTER 1 
Brief thesis presentation  
 
 
1.1 Short overview  
 
Microencapsulation is currently described as the technique that permits the physical 
containment into functional matrices of several categories of compounds that can benefit 
from this procedure. Vitamins, polyphenols, bacteriocins, living cells and other many sensitive 
compounds can be efficiently protected, delivered, released and easier handled when in 
microencapsulated form during their utilization and storage. Microencapsulation of living cells 
has gradually become an important   area of intense research and industrial development 
within the wider field of microencapsulation. First applications of encapsulated 
microorganisms in the food sector were mainly confined to fermentation processes in which a 
higher recovery of enzymes, ethanol, lactic acid or antimicrobial peptides alongside a higher 
cell density were obtained with the use of encapsulated microorganisms. More recently, the 
encapsulation of probiotic bacteria has gained a great attention because of the undoubted 
potentiality of this technology to provide protection toward probiotics by enhancing their 
capability to cope with different stress factors.  Probiotics are defined as live microorganisms 
able to confer health benefits to the host when administered in adequate amounts and, in 
order for probiotics to preserve their expected health-promoting effects, they need to survive 
during passage through the gastrointestinal tract. Accordingly, the most investigated area in 
the field of probiotic encapsulation is the one dealing with the development of microcapsule 
systems able to protect bacteria against gastrointestinal barriers and to efficiently mediate their 
delivery to the intestine, their target site of action. Furthermore, because probiotics are 
becoming an important resource for the maintenance and restoration of the normal intestinal 
microbiota, and in general for the human wellbeing, a great attention is currently given to the 
extension of the categories of foods carrying probiotics. At this regard, microencapsulation is 
also regarded as a valid strategy for the improvement of probiotic viability against 
technological and food-related hurdles in order to i) increase their survival during the 
manufacturing and the storage of foods and iii) to contribute to the development of 
innovative probiotic food carriers. Despite the relevant improvements toward the useful 
application of microencapsulation technology to probiotic microorganisms, some challenges 
still exist and need to be addressed to enable wider industrial acceptance of cell microcapsules 
in various production processes. Typical examples are the development of easy to use, stable 
and cheap microcapsules suitable for food applications, the monitoring of cell stability along 
the entire food production including a real storage period and the assessment of the effect of 
new micro-environment created within the capsules on cell metabolism.   
This PhD thesis deals with this context. 
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1.2 Aims and outline  
 
The overall objective of this research is to contribute to the evidences supporting the 
application of microencapsulation technology for the improvement of living cell resistance 
and functionality. This general aim has been addressed through the accomplishment of three 
main research topics such as i) the improvement of probiotic cell survival and functional 
features under stress conditions; ii) the evaluation of the effect of microcapsules on 
technological and functional properties of starter culture and iii) the investigation at cellular 
level, through application of proteomics, to unravel fundamentals supporting increased cell 
viability attributed microencapsulation. These objectives were achieved making use of a 
research plan structured according to the following thesis outline. 
 
The first step toward the achievement of the aim of this thesis was to validate the extrusion 
vibrational nozzle technology, for the first time used in our laboratories, at the encapsulation 
of living cells. Hence, the Chapter 3  reports the production of alginate and chitosan coated 
alginate-based microcapsules loaded with probiotic Lactobacillus reuteri DSM 17938 cells 
according to the matrix microcapsule morphology (see pf. 2.2 of the Literature Review at 
Chapter 2). This encapsulating system has been tested for entrapment efficiency and cell 
viability, for capability to produce microcapsules with suitable morphological properties for 
food application and for the attitude of the resulting microcapsules to resist to lyophilisation 
process and to protect probiotic cells during some preliminary tests (e.g. gastrointestinal 
passage).  
Chapter 4 has as main topic the tailoring of chitosan coated alginate matrix microcapsules. 
Indeed, this base microcapsule type has been modified in its composition, for the addition of 
xanthan gum used as filling agent and in its structure, for the development of core-shell type 
microcapsules (see pf. 2.2 of the Literature Review at Chapter 2).  This Chapter also starts the 
experiments aimed at the determination of the best microcapsule systems in terms of cell 
protection. At this purpose, all microcapsule systems produced have been further investigated 
for their ability to protect probiotic cells under different thermal stress conditions.  
Same microcapsule systems have been applied in experiments reported in Chapter 5  for the 
assessment of their ability to protect new isolated, interesting and potentially probiotic 
lactobacilli that exhibited poor native ability to withstand the stress for gastrointestinal 
environment. These experiments have been performed according a more complex protocol 
for a better simulation of the human gastrointestinal conditions than the one followed in 
Chapter 1, in order to study the effect of the new solutions (saline based solutions plus 
lysozyme or digestive enzymes and bile salts) on microcapsules and on strain viability.  
Results produced and reported in Chapters 3, 4 and 5 allowed the utilization of the most 
suitable microcapsule types for their application in real food systems. Accordingly, Chapter 6 
focused on the application of microencapsulated probiotics in three different food matrices 
selected on the base of: i) differences in the nature of stress factors they pose against probiotic 
viability and ii) broadening  the categories of food products functionalized and delivering 
probiotics.   
Chapter 7  arises from the need to understand the effect of microcapsules here applied on 
metabolic features of bacteria. At this purpose, a yoghurt starter culture has been 
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microencapsulated and its ability to ferment milk has been evaluated alongside the production 
of volatile compounds through GC-MS to assess the effect of new microenvironment created 
by the capsules onto microbial activity. Furthermore, by using a commercial probiotic 
Lactobacillus delbrueckii as component of the yoghurt starter culture, it was also possible during 
the same experiments to test the aptitude of alginate-based microcapsules to protect bacteria 
along the production, the storage and simulated digestion of a food.  
Chapter 8 reports on a preliminary investigation through proteomic approach about the 
possible cellular reasons that can account for the increased resistance of encapsulated 
probiotic bacteria during simulated gastrointestinal transit.  These experiments also aim at the 
validation of proteomics by 2D SDS-PAGE coupled to MALDI TOF as useful tool for the 
investigation of possible molecular modifications of encapsulated bacteria under several stress 
conditions or during the many different processes carried out with microencapsulated bacteria.  
The last chapter, the Chapter 9 , presents a critical synthesis   of the main findings achieved 
from the entire research, andconclusions and recommendations based on   knowledge 
generated.  
 
 
	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2                                                                                                             Literature Review 
 
 
CHAPTER 2 
 
Literature Review 
 
2.1 General introduction 
Cell microencapsulation has its roots in the primordial microbial immobilization technique, 
referred to as the procedure for physical confinement of cells to a certain defined space with 
the main purpose of preserving their viability. Through the tailoring of innovative techniques 
and the research on new suitable encapsulating materials, microencapsulation has become a 
sophisticated technology for the entrapment of living cells targeting a variety of applications.  
It can be defined as the engineered inclusion of cells into functional matrices to form solid 
objects with variable size (1-1000 µm), shape (e.g. spherical, droplet, irregular) and 
morphology (e.g. coated/non-coated matrix or reservoir microcapsules, single/multi-core, 
single/multi-layers). Currently, cell microencapsulation still accounts many applications in the 
research field, as suggested by the continuous growth in scientific publications, along with the 
scaling-up of the technology for the industrial development. Initial research on living cell 
immobilization dates back to 70-80’s. Typical initial research efforts include the demonstration 
that this procedure enhanced aspartase activity in E. coli (Chibata et al., 1974); that when 
yoghurt bacteria (L. delbrueckii and S. thermophilus) were entrapped in different alginate particles 
with the aim to improve a continuous pre-fermentation of milk for yoghurt production 
(Prévost and Diviès, 1987; 1988a and b). The use of immobilized microbial cells in several 
biotechnological processes was found to be more profitable over the utilization of same cells 
in free form (Rathore et al., 2013). This practice was found advantageous in a number of 
industrial applications including improved production of some metabolites (e.g. lactate, 
ethanol), facilitating the separation of cells from fermentation products, enhancing 
fermentation process due to higher cell density achieved, permitting the reuse of immobilized 
cells. In addition, the procedure has also been proved to enhance cell endurance against 
environment stress-related factors and thus prolonging cell viability. Because of the versatility 
of immobilization, and later of the microencapsulation, for the entrapment of many different 
microbial cells, this technology is still being explored in as many different applications. Typical 
examples, including the production of biofuels, environmental decontamination, novel food 
development and enzymes, vitamins, food and pharmaceutical products are presented in table 
2.1. In the field of food science and technology, immobilization/microencapsulation 
technology gradually became a tool for the improvement of the performances of 
microorganisms in various areas of technological interest (e.g. starter cultures, biocatalysts). In 
addition, the technology is also being applied as a strategy for protection of microorganisms 
considered beneficial (i.e. probiotics) to human and/or animal health.  
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Table 2.1  
Applications and purposes of immobilized/encapsulated microbial cells in different technological processes 
 
 
Encapsulated cells Immobilization/encaps
ulation carrier 
Purposes of application Reference 
• Bio fue l  produc t ion  
Clostridium acetobutylicum 
SE25  
AquaMats AO Enhancement of butanol 
production 
Li et al., 2016 
Synechocystis sp. PCC6803 HFE-7500 oil Increment of cell cyanobacteria 
photosynthetic growth and 
production of lactate 
Hammar et al., 
2015 
• Environmental decontamination 
Anthracophyllum discolor  
Sp4 CCCT 16.5 
Alginate-CaCl2 Degradation of herbicide 
atrazine 
Elgueta et al., 
2016 
Ogataea polymorpha 
VKMY-2559 
Organic silica sol-gel Purification of methanol 
containing industrial 
wastewater 
Kamanina et al., 
2016 
Lysinibacillus fusiformis B26 Agar and calcium alginate Decolourization of synthetic 
dye 
Dogan et al., 2016 
• Produc t ion o f  ingred i en ts  fo r  food industry   
Lactococcus lactis; 
Lactobacillus plantarum 
NCIM 2084;  
Lactobacillus delbrueckii 
NCIM 2365; 
Hexamethylene 
diisocyanate and 
glutaraldehyde and 
chitosan; Polypropylene 
matrix and chitosan; 
Palmitoylated alginate 
Enhancement of lactic acid 
production 
Groboillot et al., 
1993; Krishnan et 
al., 2001; Rao et 
al., 2008 
 
Saccharomices cerevisiae; 
mixed starter culture 
from Loog-Pang (Thai 
rice cake)  
Carboxymethylcellulose-
alginate- CaCl2; Silk 
cocoons 
Enhancement of ethanol 
production  
Talebnia and 
Taharzadeh, 2007; 
Khamkeaw and 
Phisalaphong, 
2016 
Candida guilliermondii Alginate- CaCl2 Xylitol production  Carvalho et al., 
2003 
Enterococcus faecium A2000; 
Lactobacillus curvatus 
MBSa2 
 
Alginate-CaCl2 Enhancement of bacteriocin 
production 
Ivanova et al., 
2000; 
Barbosa et al., 
2015 
Streptomyces sp. RCK-SC Polyurethane foam (PUF) Enhancement of pectinase 
production 
Kuhad et al., 2004 
• Fermentat ion o f  food matr i c e s   
Lactoferm ABY 6; Chitosan coated alginate-
CaCl2 
Fermentation of whey based 
substrate and improvement of 
bacterial survival  
Krunić et al., 2015 
Lactobacillus plantarum PCS 
26 
Alginate-CaCl2 Fermentation of apple juice and 
prolongation of probiotic 
viability 
Dimitrovski et al., 
2015 
Lactobacillus plantarum and 
Staphylococcus xylosus 
Alginate-starch Improvement of cells viability 
during meat thermal treatment 
for fermented sukuc 
preparation 
Bilenler et al., 2017 
Probiotic Lactobacillus 
delbrueckii and Streptococcus 
thermophilus 
Chitosan coated alginate-
CaCl2 
Elucidation of fermentative 
ability of encapsulated starter 
cultures and protection of 
probiotic strain 
De Prisco et al., in 
submission 
Table continues in the next page 
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• Prote c t ion o f  prob io t i c s  and enhancement  o f  the i r  func t ions  
Lactobacillus reuteri 
CGMCC 1.3264 
Fe3O4 particles Enhancement of reuterin 
production 
Lui and Yu, 2015 
Lactobacillus reuteri 
DSM17938 
Alginate-CaCl2 Improvement of cell viability 
during storage  
De Prisco et al., 
2015 
Lactobacillus gasseri and 
Bifidobacterium bifidum;  
Lactobacillus plantarum 
TN8 
Chitosan-alginate-CaCl2 Improvement of cell viability 
during GI simulated transit 
Chávarri et al., 
2010; Trabelsi et 
al., 2013 
• Development of new foods 
Lactobacillus rhamnosus 
GG; Bifidobacterium 
animalis BB-12 
Whey proteins; cellulose 
acetate phthalate  
Probiotic fruit juices Doherty et al. 
2012; Antunes et 
al., 2013 al.,  
Lactobacillus reuteri DSM 
17938 
Chitosan coated alginate-
CaCl2 
Probiotic chocolate soufflè  Malmo et al., 2013 
Lactobacillus casei ATCC 
39392 
Calcium alginate-resistant 
starch 
Probiotic cream filled cake Zanjani et al., 
2012 
 
2.2 Generalities on microencapsulation technology 	
As previously mentioned, microencapsulation technology evolved  from the principle of cell 
immobilization. In broader sense, microencapsulation can be defined as the technology of 
holding sensitive compounds in/onto functional matrices as illustrated in Fig. 2.1. This 
research focused mainly on the aspects of entrapment and containment procedures. In the 
practice, microencapsulation step includes the complete envelopment of pre-selected core 
materials in either liquid, solid or gaseous phase within a defined natural or synthetic porous 
or impermeable membrane by using different techniques (De Vos et al., 2010; Whelehan and 
Marison 2011). 
 
 
Fig. 2.1 Types of cell immobilization techniques. Image by Abbel-Rahman et al., 2013 
The products that comes from microencapsulation procedure are the microcapsules, solid 
particles that can differ for their size (Fig. 2.2) and morphology (Fig. 2.3) depending on 
materials and techniques applied to produce them.  Capsule size varies and range from macro 
(>1000 µm), micro (1-1000 µm) or nano (<1 µm) ranges. Encapsulation technology applied to 
microbial cells, which are typically 1-4 µm in size, is usually referred to as microencapsulation 
(Gawkowski and Chikindas 2013). According to their morphology, microcapsules can be 
classified in five main different types (Gharsallaoui et al. 2007; Solanki et al., 2013) as 
illustrated in Fig. 2.3.  In the “core-shell” or “reservoir” microcapsule type, cells or other 
sensitive compounds are retained in the core of the capsules completely surrounded by a 
continuous entrapping membrane. Both the diameter of the core and the thickness of the 
membrane can vary. In the case of the “multicore” system the encapsulated ingredients form 
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two or more aggregations, as usually occurred in emulsification techniques (Whelehan and 
Marison 2011). When capsules are not characterized by a well-defined and spherical 
morphology they are defined “irregular” shaped. 
 
 
Fig. 2.2 Capsule size ranges for main techniques used in cell 
encapsulation for food and pharmaceutical application. Image by 
Solanki et al., 2013. 
 
 
 
 
Fig. 2.3 Different types of microcapsules used in food industry. Image by 
Solanki et al., 2013.  
 
 
In “matrix” type microcapsules, a physical separation of the encapsulating agent and the 
encapsulated ingredient does not exist since the latter is homogeneously dispersed to create a 
network with the encapsulating agent so that it is present in the entire microcapsule area. All 
microcapsule types reported above can be coated by applying a further layer of a coating agent 
that can create bonds with capsule material due to physical or chemical reactions; resulting 
particles can be referred as “multiwall” microcapsules. Besides capsule sizing, microcapsules 
morphology is an important parameter to be tailored during cell encapsulation, since it is 
reasonable a correlation between microcapsule morphology and their performances.  
The different types of microcapsules are produced from a wide range of wall materials and by 
a large number of different microencapsulation processes including spray-drying, spray-
cooling, spray-chilling, air suspension coating, extrusion, centrifugal extrusion, freeze-drying, 
coacervation, co-crystallization, liposome entrapment, interfacial polymerization, emulsion or 
micro-channel and membrane emulsification. (Anal & Singh, 2007; Gharsallaoui et al., 2007; 
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De Vos et al., 2010). Among these, extrusion, emulsion and spray drying techniques in 
particular are the most suitable to be scaled-up for industrial production of cell microcapsules 
(Burgain et al., 2011). Many comprehensive reviews (Anal & Singh, 2007; De Vos et al., 2010; 
Rokka and Rantamäki, 2010; Corona-Hernandez et al., 2013; Martín et al., 2015) have already 
dealt with major aspects of microencapsulation techniques, including methodologies and 
materials used for cell encapsulation. Therefore, this section of the thesis will only provide the 
most relevant information about materials (alginate, chitosan and xanthan gum) and technique 
(vibrational nozzle technology) selected for the present research. 
  
2.2.1 Encapsulation techniques: a focus on vibrational nozzle technology 
Although it is impossible to declare the most suitable technology in the field of cell 
encapsulation, spray drying, emulsion and extrusion are the most common microencapsulation 
techniques applied to living cells, despite many inherent disadvantages. Spray drying is the 
most widely utilized technique and it is cheap and easy to be scaled-up; however, it entails the 
application of high temperature that very often lead to the damage of cells (Anal and Singh 
2007), with the consequent loss of bacteria viability and resistance during their further 
utilization. Even though emulsion is a simply and easy to scale-up technique and it does not 
induce cell mortality, it is an expensive method that produces varying size and shape of 
microcapsules (Burgain et al. 2011). Furthermore, it requires additional steps to remove 
residues of oil used during the process. With respect to extrusion, it is a simple and cost-
effective way to manufacture homogeneous-shaped capsules with a narrow size distribution, 
which could be designed for mass production of microcapsules; furthermore new systems 
based on extrusion principles to adapt microcapsule production to industrial scale are being 
developed (Burgain et al., 2011; Whelehan and Marison 2011).  
Microencapsulation via extrusion technique is based on the principle of generating droplets 
from the extrusion of polymer matrix used as encapsulating agent, previously mixed with the 
ingredient to be encapsulated (here called cell-polymer suspension), through a nozzle of 
different diameter. By coupling this base-process of extrusion to mechanical means such as 
vibration forces it is possible to increase and tailor the normal dripping process at the orifice.  
The technology based on extrusion and vibration forces is the vibrational nozzle technology 
or vibrating technology and its potential use in living cell encapsulation has been considerably 
investigated (Brandenberger and Widmer,, 1998; Heinzen et al., 2004; Mazzitelli et al., 2008).  
In the vibrating technology controlled application of vibrational/oscillation frequency causes 
the break of the laminar jet produced when the cell-polymer suspension is extruded through a 
nozzle at certain flow rates (Whelehan and Marison 2011). Due to the action of surface 
tension forces, broken segments from the flow stream form spherical droplets. The 
characteristics of the droplets  depend on the nozzle diameter, the flow rate, the intensity of 
vibration frequency (at defined amplitude), viscosity of the liquid extruded (Serp et al. 2000) 
and the distance between the outlet and the polymerizing solution (Anal and Stevens 2005). 
By applying a permanent sinusoidal force at a defined frequency level to the cell-polymer 
suspension jet stream, the break-up of laminar jets can be controlled to form one droplet with 
uniform, equal size per hertz of applied frequency (Rayleigh 1879) as depicted in Fig. 2.4.  
Vibrating technology has been recently reported as a suitable technology for the production of 
mono-dispersed, uniform in shape and size microcapsules for food and pharmaceutical 
application using a short time for capsule production (Whelehan and Marison 2011). 
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Fig. 2.4 Controlled break-up of a laminar liquid jet into droplets of 
equal size. (Heinzen et al. 2004; Whelehan and Marison 2011). 
 
 
Since the use of solvent or other chemicals is not required, it is particularly suggested for cell 
encapsulation (Graaf et al., 2008; De Prisco et al., 2015) as well as for other food ingredients 
such as polyphenols and, in our laboratory, bacteriocins (Aizpurua-Olaizola et al., 2016; 
Maresca et a., 2016). Recently, a new device, the Encapsulator B-395 PRO, implementing the 
vibrational nozzle technology has been developed by BÜCHI (BÜCHI Labortechnik, Flawil, 
Switzerland).  The device is additionally equipped with an electrostatic dispersion unit, 
designed to negatively charge the droplet surface immediately after their extrusion. The 
repulsion forces generated among the droplets due to the equally charged surface let the 
particles to repel each other, dropping separately in the polymerising bath. The electrostatic 
charge generator avoids the formation of capsule coalescence and permit the recovery of 
microcapsule population free from agglomerates. Schematic illustration of cell encapsulation 
according to the vibrational nozzle technology is presented in Fig. 2.6. Living cells or other 
ingredients to be encapsulated are mixed with the polymer selected as encapsulating agent (1) 
before being feed to the instrument by the delivery apparatus i.e. precision syringe pump (2) 
or a pressure bottle system. Feeding rate, measured in ml/min, can be regulated by the 
“pump” function for the syringe pump system (0-60 ml/min), while when the pressure bottle 
system is used as feeding system the feeding rate is calculated as function of the pressure 
applied to force the cell-suspension (0.1-1 bar). To break down the cell-suspension liquid jet 
into droplets of equal size, the polymer passes through a pulsation chamber (3) before 
reaching the nozzle. The intensity of membrane vibration can be regulated with the 
“frequency” function, measured in Hz (0-6000 Hz). According to the supplier instruction, 
number of vibration per second leads to the formation of as many particles per sec. Droplets 
are further extruded thanks to the passage to a nozzle (4) with a different diameter (80 to 1000 
µm). Alginate solution concentration up 2.0% can be used for producing alginate 
microspheres. Final bead diameter is approximately twice of the nozzle diameter but bead 
dimensions may vary within a certain range by controlling frequency of the vibration, the 
feeding rate of the cell suspension and finally the intensity of electrostatic forces imposed, 
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allowing the production of smaller capsules as mentioned before (Serp et al. 2000; Heinzen et 
al. 2004; Whelehan and Marison 2011). 
 
 
Fig 2.6 Functional principle of vibrating technology using Buchi Encapsulator B-395 Pro (BUCHI; 
Switzerland; De Prisco et al., 2015). 
 
 
Optimal parameters of processing depends mainly on the chemico-physical characteristics of 
the substances used. A strong negative charge introduced by an electrode placed directly 
beneath the nozzle (5) causes the droplets to repel each other, resulting in the opening of the 
linear liquid jet into a cone-like shape (6), preventing the possible coalescence of the droplets. 
The magnitude of the charge necessary for satisfactory separation of the chain is heavily 
reliant on jet velocity, droplet diameter and concentration of the polymer solution used 
(Whelehan and Marison 2011). It is controlled by the “electrode” function and can be set 
between 0 and 2500V. Droplets are further let to harden in a polymerizing solution (7), usually 
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CaCl2 solution for alginate beads, to be finally recovered by a draining system (8). What above 
reported can also serve as a scheme for the production of alginate matrix microcapsules. 
Another important element of the Encapsulator device is a concentric nozzles system which 
makes the instrument suitable for production of core-shell microcapsules. The inner part of 
the capsule, the core, can be extruded through a set of nozzles with different diameters within 
a range of 80-1000 µm. The outer nozzle serves for the extrusion of shell, usually made of a 
polymer agent such us alginate. For this purpose, a set of nozzles with diameter ranging 
between 200 and 1000 µm can be used. Both matrix and core-shell microcapsules can be 
coated with an additional layer (e.g. alginate, chitosan or poly-L-lysine, Fig. 2.7) to improve 
microcapsule mechanical strength and limit the diffusion of the encapsulated agents towards 
the outer environment and the diffusion of external compounds into the capsules. 
 
2.2.2 Microencapsulating and coating agents: alginate and chitosan  
Despite the wide array of encapsulation techniques and materials available, living cells require 
the most gentle technology such extrusion in combination with suitable encapsulation agent 
that might preserve the functionality or even promote the functionalities for probiotics (de 
Vos et al. 2010).  Among all materials, the most widely used for manufacture of microspheres 
and microcapsules for food applications include natural materials such as proteins (whey 
proteins), carbohydrates (starch and maltodextrin), lipids (hydrogenated fat), acacia (Arabic) 
gums, cellulose or synthetic polymers (Nedovic et al., 2011; Whelehan & Marison, 2011).  
 
 
Fig 2.7 Steps for alginate cell-microcapsules milti-coating with poly-L-lysin and alginate. Similar procedure 
can be followed with other coating agent such as chitosan (BUCHI, Switzerland).  
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Moreover, the most widely used matrices used alone or in combination for encapsulation of 
living cells are alginate, chitosan, poly-l-yisne, whey protein, pectin, xanthan gum, carrageenan, 
carboxymethyl cellulose, gelatin, locust bean gum, resistant starch and gellan gum (Gbassi et 
al. 2011; Rodrigues et al. 2011; Rokka and Rantamäki 2015).  
The vibrating technology has mainly focused on using alginate as the encapsulation matrix for 
several applications (biotechnological and medical), but some other polymers such as gelatin 
and cellulose sulphate have also been applied.  
Alginate is a water-soluble gelling polysaccharides recognised as safe (GRAS) for human 
consumption by the Food and Drug Administration, FDA (George and Abraham 2006).  It is 
found in great abundance as part of the cell wall and intracellular material of brown seaweeds 
(Phaeophyceae). Alginate is also produced by two families of heterotrophic bacteria 
(Pseudomonadaceae and Azotobacteriaceae) and its extraction is carried out often under strict 
regulatory control (Yian Wong et al., 2000). It is is composed of alternating blocks of 1–4 
linked α-L-guluronic (G-blocks) and β-D-mannuronic (M-blocks) acid residues as illustrated in 
Fig 2.8 
 
 
 
 
Fig. 2.8 Chemical structure of alginate 
 
Both the arrangement of the monomers within the block structure and the size of the alginate 
affect the gel-forming ability, viscosity of the polymer and also three-dimensional 
macromolecular structures (Yian Wong et al., 2000). Since the gelation that permit the 
hardening of capsules made of alginate occurred by addition of divalent or monovalent ions 
(e.g. calcium ions) that link to the carbossilic residues of the G blocks, the higher the 
proportion of these, the greater the gel strength. The large use of alginate in 
microencapsulation is owing to the fact that it is an easy to prepare, cheap and safe material 
that easily forms gel matrices around the cells and mild process conditions (such as 
temperature) are needed for their performance; furthermore, especially when used in 
combination with chitosan it shows a gastric-resistant behaviour and it properly dissolves in 
the intestine and releases entrapped cells (Chávarri et al. 2012; Cook et al., 2013). Chelating 
compounds such as phosphate, citrate, EDTA and lactate, or other anti-gelling cations like 
Na+ or Mg2+ which are naturally found in biological and bioprocessing environments can 
destabilize alginate gel, and in some cases trigger the total dissolution of gel network structure 
leading to the complete release of the encapsulated ingredients (Gombotz and Fong Wee, 
1998; 2012). These chemical reactions are used in laboratory practice to obtain the artificial 
breakdown of alginates. However, alginate’s major disadvantage is its inherent low mechanical 
stability especially in acidic environment. The mechanical properties of alginate microspheres 
can be enhanced by intensifying alginate concentration but this will lead to an exponential 
increase in its viscosity, which can limit extrusion of the alginate through the nozzle 
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(Whelehan and Marison 2011). For example, doubling the concentration of some alginate may 
result to a 10-fold increase in the viscosity of the alginate solution (Stark et al. 2002; Del 
Gaudio et al. 2005). For this reason, in order to increase the mechanical stability and 
protective ability of the capsules, alginate is usually used in combination with chitosan, mainly 
used as coating agent or in combination with other polymers used as filling agent (e.g. xanthan 
gum or Guar gum) added to alginate solution prior to the encapsulation process.  
 
The second most abundant natural polymer after cellulose is the cationic polymer, chitosan. It 
is extracted as α-chitosan from chitin, the crab- and shrimp shells primary structural 
component (Shepherd et al. 1997). Chitosan is a linear co-polymer polysaccharide consisting 
of β (1–4)-linked 2-amino-2-deoxy-D-glucose (D-glucosamine) and 2-acetamido-2-deoxy-D-
glucose (N-acetyl-D-glucosamine) units (Fig. 2.9). The proportion of N-acetyl-D-glucosamine 
and D-glucosamine residues usually determines its properties, biodegradability and biological 
role. This polymer can have diverse extent of diacetylation and it can be classified in terms of 
the percentage of primary amino groups in the polymer backbone, and molecular weight. 
Typical commercial chitosan usually has a DD of 70%-95%, and an Mw of 10-1000 kDa. 
 
 
 
 
Fig. 2.9 Chemical structure of chitosan (George and Abraham, 2006). 
 
Because of its unique polymeric cationic character of chitosan, electrostatic bindings between 
amino groups of chitosan and carboxylic groups of alginate can be formed obtaining strong 
gels with suitable physic-chemical characteristics. Furthermore for its good biocompatibility, 
non-toxicity and biodegradability, chitosan is gaining importance in the food and 
pharmaceutical field (Anal and Singh 2007). However, chitosan’s antibacterial activity may 
pose a threat to the viability of probiotic bacteria. Due to this concern, and due that chitosan 
has a very good film-forming ability (Chávarri et al. 2012) but weak mechanical properties 
when used alone (Anal et al. 2003), chitosan is more used as an external shell in capsules made 
with anionic polymers like alginate (Anal et al. 2003) to form desired capsules (Riddle and 
Mooney 2004). This application of chitosan can improve the survival of the probiotic bacteria 
during storage and also in the gastrointestinal (GI) tract (Zhou et al. 1998; Capela 2006; De 
Prisco et al., 2015), and therefore, it is a good way of delivery of viable bacterial cells to the 
colon (Chávarri et al. 2010).  
 
2.3 Microencapsulation of microbial cells  
Thanks to the great versatility of microencapsulation due to the research and development of 
modern techniques and materials, this technology has been applied to many different 
microorganisms for as many purposes. As also showed in 2.1, even though the use of 
encapsulated cells have been explored also in fermentation and environmental 
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protection/decontamination, nowadays the sector of probiotic encapsulation seems to be the 
most attractive and of commercial success in food industry (Rathore et al., 2013). 
 
2.3.1 Probiotics 
According to the definition of the Expert Committee FAO/WHO (2001), probiotics are 
commonly defined as  “live microorganisms which, when administered in adequate amounts, 
confer health benefits on the host”. Belonging mainly to Lactic Acid Bacteria (LAB), some 
probiotics have a long history of traditional use in the production of dairy fermented foods 
such as yoghurt, korut and kefir. To date, the latest evidences of their healthy effects on 
humans and animals are driving the modern forward looking research on probiotic functional 
properties in order to broader their application both in food and pharmaceutical field (De 
Prisco and Mauriello, 2016). That of probiotic health benefits is an area of intensive research 
in different domains that, according to the target sites and mechanism of action could be 
distinguished in intestinal and extra-intestinal (De Prisco and Mauriello, 2016). As a matter of 
fact, probiotics showed the best evidences of their efficacy in maintenance and restoration of 
the normal intestinal microflora and in the treatment and prevention of enteric infections and 
post-antibiotic syndromes in adults and children (Prantera et al., 2002; Sazawal et al., 2006). 
Additional evidences about the beneficial action of probiotic on the gastro-intestinal tract are 
related to the improvement of lactose metabolism (REF), prevention and treatment of 
inflammatory bowel disease and irritable bowel syndrome and to their efficacy as co-adjuvant 
for the current Helycobacter pylori eradication treatment (Camilleri, 2006; Hedin et al., 2007; 
Ruggiero, 2014). Among extra-intestinal effects, some promising outcomes in the use of 
probiotics have been individuated in the reduction of serum cholesterol level and blood 
pressure, reduction in the incidence of respiratory diseases, prevention of some cancers and 
treatment of urogenital diseases and bacterial vaginosis in women (Falagas et al., 2007; Khan 
et al., 2012). Although each probiotic effect is strictly related to a strain specific action and to a 
definite metabolic function, a general mechanism correlated to the beneficial action of 
probiotic has been delineated. This general mechanisms for probiotic Lactobacillus have been 
reviewed by Lebeer et al. (2008) and have been individuated in: a) adaptation mechanisms, 
related to probiotic cell ability of adaptation and colonizing the host; b) in probiotic 
mechanisms, mediated by an immunomodulatory effect (interaction and stimulation of host 
immune system), a microbe-microbe interaction at the bases of pathogen inhibition and in the 
epithelial barrier protection (Fig. 2.10).  
 
2.3.1.1    Probiotic foods, health claims and labels 
The reported evidences for the impact of probiotics on many end points of human health is 
driving the commercial development of products containing them (De Prisco and Mauriello, 
2016). Indeed, probiotic food products comprise between 60 and 70% of the whole functional 
food market (Tripathi and Giri, 2014). The growing consumption of probiotic 
microorganisms includes foods (nutraceuticals or functional foods), food ingredients and 
supplements. It is common for probiotic products to be marketed on the premise that they 
have an important effect on the intestinal microbiota. Their most commonly reported claim 
“its consumption promotes the balance of the intestinal microflora” did not configure as a 
health claims rather than a structure/function claim because it is referred to a physiological 
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effect of the normal, not diseased, structure or function of the human body (Sanders, 2009). 
According to Rijkers et al. (2010) although a great number of health claims applications, often 
supported by high quality research on taxonomic, functional and clinical data, have been 
submitted at European Food Safety Authority (EFSA), no favourable opinion have been 
issued despite many biological evidences proved for many probiotic strains during in vitro and 
in vivo test. Also in the United States the Food and Drug Administration (FDA) has not yet 
approved any health claim for probiotic strains or products. Certainly, the scientific data to 
support health claims for probiotic products are often difficult to be collected and, 
consequently, to be provided (Farnworth, 2008). 
 
 
 
Fig. 2.10 General mechanisms of action of probiotic lactobacilli. Image by Lebeer et al., 2008. 
 
It is also worth underline that the lack of proper evidence-based studies might be related to 
fact that clear guidelines to be followed by scientific research groups during the preparation of 
clinical trials are not still available. Instead, probiotic foods received FOSHU approval (Food 
for Specific Health Use) in Japan, thus they are regularly considered as products having 
beneficial effects on the physiological functions of the human body in maintaining and 
promoting health, and improving health-related conditions. In particular, foods carrying 
beneficial bifidobacteria and LAB have been included in the segment of foods helping the 
modification of gastrointestinal conditions. Health claims on FOSHU correspond to other 
function claims of the Codex Alimentarius or structure/function claim in the United States 
(Yamada et al., 2008) and, in alignment with foreign jurisdictions, claims on reduction of 
disease or disease risk are not allowed for probiotics. About the dose of assumption, no 
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specific cell load is recognized to guarantee a health effect even thought a dose of 109 
CFU/die is generally recommended. At this regard, it is paramount that cell probiotic load and 
composition comply with food labels. In fact, a serious weakness in the field of probiotic 
products is that the viability of the bacterial strains involved does not reflect what is reported 
on the label about the live microorganisms assumed with the food. From an exploration of the 
global market it raised that the currently employed probiotic strains exhibit little or no survival 
in final goods, showing cell loads lower than they are labelled, so the quality of the foods that 
carry them are still scarce (Corona-Hernandez et al., 2013).  
 
2.3.1.2 Microencapsulation: a possible tool to overcome technological hurdles 
A wide range of foods including fermented and non-fermented dairy products, ice creams and 
frozen desserts, fruit juices, peanut butter, cereal-based products, reduced fat (bio)spread have 
been enriched in probiotics to be evaluated as possible carriers of these beneficial 
microorganisms and to be placed on the market (Charteris et al. 2002, Klu et al., 2014; Molin, 
2001; Sheu et al., 1993). To date, among the probiotic foods available on the market, 
fermented and non-fermented dairy products are still the most consumed by population. Most 
common probiotic strains added to foods belong to several species of Lactobacillus and 
Bifidobacterium, but also a yeast, Saccharomyces cerevisiae (boulardi), is used. Other genera 
(Enterococcus, Bacillus, and Escherichia) include strains recognized as probiotics but their 
main use is for food supplement production (Douglas et al., 2008; Santosa et al. 2006). 
Different factors that could affect microorganism behaviour and robustness into the different 
food environments have to be considered because they can interfere with the essential 
requirement of probiotics to achieve the intestine alive and metabolically active. Some are 
intrinsic, for example the type of culture selected, growth stage, subcellular injuries by heat or 
osmotic stress. The extrinsic factors are composition of food matrices, pH value, oxygen level, 
food manufacturing conditions and storage time (Reid et al., 2007; Soukoulis et al., 2014b). Ad 
example in Fig. 2.11 are reported the adverse factors affecting probiotic viability during cheese 
manufacture. Therefore, also the loss in probiotic viability during gastrointestinal transit, 
where the principal stressors are the shifting pH and bile, is to be considered as a hurdle that 
probiotics have to overcome to fulfil their biological role. At this regard, different strategies 
which improve probiotics technological and gastrointestinal robustness have been applied to 
get “super-fit” bacteria; careful selection of strains with highest native technological attitude, 
use of cell-protectants, strain adaption to a sub-lethal dose of a specific physical or chemical 
stress, genetic manipulation (Guidemond and Sànchez, 2012; Mills et al., 2011) as well as 
technological approach dealing with the inclusion of probiotics in edible films (Soukoulis et 
al., 2014a) or their microencapsulation (Anal and Singh, 2007; De Vos et al., 2010; Rokka and 
Rantamäki, 2010). Microencapsulation of bacterial cells has been described by some authors 
(O’Riordan et al., 2001; Anal and Singh, 2007; Sohail et al., 2012) and the main purpose, or at 
least, the most investigated aspect until now, is the protection of the cells under 
gastrointestinal conditions.  
Microencapsulation of bacterial cells has been described by some authors (O’Riordan et al., 
2001; Anal and Singh, 2007; Sohail et al., 2012) and the main purpose, or at least, the most 
investigated aspect until now, is the protection of the cells under gastrointestinal conditions. 
Yet despite, another challenge of microencapsulation is to protect probiotic cells in foods 
usually not considered as their vehicle such as bakery products (Malmo et al., 2013). 
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Microencapsulation, apart to the aforementioned effects, could offer many advantages in 
enhancing the handling of probiotic cultures as well as the masking of taste and aroma given 
by production of different metabolic compounds (e.g. acetic acid) produced during 
fermentation in foods where they are not required. Additional important aspect is the efficacy 
of encapsulation in improving probiotic survival after their inclusion in powdered formula 
where there is the detrimental effect of low water activity and oxygen exposure (Weinbreck et 
al., 2010).  
 
 
 
Fig. 2.11 Main factors affecting viability of probiotic bacteria in cheese. Image by De Prisco and 
Mauriello, 2016. 
 
Selection of capsule materials as well as the technologies adopted in the fabrication of tailored 
probiotic microcapsules is of paramount importance because it strictly reflects the final 
morphological and functional properties of the capsules. Materials themselves play an 
important role in determining size, morphology, texture, porosity and other relevant 
properties of the capsules influencing the success in protecting or in targeting the delivery of 
probiotics. Certainly, food-grade biopolymers (i.e. alginate, chitosan, pectin, starch, 
carrageenan and milk proteins) are the most investigated and used matrices for cell 
encapsulation because of their effectiveness in protecting probiotics under several stress 
conditions (e.g. gastric pH, bile salts, enzymes) by working as real physical barriers or by 
exercising a buffered action, for example during the fermentation process. Their availability, 
low cost and biocompatibility are relevant requirements as well. Among the technologies 
applied for capsule production, emulsion, spray drying and extrusion are the most studied and 
applied on both laboratory and industrial scale. However, new technologies as complex 
coacervation (Bosnea et al., 2014) and vibrational extrusion technology (De Prisco et al., 2015) 
are emerging with promising results about cell entrapment efficiency, goodness of capsules in 
terms of morphological and functional properties as well as their scale up. Even thought the 
microencapsulation is the main system to preserve probiotic viability against different stressors 
encountered during processing and storage of foods, few works investigate the functionality of 
microcapsules in protecting cells during their application in some foods (e.g. bakery and 
fermented meat products). May be as a consequence, non-dairy foods still represent only a 
niche in the market of probiotic foods.  As recently reviewed by De Prisco and Mauriello 
(2016), the application of encapsulation to probiotic cells contributed to the research 
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development of conventional and non-conventional probiotic products. Some applications of 
encapsulated probiotics in bakery, meats, fruits and vegetables and dairy products have been 
reported in Tab. 2.2. 
 
Table 2.2 Food products functionalized by addition of probiotic microcapsules within several food categories 
 
 
2.3.2 Starter Cultures 
 
Despite the great interest reserved in the last years to the encapsulation of probiotics, 
microencapsulation of bacteria used to lead food fermentations or for the recovery of 
metabolites (e.g. ethanol, lactic acid) is another interesting subfield of cell encapsulation 
Bakery Products 
 
• Bread (Altamirano-Fortoul et al., 2012; Soukolis et al., 2014); 
• Biscuits (Reid et al., 2007); 
• Chocolate soufflé (Malmo et al., 2013); 
• Stuff cakes (Zanjani et al., 2012) 
Meat derivatives  
 
• Fermented sausages (Kearney et al., 1990; Muthukumarasamy and Holley, 2006; Sidira et al., 2014) 
Fruit and vegetable juices 
 
• Raspberry (Anekella and Orsat, 2013); 
• Acerola nectar (Antunes et al., 2013); 
• Longan (Chaikham et al., 2012 and 2013); 
• Cranberry (Doherty et al., 2012;  Nualkaekul et al., 2013); 
• Pomegranate (Doherty et al., 2012; Nualkaekul et al., 2012); 
• Berry (Fratianni et al., 2014); 
• Carrot (Ivanovska et al., 2014); 
• Orange (Krasaekoopt and Watcharapoka, 2014; Rodrigues et al., 2012); 
• Peach (Rodrigues et al., 2012); 
• Apple (Ying et al., 2013) 
Dairy products 
 
Yoghur t  
• Plain yoghurt from bovine milk (see De Prisco and Mauriello, 2016); 
• Plain yoghurt from buffalo milk (see De Prisco and Mauriello, 2016); 
Cheese  
• Feta (Kailasapathy and Masondole, 2005); 
• Cheddar (Amine at al., 2014; Fortin et al., 2011); 
• White Iranian brined cheese (Mirzaei et al., 2012; Zomorodi et al., 2011); 
• White brined cheese (Ozer et al., 2009); 
• Kasar (Ozer et al., 2008); 
• Mozzarella (Ortakci et al., 2012); 
• Fiordilatte (Minervini et al., 2012); 
• Pecorino (Santillo et al., 2014); 
• Oxaca (Rodríguez-Huezo et al., 2014). 
Other food products 
• Ice cream (Champagne et al., 2015; Homayouni et al., 2008); 
• Mayonnaise (Khalil and Mansour, 1998); 
• Maize fermented beverage (McMaster et al., 2005); 
• Soured milk fermented beverage (McMaster et al., 2005). 
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(Westman et al., 2012).  Both immobilization and microencapsulation of LAB have been 
suggested to improve fermentations in meat derivatives and dairy sector due to effect of 
preservation of cell viability, the reuse of starter cultures (Groboillot et al., 1994; McLoughlin 
and Champagne, 1994) and an easier recovery of cell-free metabolites. On the contrary, the 
use of microcapsules to improve the fitness of starter cultures and the comparison between 
fermentation performances of cells in free or microencapsulated form are still scarcely 
investigated. Similarly, also the study of the metabolism of microencapsulated bacteria is 
poorly explored. Encapsulation can influence cell growth and metabolism due both to the 
close contact among cells and to an increased diffusion resistance that may lead to nutrient-
limited condition into the capsules (Westman et al., 2012;). Moreover, this condition could 
affect more strongly cells in the inner part of capsules rather than that located in the external 
part because of their increased contact with nutrients in the environment. In the same way, an 
increased contact with toxic substances, stressors and metabolites from fermentative process 
can involve cells on the outer layers of capsules, leading to their higher death rate. All this 
factors obviously can lead to variation in cell physiology. So, it is crucial to monitor the 
changes in the microenvironment as well as the external environment, and investigate their 
effects on the cells and on the biotechnological process of interest. Currently, few experiments 
have been carried out to explore physiology and metabolic behaviour of microencapsulated 
cells and most of them concern Saccharomyces cerevisiae and in general yeasts involved in ethanol 
production. To better understanding cell metabolism total carbohydrates, RNA, proteins, and 
two important carbohydrate reserves (glycogen and trehalose) of encapsulated Saccharomyces 
cerevisiae were analysed for the first time by Talebnia and Taharzadeh (2007). Also the 
fermentative capacity of encapsulated cells was monitored. They found that total cell proteins 
and RNA content decreased during 20 continuous fermentation cycles while ethanol 
production slightly increased. However, the most relevant finding is the discovering of higher 
accumulation in the cytosol of encapsulated cells of glycogen and trehalose, important 
reserved carbohydrates accumulated by cells when starvation and environmental stress occur. 
This corroborates the fact that encapsulated cells actuate some important metabolic changes. 
These modifications in metabolism surely are at the base of the enhanced cell viability that 
thus, is not only due to physical protection of capsules membrane that limits the diffusion of 
inhibitors. Two contributing reasons for increased tolerance were proposed by Westman et al., 
2012a; i) the ability of cells in the cell pellet inside the capsule to convert inhibitors to less 
inhibitory compounds, leaving a less inhibitory medium to the interior cells, ii) the partially 
nutrient-limitation that interests encapsulated cell that triggers the environmental stress 
response which in this case is favourable since it likely increases the general tolerance toward 
further stress. These findings have also been supported by proteomic analysis revealing higher 
levels of several stress-related proteins as well as of proteins specifically important for the 
defence against inhibitors item of the study (Westman et al., 2012b). Food sectors that better 
exploited the advantages in the use of immobilized cultures are the ones of wine and brewing.  
In this context, the use of many yeast and lactobacilli strains in immobilized form permitted to 
production of alcoholic beverage with improved quality and sensorial properties where target 
metabolism such as the malolactic fermentation can be controlled (Nedovic et al., 2014).  
Finally, the current literature shows the potential of immobilization of cell cultures and of 
yeasts in particular as an important tool for the food sector, for carrying out optimized 
fermentations by high cell density, the improvement of metabolites production and reuse of 
biocatalysts as well as reduced risk of microbial contamination and physical and chemical 
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protection of the cells from fermentative harsh environment. Besides this premise, additional 
studies are needed to promote the industrial application of immobilized/encapsulated cells 
aimed at the developing of suitable and scalable encapsulation systems, the study of 
interaction between the precursors of the food matrices and cells and of related kinetics and 
finally the exploitation of encapsulated cell metabolism.  
 
 
2.4    Market availability of microencapsulated cells for industrial application 
 
According to a recent global industry analysis, the value of the global probiotic market, in 
strong growth from 2008, is predicted to get better until to exceed about 34 billions € (37.9 
billions $) in 2018 (Global Industial Analysis, 2013). The most of foods (including beverages) 
available on the market are enriched with free probiotic bacteria while only a small part 
contains probiotics in microencapsulated form. Among the latter, especially supplements are 
formulated with microencapsulated cultures, although in the wake of the intense scientific 
research carried out in the last decades to promote the food industrial applications of 
microcapsules, it is likely to witness a remarkable growth of foods containing them. In a work 
of 2011, Champagne and Kailasapathy (2011) reviewed the situation of products available on 
the market delivering microencapsulated probiotics. Even thought some notices about use of 
microcapsules from some food companies (Agropur, Kraft, Micropharma Inc. and Yoplait 
Inc.) for the functionalization of dairy product have been reported, to the extent of our 
knowledge, through an accurate exploitation on Internet, no products claiming to contain 
microencapsulated probiotics have been found. However, it should be highlighted that 
application of microcapsules in foods is not necessarily declared in label or advertised. 
Curiously, two products constituted by chocolate (ProBiotic bites) and cereals (YogActive 
plus) beads surrounding probiotic cells have been launched on the market. Obviously, because 
they appear like big size capsules they cannot be considered microcapsules. In this on-going 
scenario, the interest on the application of microencapsulation technology in food production 
from some enterprises is arising. Although many enterprises headquartered in Europe, 
especially Northern Europe, are mastering on probiotic microcapsules enhancement and 
selling, the application of microencapsulated probiotics in food is far from being a real 
industrial business. However, as above reported, it should be highlighted that functional food 
producers do not necessarily declare on labels the application of encapsulated probiotics. 
Vesale Pharma is one of the most known producers of probiotic food supplements, which on 
January 2011 filed the Intelicaps® patent, a technology based on gentle extrusion process for 
production of stable probiotic microcapsules having a diameter of 150-600 µm and promising 
to resist to many adverse conditions. Another one is the French Capsulae, a research and 
development enterprise that offers customized solutions in the field of microencapsulation. 
Even Lallemand, a well-known biomass producer enterprise, has a Health Solutions Division 
where a patented probiotic microencapsulation technology, the Probiocap®, has been 
developed. It could be interesting to investigate the reasons why, although the extensive 
research and the presence of enterprises in the arena, the microencapsulation of probiotics is 
not usually practiced for developing of probiotic foods. Our opinion is that, like in other 
fields, more spreading of scientific results towards industry should be performed in order to 
offer for example new business chances in the production of desirable and currently 
unavailable probiotic foods like bakery products or instant hot beverages. Accordingly, the 
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European Patent n. 2451300 A1 describes compositions of heat resistant probiotic capsules. 
Furthermore, the invention relates to the health food products, particularly to bakery probiotic 
products. As already noted by Cheow and Hadinoto (2013), the method described in this 
patent seems to be too tricky and lengthy due to multiple coating procedures that can be 
costly upon scale-up. Proenol in Scott Laboratories developed ProElif®, an encapsulated yeast 
product for sparkling wine production. Yeasts are encapsulated in double alginate layer and 
are sold on he premise that they can be directly inoculated into the bottle, eliminating the need 
to prepare a starter culture, ensuring ensure the control of the number of cells per bottle and 
facilitating cells removing from wine. ProRestart and ProDessert are other commercialized 
encapsulated yeasts for winery industry. These products contain yeast cells encapsulated in 
alginate that are also acclimatized to alcohol and other harsh conditions. Unfortunately, no 
data about commercial availability of more encapsulated starter culture seem to be available. 
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CHAPTER 3 
 
Validation of microencapsulation of living cells 
by vibrating technology 
	
	
3.1 Introduction 
 
Microencapsulation of living cells is becoming a very diffuse technique in several fields of 
biosciences including medicine (Blasi et al., 2013), nutraceutical sciences (Burgain et al., 2011) 
and food technology (Rodrigues et al., 2012; Malmo et al., 2013). Particularly, in the field of 
probiotic cells, microencapsulation serves as a strategy to i) improve their viability during their 
processing and storage, ii) to protect their viability and metabolic activity during GI transit and 
iii) to contribute to the development of new functional food products. Despite of a wide 
choice of encapsulation technologies and materials, living cells require gentle techniques and 
one of this is the extrusion (De Vos et al., 2010). This last is evolved in the vibrating 
technology, as recently described by Whelehan and Marison (2011). This is an almost new 
technology, developed before in the Inotech laboratories and then in the Buchi ones. Even 
though this technique was used for the first time in 1985 by Hulst et al. (1985) and some other 
authors used it in the last three decades (Brandenberger and Widmer, 1998; Serp et al., 2000; 
Mazzitelli et al., 2008; Dorati et al., 2013), only few works (Martoni et al., 2008; Shi et al., 
2013) described the microencapsulation of bacterial cells by using the vibrating technology. 
The aims of this work were to assess the effectiveness of bacterial cell microencapsulation 
using vibrating technology, to evaluate the cell viability during the storage of fresh and freeze-
dried microcapsules and to investigate some of the probiotic and technological properties of 
probiotic strains after microencapsulation by vibrating technology. At this purpose Lactobacillus 
reuteri DSM 17938 was selected as probiotic strain model.  
Lactobacillus reuteri DSM 17938 is a generally recognized as safe (GRAS) probiotic strain 
deposited by BioGaia in the Deutsche Sammlung von Mikroorganismen und Zellkulturen 
(DSMZ) and referenced in the scientific literature also as SD 2112, ING 1 and MM53. Lb. 
reuteri DSM 17938 derives by the depletion of two plasmids encoding for antibiotic 
(lincomycin and tetracycline) resistance (Roos and Rosander, 2005; Rosander et al., 2008) from 
the strain ATCC 55730, isolated in Perù from human breast milk (Johnson et al., 2006). This 
probiotic strain is characterized as gastro-intestinal resistant (Wall et al., 2007) and it was 
found to encode for protein MapA, a mucus adhesion promoting protein, and able to bind 
mucus and intestinal epithelial cells Caco-2 (Ouwehand et al., 2001; Miyoshi et al., 2006). 
Later, in a study of 2007, it was demonstrated that calcium ions significantly increased the 
adherence of Lb. reuteri to intestinal mucosa, suggesting the strategic inclusion of this strain in	
milk-based formula (Larsen et al., 2007). Furthermore, its selective ability in binding intestinal 
cells of IBD affected patients, more then that affected from diverticulitis or rectal carcinoma 
(Ouwehand et al., 2003) encouraged the selective use of probiotic strains in the treatment of 
specific syndromes. The probiotic effect of Lactobacillus reuteri DSM 17938 has been widely 
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investigated both in vitro and in vivo on animals and humans (adults and childrens). Similarly to 
other strains of this species, Lb. reuteri DSM 17938 is a producer of antimicrobial substances 
(reuterin) and its consumption has been correlated to a stimulation of immune system ad 
exemplum through i) increasing of anti-inflammatory interleukin 10 in pregnant women 
(Jacobson et al., 2005); increasing of B and T-lymphocytes and decreasing of gastric mucosal 
histiocytes (Valeur at al., 2004); iii) reducing fecal calprotectin (Mangalat et al., 2012). Besides 
the efficacy on adults in the suppression of H. pylori, reduction of gingival inflammation and 
plaques and IBS symptoms (Niv et al., 2005; Krasse et al., 2005; Caglar et al., 2006), Lb. reuteri 
DSM 17938 is highly recommended for paediatric use beyond its proved efficacy in limiting 
the relapse to eczema in infants related to cow’s milk consumption, reducing acute diarrhoea 
and diarrhoea from rotavirus in children and in other conditions (Szajewska et al., 2014; 
Urbanska and Szajewska, 2014). Since also it’s safety and tolerability has been widely 
confirmed in vivo (Wolf et al., 1995, 1998; Mangalat et al., 2012), this probiotic strain is 
included in many pharmaceutical formulations (BioGaia ProTectics drops, BioGaia ProTectics 
chewing gum, BioGaia ProTectics straws) while its spreading in foods is still only confined to 
research level.  
 
3.2 Methodologies and materials  
3.2.1 Microorganisms and culture conditions 
Lactobacillus reuteri DSM 17938 was isolated from Reuterin® (Noos S.r.l.; BioGaia AB, 
Stockholm, Sweden) and cultured in MRS Broth (OXOID Ltd., Basingstoke, Hampshire, 
England) at 37°C, checked for purity and maintained on MRS Agar (Oxoid). Free and 
microencapsulated cells of Lactobacillus reuteri DSM 17938 were routinely cultured and counted 
on MRS Agar at 37°C for 48 h in aerobic conditions. Pseudomonas fragi 25P used in reuterin 
production test, belonging to microorganisms collection of Department of Agriculture, 
University of Naples Federico II, was previously isolated from fresh meat sample (Ercolini et 
al., 2009). It was cultured in Tryptone Soya Broth (TSB, Oxoid) supplemented with 5 g/L 
Yeast Extract Powder (Oxoid) at 20°C. 
 
3.2.2 Encapsulation of Lactobacillus reuteri DSM 17938 
Microencapsulation of bacterial cells was carried out by using the Encapsulator B-395 Pro 
equipped with an 80 µm nozzle and a syringe pump (BÜCHI Labortechnik, Flawil, 
Switzerland). In detail, cells from a defined volume of Lactobacillus reuteri DSM 17938 culture in 
the early stationary phase were harvested by centrifugation at 5200 g for 15 min. Cell pellet 
was washed once in an equal volume of a sterile quarter-strength Ringer solution (Ringer), 
harvested by centrifugation and finally suspended in an equal volume of a 20 g/L alginate 
(Sigma, Milan, Italy, product n. A2033) solution, previously degassed and sterilized, to reach a 
concentration of about 9.40±0.10 Log. The syringe, used in the feeding system, was loaded 
with 50 ml of the alginate cell suspension and placed on the Encapsulator according to the 
instruction of supplier. The microencapsulation conditions used were: flow rate 2.91 ml/min, 
vibration frequency 1740 Hz, electrode voltage 950 mV. Alginate droplets containing bacterial 
cells were hardened in 200 ml of a 0.5 mol/L CaCl2 solution (in ratio 4:1 with alginate cell 
suspension) for about 20 min in stirring to obtain monodisperse cross-linked microcapsules. 
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Suspension was left 30 min at room temperature for the sedimentation of microcapsules and 
then a volume of 150 ml of the upper phase was gently sucked and discarded to restore the 
initial cell concentration. Alginate microcapsules (AA) were routinely stored at 4°C for further 
experiments. 
 
3.2.3 Coating of alginate microcapsules with chitosan 
A 7 g/L chitosan solution was prepared dissolving Chitosan (Sigma, product no. 448869) in a 
0.14 mol/L acetic acid solution (pH 3.2) under stirring at 8000 rpm for 20 min at 50°C. The 
solution was sterilized at 121°C for 15 min. A were added 1:10 (w/v) and stirred at 4000 rpm 
for 15 min to obtain, after sedimentation and gentle draining of supernatant, chitosan-alginate 
microcapsules (AM). They were suspended in Ringer to rich the same volume of A sample 
and routinely stored at 4°C.  
 
3.2.4 Freeze drying of alginate microcapsules 
Pellets from A and M after discarding excess of CaCl2 solution were diluted in a volume of 
sterile skimmed milk (Oxoid) to restore the cell concentration of alginate-cell suspension. It 
was frozen at -18°C overnight and then subjected to lyophilization process (Thermo Scientific 
Heto PowerDry PL6000 Freeze Dryer). For scanning electron microscopy (SEM) analysis 
skimmed milk was replaced with 50 g/L trehalose and 50 g/L sucrose solution (Chen and 
Mustapha, 2012). Freeze-dried AA and MM are below referred as FAA and FMM, 
respectively. For cell counting of freeze-dried microcapsules they were before resuspended in 
Ringer in order to make the initial solid content. 
 
3.2.5 Entrapment efficiency (EE) of microencapsulation process  
Cell loading was determined on integer and disrupted fresh and lyophilized AA and MM. 
Microcapsules were serially diluted in Ringer or 0.5 mol/L phosphate buffer solution pH 7.0 
(Gombotz and Wee, 1998) and plate-counted. Entrapment efficiency (EE) was calculated by 
dividing the viable count of disrupted microcapsules by the cell load before the 
microencapsulation (Graff et al., 2008). Furthermore, we calculated for all samples the average 
number of CFU for each microcapsule with the formula: N=Nd/Ni, where N is the average 
number of CFU for each microcapsule; Nd is cell count (CFU/ml) of disrupted 
microcapsules; Ni is cell count of integer microcapsules. We supposed that each colony is 
derived from a single integer microcapsule and therefore the measure unit of Ni (CFU/ml) 
may be replaced from microcapsules/ml.  
 
3.2.6 Sizing of microcapsules by light microscopy 
Samples were analysed by using a Zeiss Axiovert 135 light microscope (Carl Zeiss S.p.A., 
Arese, MI, Italy) at x 320 and x 200 magnification and a calibrated micrometer. About 20 
microcapsules from each encapsulation trial were analysed immediately after the process, 
during the storage at different conditions and after each treatment described below. 
 
3.2.7 Scanning electron microscopy (SEM) analysis of microcapsules 
	 37	
Samples were analysed with a scanning electron microscopy (SEM-Evo 40, Carl Zeiss, 
Oberkochen, Germany) to examine the surface morphology of microcapsules. AA and AM 
were rinsed three times with MilliQ water (Lichrosolv Water for Chromatography) and then 
10 µl of the sample was placed on a pin type SEM specimen mount and maintained at 42°C 
for 1 h in order to reach a gentle dehydration of the microcapsules and their fixing. FAA and 
FAM were directly placed on the SEM specimen mount previously coated with a double sided 
tape to fix the microcapsules. All samples were sputter-treated in a metallizer (Agar Sputter 
Coater) with gold-palladium to reach a thickness of coating of 100 Å and then observed in 
high vacuum mode. 
 
3.2.8 Evaluation of cell viability during storage of alginate matrix microcapsules 
Pellet from AA after discarding excess of CaCl2 solution was diluted in a volume of different 
sterile solutions to restore the cell concentration of alginate-cell suspension. Solutions were: i) 
Ringer, ii) 9 g/L sodium chloride (NaCl) and iii) 0.5 mol/L calcium chloride (CaCl2). Samples 
were stored for 28 days at 4 and 20°C and viable counting was performed on MRS agar at 0, 7, 
14, 21 and 28 days. Cell load was determined after disruption of microcapsules. Free cells were 
managed in the same way and used as control sample. 
 
3.2.9 Simulated gastrointestinal (GI) conditions  
A 5 g/L sodium chloride saline solution added with 3 g/L pepsine (Sigma, product no. P7000) 
at pH 2.5 was prepared (gastric simulating solution, GSS). Intestinal condition was simulated 
with a 5 g/L bile (Sigma, product no. B8381) solution (ISS, intestinal simulating solution). 
Both solutions were sterilized by filtration (0.22 µm). One ml of AA and AM was suspended 
in 9 ml of GSS and ISS and incubated at 37°C with shaking by hand each 30 min for 3 and for 
4 h, respectively. After treatment samples were plate counted after their disruption. Free cells 
were used as control. 
 
3.2.10 Osmotic stress conditions  
The resistance of free and microencapsulated Lactobacillus reuteri DSM 17938 cells in osmotic 
stress condition was evaluated by using a medium with a high sugar concentration. In 
particular, 100 g of apricot jam were inoculated with 1 g of AA or AM. Samples were stored at 
4°C and analysed for viable count immediately after the adding and after 3 h. Free cells, used 
as control, were decimally serially diluted in Ringer, while AA and AM in 0.5 mol/L 
phosphate buffer pH 7.0, both supplemented with 100 g/L sucrose (Sigma) and plate 
counted. 
 
3.2.11 Reuterin production assay  
An antagonistic deferred agar spot test was carried out to detect reuterin production against 
Pseudomonas fragi 25P. Briefly, 10 µl of free cells and microencapsulated cells were spotted on 
MRS Agar supplemented with glycerol (250 mmol/L) and incubated at 37°C for 24 h. After 
cell growth, the plates were covered with 10 ml of TSB supplemented with 7,5 g/L agar and 5 
g/L yeast extract seeded with 2% of an overnight culture of the Pseudomonas fragi 25P. After 
the incubation at 20°C for 24 h, the antimicrobial activity was observed as a growth inhibition 
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zone of the indicator strain. 
 
3.2.12 Monitoring of cell damage by a fluorescence microscopy test  
Free and microencapsulated Lactobacillus reuteri DSM 17938 cells were dyed by using a 
LIVE/DEAD® BacLight™ Bacterial Viability Kit (Molecular Probes, Eugene, Oregon, USA) 
to investigate cell membrane damage at different steps of the microencapsulation process and 
after the exposure to previously described stress conditions. Samples were stained and 
visualized by epifluorescence microscope according to the procedure followed by Malmo et al. 
(2013). It was possible to distinguish between damaged and non damaged cells, stained in red 
and green, respectively. Images were captured by a Nikon Coolpix 4500 Digital Camera 
equipped with a microscope adapter. 
 
3.2.13 Data analysis 
Analysis was carried out in triplicate and the cells viability after microencapsulation was 
calculated as average of five independent experiments. A Two-way Anova test and a t-test 
analysis (Microsoft Excel for Mac version 11.5) were performed to ascertain significant 
differences between averages; significance was declared at P<0.05.  
 
3.3 Results and discussion 
3.3.1 Entrapment efficiency (EE) and bacterial survival  
The bacterial load before and after microencapsulation was evaluated to assess the efficiency 
of microencapsulation experiments (Table 3.1). Results of viable counts of disrupted AA 
revealed a reduction in the cell load with respect to the alginate-cell suspension of only 0.35 
Log cycles suggesting a high EE value (Table 1). This is corroborated by a cell count of about 
103 CFU/ml which was recovered in the CaCl2 supernatant of AA (data not shown). Viable 
cell counts from integer and disrupted AA were significantly higher (P<0.05) compared to 
counts from AM samples (Table 1). CFU for each microcapsule was estimated to be 99 for 
AA and 92 for AM (Table 1). In addition, the bacterial load of lyophilized microcapsules 
showed 100% survival immediately after the freeze drying process (Table 3.1).  Verification of 
the integrity of cell membrane of the microencapsulated cells following the staining reaction 
by fluorescence microscope (Fig. 3.1) show that all the cells in both AA and AM were green 
thus indicating lack of damage. 
 
3.3.2 Morphology of microcapsules 
Size of AA and AM was evaluated immediately after their production and during the storage 
in different conditions (only for AA). Optical microscopy images are reported in Fig. 3.2. 
They show microcapsules with an average diameter (± standard deviation) of 110±5 µm in 
both samples, suggesting that chitosan coating did not lead to a significant variation in 
microcapsule bead diameter. Moreover, size of AA remained unchanged during their storage 
in different conditions (data not shown). Images show microcapsules regular in shape and 
without agglomeration among them and the border-line of AM less regular compared to that 
of AA. 
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Tab. 3.1 Bacterial load (Log CFU/ml) of microcapsules before (AA and AM) and after (FAA and FAM) 
freeze-drying obtained by using a cell/alginate suspension of 9.40±0.10 Log CFU/ml and parameters of 
microencapsulation yield. 
Microcapsule 
samples 
  Parameters 
Intact Disrupted  EE (%) 
N 
(CFU/microcapsule) 
Survival after 
drying (%) 
AA 7.14±0.20A 9.15±0.14 A  97 99 - 
AM 6.89±0.15B 8.82±0.22 B  - 92 - 
FAA 7.27±0.23 A 9.19±0.13 A  - 99 100 
FAM 6.81±0.18B 8.92±0.20 B  - 92 100 
∗  Mean results of five independent trials ± standard deviation. Different indices within the same column 
indicate a significant difference (P<0.05). 
 
 
 
 
 
 
 
 
 
 
 
	
	
	
Fig.	3.1	Fluorescence	microscopy	images	at	x	400	magnification	of	stained	Lactobacillus	
reuteri	DSM	17938	in	alginate,	AA	(a)	and	chitosan-alginate,	AM	microcapsules	(b).			
	
	
Fig.	3.2	Optical	microscopy	images	of	alginate	microcapsules,	AA	at	x	200	magnification	(a)	and	of	chitosan	coated	alginate	microcapsules,	AM	at	x	320	magnification	(b).			
SEM images show that AA were perfectly spherical in shape, rough and continuous in surface 
without hollow zones or cracks (Fig. 3.3a). Occasionally, collapsed microcapsules were 
50 
µ
a	 b	
a	 b	
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visualized (Fig. 3.3b). As shown in Fig. 3.4a, chitosan coating led to a little modification of 
microcapsules shape that appeared wrinkled and rougher compared to AA. The surfaces of 
AM samples were also found to be continuous without any observable hollow or cracks. On 
the other hand, increased roughness and more marked spongy-like features were observed on 
the surface of AM (Fig. 3.4b) compared to that of AA (Fig. 3.3c).  
Both microcapsules were found to retain their shape after freeze-drying (Fig. 3.5a and 3.6a). 
However, the surface of FAA (Fig. 3.5b) appeared more plain and skinny than the case before 
freeze-drying (Fig. 3.3c) while FAM surface roughness remained fairly the same after freeze 
drying (Fig. 3.6b).  
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Fig.	 3.3	SEM	images	of	alginate	microcapsules	(AA).	a)	AA	with	a	characteristic	morphology	at	x	1600	magnification;	b)	collapsed	AA	at	x	4300	magnification;	c)	particular	of	AA	surface	at	x	15000	magnification.	
b	
c	
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Fig.	 3.4	 SEM	 images	 of	 chitosan-alginate	 microcapsules	 (AM).	 a)	 AM	 with	 a	characteristic	morphology	at	x	240	magnification;	b)	particular	of	AM	surface	at	x	15000	magnification.		
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Fig	3.5	SEM	images	of	freeze	dried	alginate	microcapsules	(FAA).	a)	FAA	with	a	characteristic	morphology	at	x	2400	magnification;	b)	particular	of	FAA	surface	at	x	15000	magnification		
a	
b	
	44	
																													
	
	
	
	
	
	
	
	
	
	
Fig.	3.6	SEM	images	of	freeze	dried	chitosan-alginate	microcapsules	(FAM).	a)	FAM	with	a	characteristic	morphology	at	x	2400	magnification;	b)	particular	of	FAM	surface	at	x	15000	magnifications.		
3.3.3 Survival of probiotic cells during storage of A 
Survival kinetics of free and microencapsulated Lactobacillus reuteri in alginate matrix stored in 
a	
b	
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different conditions are reported in Fig. 3.7. The storage at 20°C led to a dramatic decrease in 
viability for both free and microencapsulated probiotic cells. Total reduction in the cell load 
was observed on the 14th day of storage for free cells in CaCl2 and on the 21st day of storage 
for all other samples except for A in NaCl, where total cell reduction was observed at the end-
point of the storage period (Day 28: Fig. 3.7a). Different results were obtained for samples 
stored at 4°C (Fig. 3.6b). Best microcapsule preservation was achieved for A stored in Ringer 
and in NaCl for which only 1 Log reduction in viable cell counts (P<0.05) was observed after 
28 days in both cases. On the contrary, viable count of free cells in the same solutions 
decreased by about 3 Log cycles at the end of storage. Furthermore, a reduction of 3 Log 
cycles in viable cell count was registered for A in CaCl2 while about 4.5 Log reduction was 
observed in the case of free cells instead (Fig. 3.7b). 
	
	
Fig. 3.7 Survival kinetics of free and microencapsulated Lactobacillus reuteri DSM 17938 in alginate 
capsules (AA) stored in Ringer (R), NaCl (P) and CaCl2 (C) at 20°C (a) and 4°C (b) along 28 days. 
Differences between mean values were analysed by two-way ANOVA. Significance was declared at p≤0.05. 
The error bars represent standard deviations. 	
3.3.4 Gastrointestinal (GI) stress conditions  
The results of viable counts and survival percentage of free and microencapsulated 
Lactobacillus reuteri cells after exposure to simulated GI conditions are shown in Fig. 3.8. 
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Results show that free cells were very sensitive to GSS.  AA significant (P<0.05) reduction of 
2.09 Log cycles was observed after 3 hours, resulting in a percentage survival of less than 1%. 
On the contrary, treatment of free cells for 4 hours in ISS led to a reduction of only 0.82 Log 
cycles which translates to about 16% of cell survival. Both AA and AM conferred resistance to 
cells in GI conditions (P<0.05) with exception of A in GSS where a significant (P<0.05) but 
moderate cell count reduction of about 0.35 Log cycles was observed.  	
	
	
Fig.	3.8	Viable	counts	and	survival	percentage	of	free	and	microencapsulated	Lactobacillus	reuteri	DSM	17938	before	and	after	incubation	in	GSS	for	3h	and	in	ISS	for	4h.	The	error	bars	represent	standard	deviations.	Different	letters	labeling	bar	graphs	of	the	the	sample	categories	indicate	that	mean	values	are	significantly	different	(p≤0.05)	as	determined	by	t-test.		
Results of viable staining of both microcapsule types after GSS (Fig. 3.9a and 3.9b) and 
ISS treatments (Fig. 3.9c and 3.9d) are depicted in Fig. 3.9. Generally, microcapsules 
maintained their shape and size features. However, after GSS treatment a modest but clear 
reduction in size of AM, as well as their aggregation was observed (Fig. 3.9b). 
Epifluorescence microscopic images showed that most of the cells were green-stained for 
all samples although in a few cases, zones of some capsules appeared light red. However, 
this red staining was much less marked than observed in the case of the free damaged cells 
(data not shown). The presence of free cells indicates a slight release of cells from both 
microcapsules when they were exposed to the GSS (Fig. 3.9a and 3.9b). Finally, green 
stained debris were clearly visible after 4 hours of exposure of AM to ISS (Fig. 3.9d). 	
3.3.5 Osmotic stress condition 
Results of this experiment are reported in Fig. 3.10. It was observed that both 
microcapsules were able to protect probiotic cells from osmotic stress. In fact, at time zero 
(T0), a reduction of 1.2 Log cycles was observed for free cells while only 0.6 Log 
reduction was registered in the case of microcapsules. A further significant (P<0.05) 
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reduction in cell viability was registered at T3 for free cells (0.7 Log cycles) and AM (0.4 
Log cycles) while no variation was found in the case of the AA. Hereafter, subjecting the 
microcapsules and free cells to osmotic stress beyond 3 h led to a significant (P<0.05) over 
reduction of viable cell count by about 2 Log cycles for free cells and by about 0.67 and 1 
Log cycle in the case of AA and AM, respectively. 
 
	
	
Fig. 3.9 Fluorescence microscopy images at x 400 magnification of viable staining of microencapsulated 
Lactobacillus reuteri DSM 17938 after treatment in gastrointestinal conditions. Alginate microcapsules, AA 
(a) and chitosan coated alginate microcapsules, AM (b) after 3 h in GSS, AA (c) and AM (d) after 4 h in ISS.  		
3.3.6 Reuterin production 
Results of reuterin test showed that neither alginate microencapsulation nor further chitosan-
coating of AA affected the antimicrobial substance production by Lactobacillus reuteri. The AA 
and AM showed an inhibition halo of the indicator strain by 38 and 31 mm, respectively, 
compared to 42 mm produced by free cells. 
 
3.4 Discussion	
Extrusion, emulsion and spray drying are the main techniques reported in literature for the 
microencapsulation of probiotic bacteria. Emulsion technique is easy to scale up but the main 
disadvantages are the high cost and varying size and shape of microcapsules (Burgain et al., 
2011). 
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Fig. 3.10 Viable counts of free and microencapsulated Lactobacillus reuteri DSM 17938 before and after 
incubation at 4°C in apricot jam for 0 (T0) and 3 (T3) hours. The error bars represent standard deviations. 
Different letters labelling bar graph of the same sample category indicate that mean values are significantly 
different (p≤0.05) as determined by t-test. 
 
Extrusion, instead, is a simple and cheap method producing homogeneous-shaped capsules 
with a narrow size distribution, which could be designed for mass production of 
microcapsules (Whelehan and Marison, 2011). In both systems, due to the gentle operation 
conditions, a slight damage is usually registered on the bacterial cells (Burgain et al., 2011). On 
the contrary, spray drying, which is the most commonly used microencapsulation method in 
the food industry, causes cell envelope damage owing to the high temperature	applied during 
the process (Anal and Singh, 2007). 
In this study the vibrating technology, a special system based on the extrusion technique, was 
applied to microencapsulate cells of the well-known probiotic strain Lactobacillus reuteri DSM 
17938. Two important outcomes of the microencapsulation process of living cells are the 
structural quality of the microcapsules and the microencapsulation yield. The former was 
studied by microscopic investigations and the latter by viable counting of cells released 
following the disruption of microcapsules. In agreement with Whelehan and Marison (2011) 
by means of the vibrating technology microcapsules with perfect spherical shape and a 
diameter of 110±5 µm were obtained (Fig. 3.1). SEM image (Fig. 3.4) showed smaller 
diameter but it could be a consequence of the preliminary treatment of samples for the 
microscopic analysis. Solanki et al. (2013) recently reviewed literature on microencapsulation 
of probiotic cells and reported 356 µm as smallest diameter of beads that could be obtained by 
extrusion technique at that time. On the other hand, microcapsules loaded with fluorescein 
and produced by vibrating technology at high frequency had a diameter of 158 µm although a 
wide range of other sizes were also reported (Dorati et al., 2013). Our opinion is that the 
dimension of microcapsules can affect the average number of cells that each microcapsule can 
hold. Thus a smaller microcapsule containing fewer cells is likely to ensure a more 
homogeneous behaviour of the bacterial population in it both in terms of resistance to stress 
conditions and metabolic activity. Furthermore, some authors have alluded to the impact of 
microcapsule dimension on organoleptic characteristics of some foods. For example, 
Kailasapathy et al. (2006) found that microspheres of about 300 µm containing probiotic 
bacteria cause a significant increase in the smoothness of yogurt compared to that with free 
a 
 a 
a 
b 
b b c 
 
b 
 
c 
 
0 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
Free cells AA AM 
L
og
 C
FU
/g
 
Before 
treatment 
T0 
T3 
	 49	
cells. Similar results were reported by Krasaekoopt and Kitsawad (2010), who found some 
modifications in the texture characteristics of fruit juice supplemented with microcapsules 
containing probiotics. Finally, Truelstup-Hansen et al. (2002) suggested that microcapsules 
with a size below 100 µm could avoid negative sensory impact in food products. 
In this study, the morphology of microcapsules by SEM analysis was investigated and resulting 
findings indicates that the conditions of microencapsulation applied (i.e. technique, alginate 
concentration and CaCl2 solutions, combination of alginate with bacterial cells) promote 
formation of capsules with reduced diameter, perfectly spherical and continuous in surface 
dimension. SEM images (Fig. 3.3-3.6) show that cells are not visible on the surface of 
microcapsules. Furthermore, the absence of cracks ensures the protection of bacterial cells 
from adverse environment conditions. Also atypical microcapsules (Fig. 3.3b) did not show 
the presence of cells on the surface, sustaining the hypothesis that they take origin from 
“collapsing and not breaking phenomena”. Our results on the effect of chitosan coating are 
also in agreement with those reported by Lee et al. (2004). 
The results from this study on the encapsulation yield (Tab. 1) are in agreement with the 
current literature describing the application of extrusion technique for living cells 
microencapsulation. Shi et al. (2013) reported an encapsulation yield close to 100% when cells 
of Lactobacillus bulgaricus were microencapsulated in alginate-milk microspheres through 
vibrating technology. Graff et al. (2007) reported an encapsulation rate of 53% using the same 
technology to encapsulate Saccharomyces boulardii in chitosan-alginate. We report a parameter 
that is not usually calculated by other authors, that is the estimated number of CFU for each 
microcapsule (N). In fact, we reasonably assumed that 1 bacterial colony originates from 1 
microcapsule, so by counting cells from intact microcapsule samples we produced data for the 
number of microcapsules. We registered a little difference of N value between AA and AM 
(Tab. 1), probably due to a release of cells during chitosan coating. Also Graff et al. (2007) did 
not register reduction of cell load after chitosan coating, while in a previous work (Malmo et 
al., 2013) we reported a more marked reduction of cell load when chitosan coating was carried 
out on microcapsules obtained by spray drying. However, our opinion is that spray drying 
produces microcapsules with features too much different form that obtained by vibrating 
technology to permit a suitable comparison. 
Freeze-drying of microcapsules was performed to confer further viable cell stabilization. 
Solanki et al. (2013) reported that combining encapsulation with freeze-drying could reduce 
cell membrane damage from freezing. Our results showed that in addition to having high 
survival (Tab. 1), microcapsules maintained their morphological characteristics after 
lyophilization (Fig. 3.5 and 3.6). High cell survival was reported also by Chen and Mustapha 
(2012), who lyophilized Lactobacillus acidophilus microcapsules produced by extrusion/emulsion 
technique. 
Our results showed that cells of Lactobacillus reuteri DSM 17938 were well preserved during 
storage at 4°C when microencapsulated in alginate matrix (Fig. 3.7). However, better probiotic 
protection systems were described by other authors (Rodrigues et al., 2012; Shi et al., 2013), 
whose results could be related to the efficiency of a double layer system in preserving the 
viability of different probiotic strains during a long-term storage. This provides credence to 
findings from this study, which shows that greater stability could be obtained by coating 
alginate microcapsules with chitosan or other different matrices. On the other hand, it should 
be highlighted that different results could be due to different resistance of the 
microencapsulated strains. 
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In order to extrapolate their benefit effects on the human or animal hosts, probiotic strains 
have to resist stressful conditions in the gastro-intestinal tract (Expert Committee 
FAO/WHO, 2002). Lactobacillus reuteri DSM 17938 showed to be very sensitive in gastric-
simulated condition (Fig. 3.8). This was also reported in a previous study (Malmo et al., 2013). 
The results of the current study strengthen the findings from other studies which show that 
microencapsulation in alginate matrix improve cell resistance to gastric pH, which is further 
increased when alginate microcapsules are coated with other matrices (Li et al., 2010; Rajam et 
al., 2012). In contrast with the previous work (Malmo et al., 2013) the microcapsules obtained 
with alginate alone (AA) did not show any evidence of the effect of bile salts (Fig. 3.8). Again, 
the difference in findings between this study and the work of Malmo et al. (2013) could be 
attributed to differences in microencapsulation technologies applied in the different study. 
Although with little difference, it was observed that AA performed better than AM in 
protecting probiotic cells from bile salts. This finding is in agreement with results reported 
earlier by other authors (Li et al., 2010; Malmo et al., 2013). The better protective effect of the 
AM could be due to the combination of the physical barrier offered by encapsulating matrix 
and the reaction between chitosan and bile salts that resulted in the formation of an insoluble 
complex (green stained debries in Fig. 3.9d) and in the limited diffusion of bile salts into the 
matrix core (Corona-Hernandez et al., 2013). 
During food processing and storage, probiotic bacteria if added to the food matrix inevitably 
get exposed to several stressful conditions (oxidative stress, temperature, pH variations and 
osmotic stress), which ultimately affect their survival. In considering the effects of the 
aforementioned stress factors, it is important to recognise the requirement that any probiotic 
food product must contain at least 106-107 CFU/g of the viable probiotic bacteria at the time 
of consumption in order to have beneficial effects of the probiotic exerted on human health 
(Expert Committee FAO/WHO, 2002). High sugar content as found in foods such as 
confectionaries, jams, fruit nectars, etc., confers high osmotic condition likely to affect survival 
of probiotic strains in such foods. In this study therefore, we tested the survival of free and 
microencapsulated cells in apricot jam. Apricot jam was selected to represent foods with high 
osmotic pressure. Surprisingly, AA exhibited a higher efficacy than AM in protecting probiotic 
cells from osmotic stress in apricot jam. . The low performance of AM observed could be 
attributed to the mechanical injury on probiotic cells brought about by increased pressure 
within microcapsules due to the stronger alginate-chitosan wall following the efflux of alginate 
interstitial water into the jam matrix. 
 
3.5  Conclusions 
This study demonstrated that microencapsulation by vibrating technology can produce stable 
probiotic microcapsules with dimension and morphological characteristics suitable for food-
based applications. In particular, we demonstrated that: (i) alginate-based microcapsules 
improved Lactobacillus reuteri DSM 17938 survival during storage and exposure to 
gastrointestinal and osmotic stress conditions and that immobilisation of the organism in the 
alginate-based microcapsules did not affect reuterin production and diffusion of the 
antimicrobial substance out of the microcapsules; (ii) Co-encapsulation of the probiotic in 
chitosan-alginate matrix enhanced survival of the probiotic. These findings indicate that 
microencapsulation by vibrating technology is a promising tool that can be exploited for 
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protection of probiotic bacteria during food processing, storage and their delivery in foods not 
usually considered as a vehicle of probiotics. 
 
Notes  
This chapter reports the content of original paper entitled “Microencapsulation by vibrating 
technology of the probiotic strain Lactobacillus reuteri DSM 17938 to enhance its survival in 
foods and in gastrointestinal environment” by De Prisco A. Maresca D., Ongeng D. and 
Mauriello G., (2015) published on LWT-Food Science and Technology. 61: 452-462.  
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CHAPTER 4 
 
Enhancement of probiotic stability via entrapment in alginate-based 
microcapsules during exposure to high temperature 
 
 
4.1  Introduction 
 
The last decade has encountered an increased interest of researchers towards the 
encapsulation of probiotic bacteria. The main reason is undoubtedly the enhanced resistance 
of encapsulated microorganisms to gastrointestinal transit. However, the interest of industry 
towards the probiotication of different food categories has introduced a new challenge with 
the respect to the resistance of probiotics to technological hurdles (De Prisco and Mauriello, 
2016). Typical technological hurdles experienced in the food industry include low water 
activity, acidic pH, high salt/sugar content and food additives, high temperature is 
undoubtedly one of the most challenging to overcome. Indeed, since probiotic strains applied 
in foods belong mostly to lactic acid bacteria (LAB) group, they are naturally selected 
following exposure to intrinsic stress factors (e.g. low pH, endogenous microflora, low aw) 
associated with specific harsh environment such as those encountered in cheese of sour dough 
(Corsetti and Settanni, 2007, Shiby and Mishra, 2014). High temperatures applied during food 
pasteurization, cooking and warming act as barrier for bacteria viability and in case of 
probiotics, strongly limit their application in baked foods as well as in that foods to be warmed 
prior to their consuming. Microencapsulation has been proposed as tool to increase cell 
tolerance to high temperature. Furthermore, its application combined to other technological 
approach such as the use of prebiotic edible films (Soukoulis et al., 2104a), the addition of 
cysteine for encapsulation of Bifidobacteria, the encapsulation of biofilm-forming bacteria 
(Cheow et al., 2013, 2014) and the inclusion of microcapsule in starch-based film (Altamirano-
Fortoul et al., 2012), frozen bakery products (Malmo et al., 2013) and cream filled cake 
(Zanjani et al., 2012) have been successfully explored.  In the wide scenario of 
microencapsulation applied for probiotic endurance, most of published works make use, in 
order of number, needle system, emulsion and spray drying as encapsulation technology. 
Furthermore, the principal problems of these technologies are that microcapsules are irregular 
in shape (spray drying), irregular in size (emulsion) and too big to keep food sensorial 
properties unaffected (needle system). Vibrating nozzle technology, one of the latest 
developed encapsulation technology based on extrusion principle combine together the 
production of regular shaped microcapsules with uniform and mouldable sizing. Furthermore, 
through the application of this technology is also possible to produce two morphological types 
of microcapsules know as matrix and core-shell microcapsules. On the other hand, it is well 
known that alginate represents the ideal encapsulating agent due to its low cost, high 
availability, ability to form strong gel and affinity with living cells. Yet despite, it might result 
ineffective in protecting bacteria against high temperature or acidic environment due to the 
too porous structure of the gel. To limit this drawback and to aid the forming of stable and 
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“insulated” microcapsules it is possible to i) increase the concentration of alginate solution; ii) 
use co-encapsulating agents; iii) provide a coating to alginate capsules with chemically 
compatible coating agents and iv) increase the number of layers.  
The major challenge of this set of experiments is to conciliate the production of microcapsules 
able to confer protection toward cells during heat exposure and that result suitable in their size 
for food application. For this purpose vibrating technology has been applied to produce both 
matrix and core-shell capsules by using alginate as primary encapsulation matrix, coupled with 
two natural filling, stabilising and thickening agents as xanthan and locust bean gum, and 
chitosan used as coating agent for the enhancement of Lactobacillus reuteri DSM 17938 viability 
under thermal stress condition. Finally, bacterial thermoresistance has been assessed in whole 
fat and skimmed milk in order to evaluate the combined effect of the encapsulation and of 
different food matrices.  
 
4.2 Materials and methods 
4.2.1 Strains and culturing conditions 
Lactobacillus reuteri DSM 17938 isolated from Reuterin™ (Noos S.r.l.; BioGaia AB, Stockholm, 
Sweden) was used. The probiotic strain was cultured in MRS Broth (Oxoid) at 37°C, checked 
for purity and maintained on MRS Agar (Oxoid). Free and microencapsulated cells of 
Lactobacillus reuteri DSM 17938 were routinely counted on MRS Agar at 37°C for 48 h in 
aerobic conditions. 
 
4.2.2 Encapsulating and coating solutions 
Alginate (Sigma, A2033), xanthan gum (Sigma, G1253) and locust bean gum (Sigma, G0753) 
were utilized as matrices for microcapsules production. Chitosan (Sigma) was applied as 
microcapsules coating agent. Alginate solution was prepared by dissolving alginate in 
preheated deionized water to obtain 1.6 or 1.8% alginate solutions. To prepare alginate- 
xanthan gum or locust bean gum mixed solutions, both xanthan and locust bean gum were 
added to 1.6% alginate solution until its complete solubilisation was achieved in order to 
obtain the highest concentration as possible. Resulting alginate-xanthan and alginate-locust 
bean gum solution had a final concentration of 2% of solute content with an alginate: xanthan 
or alginate: locust bean gum ratio of 4:1. Chitosan (Sigma, 448877) solution was prepared by 
dissolving 0.8% chitosan in preheated (55°C) acetic acid solution (pH of 3.2) as reported by 
De Prisco et al. (2015). All the solutions were autoclaved immediately after their preparation 
and left to cool down at room temperature before their use.  
 
4.2.3 Microencapsulation of Lactobacillus reuteri cells 
Microencapsulation of Lactobacillus reuteri cells was performed via vibrating nozzle technology 
as described in previous works (De Prisco et al., 2015). Alginate-locust bean gum solution was 
not compatible with extrusion through the 80 µm nozzle. Thus, only alginate and alginate-
xanthan solutions were utilized to produce matrix and core-shell microcapsules for a total of 
four microcapsule systems. Cultures of Lactobacillus reuteri in the early stationary phase were 
harvested by centrifugation at 5200 g for 15 min. Cell pellets were washed twice in sterile 
quarter-strength Ringer solution (Ringer, Oxoid) and harvested again by centrifugation to be 
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finally suspended in a volume of 1.6% alginate or alginate-xanthan solution that was equal to 
the initial volume of cell cultures to obtain a final cell load of 9.18± 0.31. Matrix 
microcapsules were prepared by extruding cell suspensions through a single-nozzle system 
having a diameter of 80 µm following procedure by De Prisco et al. (2015). Differently, for 
core-shell microcapsule production a double concentric-nozzle system was used. The inner 
nozzle measuring 80 µm in diameter was used for extrusion of cell suspension to obtain the 
cell-loading core of the capsules. The outer nozzle having a diameter of 200 µm was used for 
the extrusion of 1.8% alginate solution in order to produce the cell-free shell of microcapsules.  
Optimal values of membrane vibration frequency, flow rate and of voltage of magnetic field 
were reported in Tab. 4.1. Hardening of droplets after extrusion was obtained by their 
incubation in a 0.5 M CaCl2 solution for 20 min.  After the removing of CaCl2 solution, all 
microcapsules pellets were washed twice with Ringer; then, they were further coated with a 
0.8% chitosan solution by gentle stirring at 200 rpm for 30 min to obtain chitosan coated 
alginate matrix (AM), alginate-xanthan matrix (XM), alginate core-shell (CAM) and alginate-
xanthan core-shell (CXM) microcapsules. Microcapsules were let to sediment, rinsed twice 
with Ringer solution and finally resuspended in the double of their volume (v/W) of Ringer to 
be stored at 4°C until their use. An overnight culture of Lb. reuteri, prepared in the same day of 
bacterial cultures used for encapsulation were pelletized, washed twice and finally suspended 
in a volume of Ringer to be stored at 4°C to be used as control in further tests as following 
described.  
 
Tab.  4.1 Working parameters in the production of chitosan coated alginate (AM) and alginate-xanthan 
(XM) matrix microcapsules and chitosan coated alginate (CAM) and alginate-xanthan (CXM) core-
shell microcapsules filled with Lactobacillus reuteri cells 
 
Parameter 
Microcapsules type 
Matrix Core-shell 
AM XM CAM CXM 
Nozzle core (µm) 80 80 80 80 
Nozzle shell  (µm) - - 200 200 
Flow rate core (ml/min) 3.90 3.90 2.40 2.40 
Frequency (Hz) 2600 2900 4300 4300 
Electrode (W) 900 1150 2500 2500 
Flow rate shell (bar) - - 300 300 
 
 
4.2.4 Enumeration of microencapsulated cells and assessment of microcapsules morphology  
Bacterial load of AM, XM, CAM and CXM were calculated on microcapsules in intact form 
and after their disruption carried out in order to promote the total release of cells from 
alginate network. Briefly, for intact microcapsules, 2 ml of matrix microcapsules (AM and 
XM) and 2 g of core-shell microcapsules (CAM and CXM) were decimally serially diluted in 
Ringer solution while for disrupted microcapsules decimal serial dilutions were performed in 
0.2 M sodium citrate (pH 8.0) solution able to destabilize calcium-alginate network. Dilutions 
were further plate counted on MRS agar as previously described. All microcapsule types were 
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analysed by using a Zeiss Axiovert 135 light microscope (Carl Zeiss S.p.A., Arese, MI, Italy) 
equipped with a calibrated micrometer at x 400 and x 100 magnification. About 20 
microcapsules from each encapsulation trial were randomly analysed.  
 
4.2.5 Viability of free and encapsulated Lb. reuteri cells during storage of alginate and alginate-xanthan 
core-shell microcapsules 
 
Chitosan coated alginate and alginate-xanthan microcapsules (AM, XM, CAM and CXM) 
diluted in double of Ringer were stored for 28 days at 4°C and cell viability was weakly 
checked. At each time-point, microcapsules were disrupted as previously described for 
determination of total cell load. Free cells were managed in the same way and used as control 
sample. 
 
4.2.6 Thermal exposure of free and encapsulated Lb. reuteri cells  
Free and encapsulated Lb. reuteri cells were heat treated in hot-water bath (SWB-20, Major 
Science) equipped with stirring systems to carry out homogeneous thermal treatments and 
avoid microcapsule sedimentation.  In details, 5 ml of AM, XM or 5 g of CAM and CXM and 
5 ml of free cells in Ringer were resuspended in ratio 1:9 in preheated whole or skimmed milk 
and treated for 3, 5 and 10 min at 65±1 and 70±1°C. Temperature was always checked at the 
starting and final point of each experiment. Viable counts at 0, 3, 5 and 10 min were 
performed on microcapsules in disrupted form. Plating was performed on MRS Agar with 
incubation at 37°C for 48 h in aerobic conditions. Free cells were managed in the same way 
and used as control sample. Whole and skimmed milk (same brand) were purchased from 
local market.  
 
4.2.7 Monitoring of cell damage by a fluorescence microscopy test  
Free and microencapsulated Lactobacillus reuteri DSM 17938 cells were stained by using the 
LIVE/DEAD® BacLight™ Bacterial Viability Kit (Molecular Probes, Eugene, Oregon, USA) 
to investigate cell membrane damage at different thermal stress conditions. Samples were 
stained and visualized by epifluorescence microscope according to the procedure followed by 
De Prisco et al. (2016). Red, orange and green cells indicated damaged, partially damaged and 
non damaged cells, respectively. Images were captured by a Nikon Coolpix 4500 Digital 
Camera equipped with a microscope adapter. 
 
4.2.8 Statistical analysis 
Three independent productions of AM, XM, CAM and CXM were carried out. Further 
experiments were carried out in duplicate. A t-test analysis (Microsoft Excel for Mac version 
11.5) was performed to ascertain significant differences between averages; significance was 
declared at P<0.05.  
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4.3 Results 
4.3.1 Microcapsules morphology and cell load  
Morphology of AM and XM 
microcapsules are presented in Fig. 4.1 
panel a and b, respectively. Chitosan- 
alginate matrix microcapsules had and 
average diameter of 110 µm ± 10 and a 
uniform and continuous surface. Bacterial 
load on intact and disrupted A 
microcapsules was of 7.10 ± 0.29 and 9.20 
± 0.25 CFU/ml, respectively. Addition of 
xanthan to alginate- based capsules led to 
an increase of the average diameter of XM 
microcapsules that measured 120 µm ± 20 
(Fig. 4.1b) and appeared less smooth in 
their surface than A capsules with rougher 
border-line. Alginate-xanthan 
microcapsules had a cell load of 7.00 ± 15 
and 8.85 ± 15 CFU/ml, respectively. Both 
alginate (CAM) and alginate-xanthan 
(CXM) core-shell (Fig. 4.2a, b) 
microcapsules showed a similar diameter 
measuring on 320 ± 15 µm and they 
appeared perfectly round shaped with 
uniform border. Addition of xanthan in let 
to slight modification in the cell core of the capsules; indeed, as showed in panel b of fig. 4.2 
the border-line of cell alginate-xanthan core is less defined then the alginate core in CAM 
capsule (Fig. 4.2 a) and, as a consequence, a focus CXM capsules showed the presence of few 
cells in the alginate shell (little square in Fig 4.2 b). Core-shell microcapsules had a similar 
bacterial load; it was of 5.60 ± 20 CFU/ml and 8.70± 23 CFU/ml for intact and disrupted 
CAM, respectively while CXM carried 5.90 ± 25 CFU/ml and 8.60± 15 CFU/ml when in 
intact and disrupted form, respectively.  
 
4.3.2 Survival of probiotic Lb. reuteri cells during storage of alginate and alginate-xanthan core-shell 
microcapsules 
 
Survival kinetics of free and encapsulated probiotic cells are reported in Fig 4.3.  Both 
encapsulated population in CAM and CXM exhibited a significantly (P<0.05) higher viability 
than free cells. In details, in Lb. reuteri population stored in free form, a total reduction of 
3.15± 10 CFU/ml log CFU/ml was attested. Differently, slighter reduction (about 2.40 log 
CFU/g) was observed in Lb. reuteri cells in CAM. CXM was the best capsule system in 
protecting bacteria since a reduction of only 0.90± 10 log CFU/g was recorded in Lb. reuteri 
population. 
 
a	
b	
Fig 4.1 Optical images of chitosan coated alginate, 
AM (a) and alginate-xanthan, XM (b) matrix 
microcapsules at x 40 magnification 
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Fig 4.2 Optical images of chitosan coated alginate, CAM (a) and alginate xanthan, CXM (b) core-shell 
microcapsules at x 10 magnification.  
 
a 
50	µm 
50	µm 
b 
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Fig. 4.3 Survival kinetics of free and microencapsulated Lactobacillus reuteri DSM 17938 in chitosan coated 
alginate (CAM) and alginate-xanthan core-shell microcapsules (CXM) during 28 days in Ringer at 4°C. 
Differences between mean values were attested by t-test. Significance was declared at P < 0.05. The error 
bars represent standard deviations. * Bacterial load were expressed in Log CFU/ml for free cells suspension 
in Ringer and in Log CFU/g for encapsulated cells 
 
4.3.3 Survival of probiotic Lb. reuteri cells during high temperature exposure 
 
The effect of microencapsulation on the survival of Lb. reuteri exposed to thermal stress 
conditions (65 and 70°C for 3, 5, and 10 min) in whole and skimmed milk is presented in Fig 
4.4 and Fig. 4.5. In almost all the conditions tested, encapsulated bacteria exhibited the higher 
thermo-tolerance that was always more pronounced in core-shell microcapsule system. 
Furthermore, among matrix microcapsules, the one made by only alginate (AM) showed the 
best performance of probiotic cell protection. When threated at 65 and 70°C in whole milk 
free cells underwent an averaged reduction of 5.10 and 7.30 log CFU/ml, respectively (Fig 
4.4a, b). Encapsulated bacteria survived better in these conditions with a single exception for 
cells in AM capsules at 65°C that revealed a significantly higher (P<0.05) overall reduction of 
6.30 log CFU/ml with respect to free cells. Only increasing milk temperature upon 70°C, an 
effective advantage of AM microcapsules was revealed as demonstrated by a reduction of 5. 
70 ± 10 Log cycles for encapsulated cells versus the reduction 7.30 log CFU/ml of free cells. 
However, the inclusion of xanthan gum to alginate improved the protective effect of matrix 
capsules in all the conditions tested. Among core shell microcapsules, CAM showed the best 
performance of bacteria protection as indicated by cell reduction of only 1.30 and 4.10 log 
CFU/g in whole and skimmed milk, respectively. Incubation in skimmed milk during thermal 
treatment was more markedly bacterial viability in comparison whole milk as reported in (Fig. 
4.5 a, b) and as depicted in Fig. 4.6 (a and b).  Even in skimmed milk encapsulated population 
faced better the stress from high temperature than the free counterparts (Fig. 4.5 a, b) and 
strongest resistance was observed in cells in core shell microcapsules. In details, no significant 
(P<0.05) differences from treatment in whole milk were evidenced in the viability of free cells 
and cells in CXM capsules when treated in skimmed milk at 65°C. Differently a higher 
resistance was observed in cells in CAM capsules in skimmed milk with respect to the same 
treatment in whole milk, since an averaged reduction of 5.20 log CFU/ml was recorded 
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(versus a reduction 6.80 log CFU/ml in whole milk). Treatment at 70°C in skimmed milk was 
completely detrimental for free bacteria that showed no survival after 5 min of treatment. 
 
 
 
Fig. 4.4 Survival kinetics of free and microencapsulated Lactobacillus reuteri DSM 17938 in chitosan coated 
alginate (AM) and alginate-xanthan (XM) matrix capsules and in chitosan coated alginate (CAM) and 
alginate-xanthan (CXM) core-shell microcapsules during exposure at 65 (a) and 70°C (b) for 3, 5, and 10 
min. in whole fat milk.  
Differences between mean values were attested by t-test. Significance was declared at P < 0.05. The error 
bars represent standard deviations. * Bacterial load were expressed in Log CFU/ml for free cells suspension 
in Ringer and bacterial population in matrix type system and in Log CFU/g for bacterial population in core-
shell microcapsules 
 
 
Differently, a clear effect of protection of all encapsulating systems was appreciable in Fig 4.5b 
where the best performances were observed for Lb. reuteri cells in CAM microcapsules with a 
reduction after 10 min at 70°C of about 4.30 log CFU/g.  
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Fig. 4.5 Survival kinetics of free and microencapsulated Lactobacillus reuteri DSM 17938 in chitosan coated 
alginate (AM) and alginate-xanthan (XM) matrix capsules and in chitosan coated alginate (CAM) and 
alginate-xanthan (CXM) core-shell microcapsules during exposure at 65 (a) and 70°C (b) for 3, 5, and 10 
min. in skimmed milk.  
 Differences between mean values were attested by t-test. Significance was declared at P < 0.05. The error 
bars represent standard deviations. * Bacterial load were expressed in Log CFU/ml for free cells suspension 
in Ringer and bacterial population in matrix type system and in Log CFU/g for bacterial population in core-
shell microcapsules 
 
4.3.4 Probiotic Lb. reuteri cell damages during high temperature exposure 
 
For all microcapsules, the prevalence of orange/red cells gradually increased with time of 
exposure to high temperature. Cells in A and X microcapsules at 70°C in whole milk fat are 
depicted in Fig 4.6a, b.  Prevalence of red stained cells is appreciable both in A and in X 
capsules even though during the same treatment their incidence seems to be higher in X 
microcapsules  (panel b). Fig. II and III of panel b clearly indicate the gradual brake down of 
the alginate-xanthan gel network, suggesting the reason of the higher protective performances 
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of A capsules. Interestingly, through this staining technique it was evidenced a not uniform 
red staining in encapsulated cell population indicating a likely stronger gel network in 
correspondence of green cells that resulted more protected.  
 
 
Fig. 4.6 Fluorescence microscopy images at x 40 magnification of stained Lactobacillus reuteri DSM 17938 in 
chitosan alginate (panel a) and chitosan-alginate-xanthan matrix microcapsules (panel b) during thermal exposure 
at 70°C in whole fat milk for 3 (I), 5 (II) and 10 (III) min.  
 
4.4 Discussion 
 
The application of encapsulation as tool for the enhancement of bacterial thermoresistance is 
a very attractive and potential area that is gaining researcher interest, as documented by the 
increasing number of papers available on this topic (Fritzen-Freire et al., 2013; Endo et al., 
2014). Along with it, the production of microcapsules suitable for food application in terms of 
dimension is also a fundamental challenge to avoid sensorial drawbacks.   
With these experiments we aimed to test the protective performance at high temperatures of 
probiotic chitosan-alginate based microcapsules, modified in their composition, for the 
addition of xanthan gum, and in their structure since core-shell capsules have been obtained 
with the smallest diameter as possible for vibrating technology.  
The four types of microcapsules (AM, XM, CAM and CXM) obtained have also been 
characterized for cell loading, morphology and cell protection ability during refrigerated 
storage. Bacterial load was determined on microcapsules in intact and disrupted form with the 
main aim of counting the whole encapsulated bacterial population. At this purpose, differently 
from our previous work (De Prisco et al., 2015) where we reported the use of phosphate 
buffer for capsules disintegration, we used a solution of 0.2 M sodium citrate pH 8.00 since it 
was more efficacious in dissolving alginate network also in dairy matrices. All microcapsules 
Panel	a 
Panel	b 
I 
I 
II
I 
II
I 
II 
II 
	62	
showed a high bacterial load, and this is in line with our previous experiments indicating the 
high cell capacity load of alginate microcapsules obtained by vibrating technology and a high 
encapsulation efficiency approaching the 100% (De Prisco et al., 2015).  For the first time we 
obtained, by a double extrusion through a concentric nozzle system, perfectly round shaped 
core-shell microcapsules with an averaged diameter of about 320 µm and a perfect distribution 
of cell-core and shell compartments. Due to the increased size of core-shell capsules with 
respect to matrix capsules (about 120 µm) and resulting difficult handling of them, counting of 
core-shell capsules has always been performed on 1 gr. Indeed, preliminary results indicated 
high standard deviations in counting performed on 1 ml (data not showed). Most likely, this 
phenomenon was own to rapid capsule sedimentation during routinely operations and 
different number of microcapsules analysed at each experiment per ml. Filling alginate 
microcapsules with xanthan gum led to a slight increase in the capsules diameter (Fig. 4.1). 
Similarly to our results, an increment of alginate microcapsule diameter following the addition 
of xanthan was also reported by Cheow et al. (2014). Reasonably, this increase in XMC could 
be attributed to i) the most probable higher viscosity of alginate-xanthan suspension; ii) the 
swelling capacity of xanthan; iii) the bonds created by xanthan and alginate that could reduce 
the linkage of calcium ions and the consequent water molecules expulsion from the network. 
Likewise, this phenomenon implicated what observed in the morphology of CXM, where a 
weak borderline of cell-core was evidenced as also suggested by some cells visible in the shell 
(Fig.  4.2). The slower contact of Ca2+ ions with alginate-xanthan core due to the primary 
polymerization of the alginate shell could also explain what evidenced in the morphology of 
CXM capsules.  
Probiotic core-shell microcapsules (CAM and CXM) were stored in Ringer solution at 4°C 
since in a previous work this storage condition was the best to preserve bacterial viability (De 
Prisco et al., 2015).  CXM explained the higher protective effect on Lb. reuteri cells. This type 
of microcapsule showed to be the most effective in terms of prolongation of bacterial viability 
over CAM and previously tested AM (De Prisco et al., 2015). Differently, Fareez et al., (2015) 
reported better results during the storage of Lactobacillus plantarum LAB12 encapsulated in 
alginate only rather than in alginate-xanthan matrix. Thus, we could assume a strain-specific 
beneficial effect of xanthan.  
Data about the enhanced bacterial viability against high thermal stress are hardly comparable 
due to the different thermal conditions and probiotic strains tested as well as encapsulating 
matrices and suspending media utilized. Accordingly, it is difficult to establish which, among 
the different microcapsule systems, is the most effective for this item. Many approaches have 
been experienced to confer thermoresistance to probiotic cells such as i) the combined use of 
encapsulation/cell inclusion in edible film (Altamirano Fortoul et al., 2012; Soukoulis et al., 
2014); ii) the use of low-water affinity coating agent to reduce heat moist diffusion into the 
capsules (Mandal et al., 2014; Pitigraison et al., 2017); iii) encapsulation of biofilm forming 
bacteria to exploit their innate robustness (Cheow and Hadinoto, 2013; Cheow et al., 2014).  
Lactobacillus reuteri DSM 17938 did not show in its native form a notable thermoresistance; 
indeed, other probiotic strains such as Lb. plantarumTN8 and Lb. rhamnosus GG behave better 
when tested against high temperatures (Abbaszadeh et al., 2013; Trabelsi et al., 2013).  All 
microcapsules examined in this study were able to increase the survival of Lactobacillus reuteri 
cells during almost all the high temperature conditions tested (Fig 4.4 and 4.5) with greater 
preservation effect for core-shell morphology. These results confirmed what reported in 
literature about the higher efficacy of multi-layered microcapsules and of microcapsules 
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obtained by high-percentage alginate solution (Mandal et al., 2014). Alginate used as primary 
agent for capsules production showed promising thermo-protective action. This behaviour 
could be explained by alginate shrinkage that occurred for water expulsion from alginate gel 
during heat treatment leading to an increased in alginate density and the formation of more 
resistant and less permeable gel (Serp et al., 2002; Malmo et al., 2013). Interestingly, in 
accordance with Fareez et al., (2015) xanthan gum improved the preservative effect of matrix 
microcapsules. On the contrary, this effect was not evidenced in core shell capsules since 
CAM capsules were more efficacious in enhancing bacterial viability under high temperature. 
This evidence might be explained by the proper morphology of CAM capsules especially for 
what concern the core of the capsules that might create a stronger gel around cells when made 
of only alginate.  
Noteworthy are the results obtained by Cheow et al., (2014) and by Pitigraisorn et al., (2017). 
First authors let L. rhamnosus cells grow into alginate-xanthan capsules forming natural biofilm 
that act as a further natural barrier against temperatures, obtaining a good cell survival at 
100°C for 45 min in lyophilized capsules (Cheow et al., 2014). Pitigraisorn et al., (2017) 
encapsulated L. acidophilus cells in multi-layered capsules obtained via electrospraying and 
fluidized bed coating by alginate, egg albumen, stearic acid and cassava starch granules. When 
treated at 70°C for 30 min, encapsulated L. acidophilus cells only suffered a reduction of 0.6 log. 
However, microcapsules dimension tested in both studies was of at least 500 µm and the 
encapsulation process used in the above mentioned works are by far more complex then 
encapsulation in alginate-based capsules by vibrational nozzle technology.  
 
 
4.5  Conclusion 
 
Encapsulation is a key strategy to preserve cell viability toward technological stress imposed by 
food extrinsic and intrinsic factor, storage and consumption.  Accordingly, though a simple 
and non time-consuming encapsulation technique and cheap and safe polymer matrices, we 
obtained core-shell microcapsules able to increase the thermoresistance of probiotic cells and 
their viability during storage. Xanthan gum revealed a preservative effect toward cells during 
storage at 4°C and under thermal stress, even though only when included in matrix 
morphology. Accordingly, chitosan coated core-shell microcapsules obtained by alginate alone 
explicated the higher thermo-protective effect toward Lb. reuteri cells. Together, the present 
findings strongly encourage the elucidation of the possible advantageous interaction of 
xanthan with probiotic Lb. reuteri. They also strengthen the possibility of include probiotics 
encapsulated in natural polymer matrices in non dairy and non dairy product for which mild 
heat treatment or warming is required.  Further experiments could be performed to assess the 
effect of thermo-protection toward other many probiotic strains. 
 
 
Notes: 
This group of experiments has being finalized for further publication. Additional experiments 
are ongoing and they included: i) microcapsules lyophilisation; ii) thermal exposure of 
lyophilized microcapsules; iii) better assessment of the influence of food matrix of 
microcapsules morphology.  
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CHAPTER 5 
 
Endurance of new potentially probiotic Lactobac i l lus  strains to simulated 
gastrointestinal conditions through alginate-based microencapsulation 
 
5.1 Introduction 
According to current literature, probiotic bacteria are microorganisms able to confer health 
benefits to the host when administered in adequate amounts in live and active form (Expert 
Committee FAO/WHO, 2002; Bhathena et al., 2013). On the basis of this premise, probiotics 
need to overcome detrimental factors encountered in the gastrointestinal (GI) tract so as to 
retain their viability and important physiology (Lebeer et al., 2008). That of probiotic health 
benefits is an area of intensive research in different domains that, according to the target sites 
and mechanism of action, could be distinguished in intestinal and extra-intestinal (De Prisco 
and Mauriello, 2016). Probiotics are largely consumed for the maintenance and restoring of 
the normal intestinal microflora (Douglas and Sanders, 2008) but evidences about their 
potentiality in facilitate lactose metabolism, treatment of infantile diarrhea, reduction of serum 
cholesterol level and blood pressure and prevention from some cancers are also available 
(Khani et al., 2012).  Accordingly, the reported evidences for the relevant impact of probiotics 
on diverse end points of human health is driving the commercial development of products 
containing them (Tripathy & Giri, 2014).  However, after the administration of many 
probiotic strains, they might suffer a considerable loss of viability attributable to the injurious 
action of human factors (e.g. bile salts, low pH) encountered during the GI transit (Mokarram 
et al., 2009; Rodriguez et al., 2011; Zhao et al., 2012; Malmo et al., 2013). In this context, 
microencapsulation of probiotics in different matrices, especially hydrogels, has widely 
demonstrated to be a suitable strategy to preserve bacterial viability from this harsh 
environment and to target their release in the intestine (Brun-Graeppi et al., 2009; Cook et al., 
2012; Heideback et al., 2012). Over the extensively demonstrated effects of microcapsules to 
enhance bacteria resistance in simulated GI condition, the domain of the encapsulation as 
strategy for probiotic human delivery also account successfully applications i) to enhance the 
resilience time of probiotics encapsulated in alginate/poly-L-lysine/alginate/chitosan to 
promote the in situ production of folate (Ramos et al., 2016); ii) to increase bacterial viability 
under GI transit after previous inclusion and storage in foods (Picot and Lacroix, 2004; 
Sandoval-Castilla et al., 2010; Chaikham et al., 2012, 2016) and iii) for probiotic oral delivery in 
in vivo test (Del Piano et al., 2012). However, the wealth of works dealing with this topic is 
mainly focused on the encapsulation of well-known and commercialized probiotic strains that 
are expected to hold intrinsic notable features of resistance against GI factors. Differently, the 
effects of microencapsulation toward strains showing interesting probiotic and technological 
feature but a weak resistance to the GI tract are not still explored. On this premise, this 
Chapter reports the investigation of potentially protective activity in GI conditions toward 
new Lactobacillus 
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under high temperatures. Furthermore, saliva, gastric and intestinal conditions have been 
simulated, at target pH values, using lysozyme, pepsin and a pool of pancreatic enzymes and 
bile salts dissolved in saline solutions in order to reproduce as strictly as possible the real 
human gastrointestinal environment.   
 
5.2 Materials and Methods 
5.2.1   Strains and culture conditions 
New potentially probiotic strains BR35, BR7 and BM4, belonging to Lactobacillus group used 
in the present set of experiments have been previously isolated in our laboratory from faecal 
samples of healthy breast-fed babies aged between 0 and 3 months. Their belonging to 
Lactobacillus genes and identification at species level has been further accomplished through 
the sequencing of 16S rRNA tract (Maresca et al., submitted to PLOSone). The new isolated 
strains selected for this study BR35, BR7 and BM4 were grown in MRS broth (Oxoid) at 37°C 
in aerobic conditions and cultured on MRS agar at the same conditions for their enumeration.  
 
5.2.2   Microencapsulation of BR35, BR7 and BM4 isolates 
Cultures of BR35, BR7 and BM4 in their early stationary phase were harvested by 
centrifugation at 5200 g for 15 min. Cell pellets were washed twice in sterile quarter-strength 
Ringer solution (Ringer, Oxoid) resuspended and harvested again by centrifugation to be used 
for encapsulation experiments. Cell pellets were resuspended in 1.6% alginate and 2% 
alginate-xanthan solution obtaining a cell concentration of 8.15± 0.20 Log CFU/ml to be 
microencapsulated in matrix and core-shell microcapsules. Microencapsulation and chitosan-
coating were performed according to the procedure and parameters described in Chapter 4. 
Definitely, all strains (BR35, BR7 and BM4) were encapsulated in chitosan coated alginate 
(AM) and alginate-xanthan (XM) matrix microcapsules and in chitosan coated alginate (CAM) 
and alginate-xanthan (CXM) core-shell microcapsules. After their production, microcapsules 
rinsed twice with Ringer solution were finally resuspended in a volume of Ringer that was 
equal to the initial volume of the cell cultures in order to restore the initial cell concentration. 
Microcapsules were stored at 4°C until their use. 
 
5.2.3 Enumeration of microencapsulated cells  
Bacterial load of AM, XM, CAM and CXM were calculated on microcapsules in intact and 
disrupted form in accordance to what described in Chapter 4. Briefly, for intact microcapsules, 
2 ml of matrix microcapsules (AM and XM) and 2 g of core-shell microcapsules (CAM and 
CXM) were decimally serially diluted in Ringer solution while for disrupted microcapsules 
decimal serial dilutions were performed in 0.2 M sodium citrate (pH 8.0) solution. Samples 
were further plate counted on MRS agar as previously described and counts of disrupted 
microcapsules were considered the bacterial load of samples before the GI treatment.  
 
5.2.4 Cell survival after consecutive passages through simulated saliva, gastric and intestinal solutions 
 
A model stomach/intestinal passage experiment developed by Vizoso-Pinto et al. (2006) was 
here adapted to compare the survival of potential probiotic strains in their free and 
	66	
encapsulated form. To simulate the dilution of bacteria in the human oral cavity, cell pellet 
from 5 ml of bacterial cultures, 5 ml of matrix microcapsules or 5 g of core-shell 
microcapsules loading BR35, BR7 or BM4 were diluted 1:1 in a saliva simulating solution 
(SSS) at pH 7.2 containing an electrolyte solution of 6.2 g/l NaCl, 2.2 g/l KCl, 0.22 g/l CaCl2 
and 1.2 g/l NaHCO3 and 100 ppm lysozyme and incubated for 5 min at 37°C. The sample 
was subsequently diluted 1:4 (with respect to the sample initial volume) with a gastric 
simulated solution (GSS), consisting of the above mentioned electrolyte solution adjusted at 
pH 2.5 plus 0.3% pepsin. After 2 h of incubation at 37°C samples were further diluted in ratio 
1:5 in an intestinal simulating solution (SSS) at pH 7.2 consisting of 6.4 g/l NaHCO3, 
0.239g/l KCl, 1.28g/l NaCl with 0.5% bile salts and 0.1% pancreatin to be incubated for 3 h 
at 37°C. During gastric and intestinal incubation, samples were manually mixed at interval of 
20 min.  One ml aliquots of each sample were withdrawn after saliva, saliva plus gastric and 
saliva plus gastric plus intestinal incubation to be serially diluted in Ringer and counted on 
MRS agar. Bacterial load of encapsulated samples was determined on disrupted microcapsules. 
All chemicals were purchased from Sigma Aldrich. Cell membrane state during the treatment 
in GI condition of free and microencapsulated cells was analysed by using a LIVE/DEAD® 
BacLight™ Bacterial Viability Kit (Molecular Probes, Eugene, Oregon, USA). Samples were 
stained and visualized by epifluorescence microscope according to the procedure described in 
Chapter 4.   
 
5.2.5 Statistical analysis 
Three independent experiments were carried out in duplicate. One way analysis of variance 
test (Microsoft Excel for Mac version 11.5) was performed to ascertain significant differences 
between averages; significance was declared at P<0.05.  
 
5.3    Results 
 
5.3.1 Bacterial load of microcapsules and entrapment efficiency (EE)  
The encapsulation in four microcapsule systems, different for morphology and composition, 
was successfully carried out with all the bacteria tested. None of the strains were negatively 
affected by the encapsulation by vibrating technology. Bacterial loads estimated on aliquots of 
2 ml and 2 g of matrix and core-shell microcapsules, respectively are reported in Table 5.1. By 
using the method reported in Chapter 3 for the evaluation of the entrapment efficiency 
(consisting in dividing the viable count of disrupted microcapsules by the cell load before the 
microencapsulation), the efficiency of microencapsulation was found to approximate the 
100% for BR35, BR7 and BM4.   
 
5.3.2 Bacterial survival in gastrointestinal simulated conditions 
Three newly isolated and potentially probiotic strains have been enclosed in different 
microcapsule systems (AM, XM, CAM, CXM) and then treated under simulated 
gastrointestinal conditions. Their behaviour when treated in free end encapsulated form is 
reported in Fig. 5.1. All strains (BR35, BR7 and BM4) showed to be fully resistant to the stress 
from saliva (Lysozyme) simulating solution. Differently, when treated in free form all the 
strains showed different ability in coping with stress imposed by gastric (low pH and pepsine) 
and intestinal (bile salts, pancreatic enzymes) harsh conditions. Among them, BR7 showed the 
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higher survival during the incubation in GSS and the subsequent incubation in ISS with a 
survival percentage of 18 and 12%, respectively. About the 1 and only the 0.5% of survived 
cells was instead recovered in free population of BM4 and BR35, respectively, after the 
complete passage through the GI simulated tract. When encapsulated in matrix microcapsules 
these potentially probiotic strains benefited of this condition as demonstrated by the higher 
level of survival in the GI tract but with different extent. 
 
 
Tab. 5.1 Bacterial load (Log CFU/ml or g) of chitosan coated alginate and alginate-xanthan matrix microcapsules 
(AM and XM) and chitosan coated alginate and alginate-xanthan core-shell microcapsules (CAM and CXM) 
obtained by using a cell suspension of BR35, BR7 and BM4 strains of 8.15± 0.20 Log CFU/ml 
 
        BR35              BR7             BM4 
Microcapsules Intact Disrupted Intact Disrupted Intact Disrupted      
AM 6.00±0.15 8.00±0.10  6.10±0.18 8.00±0.21 6.15±0.20 8.05±0.15 
XM 6.44±0.12 8.05±0.23  6.36±0.08 8.10±0.12  6.45±0.15 8.10±0.22  
CAM 5.50±0.20  8.10±0.10  5.50±0.20  8.15±0.15 5.50±0.20  8.10±0.20 
CXM 5.90±0.19 8.15±0.15 5.90±0.19 8.10±0.11 5.90±0.19 8.20±0.10 
∗  ∗  Results show means ± standard deviation of three independent experiments carried out in duplicate.  
 
Indeed, interestingly, both AM and XM provided different effects on bacterial strains 
indicating a likely “strain-specific” protective effect of the microencapsulation since, for 
example, AM saved about 1.2, 1.5 and 1.0 log cycles in BR35, BR7 and BM4 population, 
respectively. Even though all the strains took advantage from encapsulation in both AM and 
XM, AM showed a significantly higher level of cell preservation (Fig. 5.1). Furthermore, it has 
to be highlighted the loss in viability of BR7 and BM4 in SSS when encapsulated XM. The 
core shell morphology improved the protective action of alginate and alginate-xanthan based 
microcapsules (Fig. 5.2). The viability of all the strains tested increased up to raise about the 
90% of survival at the end of the GI incubation for all the strains encapsulated in CAM and 
CXM and for two (BR35, BM4) out of the three strain tested CAM explicated the high 
protective action. An indication about cell integrity and microcapsule morphology along the 
GI tract is appreciable in Fig. 5.3 that depicts the state of free and encapsulated strain BR7. A 
gradual red staining, indicating cell membrane damage is appreciable during cell incubation in 
GSS and ISS. This phenomenon is attenuated by the protective action of chitosan-alginate and 
alginate-xanthan gel, although the best situation after ISS is the one obtained in AM. Both AM 
and XM microcapsules retained their morphology but they undergone a partially braking up in 
ISS, required for cell release into the intestinal compartment.  
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Fig. 5.1 Viable counts of three newly isolated and potentially probiotic Lactobacillus strains (BR35, BR7 and BM) 
tested during subsequent incubation in saliva (I), gastric (II) and intestinal (III) simulating solutions in free form and 
microencapsulated in chitosan-coated alginate (AM) and chitosan-coated alginate xanthan matrix (XM) capsules. 
Data are expressed as mean values of three independent replicas of experiment and bars represent standard 
deviation. Different letters labeling bar graphs of the different sample categories (free, AM and XM) in the same 
conditions (I, II and III) indicate that mean values are significantly different (P<0.05) as determined by t-test. 
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Fig. 5.2 Viable counts of three newly isolated and potentially probiotic Lactobacillus 
strains (BR35, BR7 and BM4) tested during subsequent incubation in saliva (I), gastric 
(II) and intestinal (III) simulating solutions in free form and microencapsulated in 
chitosan-coated alginate (CAM) and chitosan-coated alginate xanthan (CXM) core-shell 
capsules. Data are expressed as mean vales of three independent replicas of experiment 
and the bars represent standard deviation. Letters labeling bar graphs of the different 
sample categories (free, AM and XM) in the same conditions (I, II and III) indicate that 
mean values are significantly different (P<0.05) as determined by t-test 
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Fig. 5.3 Fluorescence microscopy images of viable staining of free BR7 (X 100 magnification) and 
encapsulated in chitosan coated alginate (AM) and alginate-xanthan matrix microcapsules ((X 40 
magnification) during incubation in gastrointestinal conditions (GSS for 2h and ISS for 2h). White spots 
indicate the braking up of the alginate network.  
 
5.4 Discussion 
Lactobacillus strains involved in these experiments have been previously obtained during an 
isolation from human faecal samples aimed at the discovering of new lactobacilli belonging to 
Lb. josseri and Lb. johnsonii species. A selected group of about 50 isolates identified as Lb. 
gasseri/L. johnsonii was further studied for technological and metabolic properties (i.e. ability to 
grow aerobic or respiratory conditions, catalase production, toleration of oxidative stress 
imposed by ROS generators) and for probiotic features such as gastrointestinal resistance and 
antimicrobial activity (Maresca et al., submitted to PLOSone). Strains BR35, BR7 and BM4 
exhibited interesting metabolic features and they were found to explicate, during agar spot and 
well diffusion agar test, antimicrobial properties against pathogen and spoilage bacteria but, 
alongside, they also showed poor resistance to the GI conditions. On this base, 
microencapsulation has been tested as strategy to confer the gastrointestinal resistance to 
interesting strains natively lacking of this property. In particular, the preservation feature of 
AM, XM, CAM and CXM toward BR35, BR7 and BM4 has been evaluated during in vitro tests 
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based on the use of lysozyme, pepsin and a pool of pancreatic enzymes and bile salts dissolved 
in saline solutions adjust to optimal pH for an adequate mimicking of human oro-gastro-
intestinal environment. Our preliminary experiments (data not shown) carried out with 
alginate and chitosan coated alginate microcapsules suggested that the chitosan coating was 
essential to preserve the intact morphology of alginate capsules during the gastrointestinal 
incubation performed according to Vizoso-Pinto et al. (2016). For the abovementioned 
evidence, we included in this study only the chitosan-coated microcapsules.  
Findings here reported indicate that all microcapsules exerted a beneficial effect on 
Lactobacillus strains. In the case of matrix microcapsules system, capsules made by alginate and 
coated with chitosan had a slightly higher protective effect toward all the strains tested. What 
was observed could be explained with a higher strength in chitosan-Ca2+-alginate gel with 
respect to the same gel added of xanthan. According to what also observed in the previous 
Chapter of this thesis, it is probable that alginate-xanthan matrix might form a more porous 
gel structure that make the microcapsules more permeable to the external compounds. This 
hypothesis should be undoubtedly confirmed with a more sophisticate capsule image and 
structural analysis. Furthermore, our results clearly indicated that encapsulation in core-shell 
morphology further improved bacterial resistance (Fig. 5.5). The bigger microcapsules sizing 
and the additional protective layer of alginate can reasonably explain this finding.  Several 
encapsulating matrices have been screened as carrier to endure probiotics against 
gastrointestinal harsh condition; alginate coupled with filling agent or coated with poly-L-
lysine or chitosan, whey proteins, gelatin and cellulose-acetate-phthalate are some examples 
(Ding et al., 2009; Nazzaro et al., 2009; Rodriguez et al., 2011; Heidebach et al., 2012; Ramos 
et al., 2016). Among them, the effectiveness of alginate-chitosan complex in the efficient GI 
delivery of probiotic bacteria has been widely and successfully explored due to its gastric 
resistance characteristic and its capacity to release cells at pH >7.0 (Anal and Singh, 2007; 
Dong et al., 2013; D’Orazio et al., 2015). Our results about the behavior of chitosan-alginate 
capsules obtained by vibrating technology confirmed this evidence. This was already 
demonstrated in our previous work (De Prisco et al., 2015), however, this experiment is based 
on the use of a more complex protocol for the in vitro evaluation of cell GI resistance in which 
the different chemical conditions can affect both cell viability and microcapsules behavior. 
Alginate based microcapsules obtained by vibrating technology showed good properties 
during GI delivery of BR35, BR7 and BM4 (Fig. 5.1 and 5.3). This is a promising findings 
since, beside the encapsulation matrices, the technology applied for microcapsule fabrication 
can strictly affect their structural properties and resulting functional performances as also 
demonstrated by Musikasang et al. (2009) who found that alginate based capsules produced by 
extrusion better protect lactic acid bacteria then the counterpart obtained by emulsion. A 
strain-dependent behaviour in taking advantage from microencapsulation procedure was 
observed and this is in line with previous findings about the performance of different species 
of probiotic lactic acid bacteria (Borges et al., 2012).  
 
5.5  Conclusion 
 
Cell loaded alginate-based capsules obtained by vibrating technology were exposed to 
gastrointestinal simulated passage in order to evaluate their ability to protect three new 
isolated and potentially probiotic Lactobacillus johnsonii/gasseri strains from this harsh 
environment. All microcapsules (AM, XM, CAM and CXM), irrespective of differences in 
	72	
morphology (matrix and core-shell) and composition (alginate and alginate-xanthan mix) 
improved the gastrointestinal resistance of all the strains tested. Among matrix type, the one 
with only alginate (AM) gave the best performance while the core-shell system showed to be 
suitable for GI delivery of living cells resulting in the highest level of protection. The chitosan-
alginate complex showed to be suitable for GI delivery of probiotic strains. Our findings 
suggested that microencapsulation might be a powerful tool to confer the important 
prerequisite that is the gastrointestinal resistance to strains with promising technological and 
functional properties.  
 
Notes: 
Due to the encouraging results exposed in this Chapter, experiments about the use of alginate 
core-shell microcapsules for probiotic delivery in the GI tract are going to be scaled up in 
collaboration with the Food Quality and Design group of Wageningen University, 
Netherlands. The behavior of Lb. reuteri provided in encapsulated form will be study during 
two weeks of trial in a Simulator Human Intestinal Microbial Ecosystem (SHIME®) consisting 
of five reactors for simulation of the stomach (acid conditions and pepsin digestion), the small 
intestine (digestive processes) and the ascending, transverse and descending colon (microbial 
processes), previously adapted with human faeces to simulate the human intestinal microbiota. 
According to a tentative plan, the main aims of the experiment will be the evaluation of i) the 
destiny of the microcapsules in intestinal compartment (e.g. site of their disruption and cell 
leakage) through microscopical observation and fluorescence in situ hybridization (FISH) of 
encapsulated Lb. reuteri for the comprehension of cell leaking kinetics, ii) the influence of 
probiotic Lb. reuteri on intestinal microbial dynamics through high throughput sequencing and 
iii) selective quantification of Lb. reuteri  by qRT-PCR.  
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Chapter 6                                                                           Encapsulated probiotics in real food systems 
 
CHAPTER 6 
 
Food functionalization by microencapsulated probiotics:  
three case studies 
 
  
6.1    Introduction 
The use of microencapsulation as strategy for the improvement of probiotic robustness in 
harsh conditions accounts many successful in vitro applications aimed to capacitate 
encapsulated probiotics to cope with stress induced by high osmotic pressure, high 
temperature conditions, low pH, complex microflora and gastrointestinal environment. 
Alongside with the aforementioned positive effects, one prerogative of microencapsulation 
technique, and probably the most important one, is to contribute to the development of new 
probiotic food carriers as well as to ameliorate the quality of marketed foods that are 
considered conventional vehicles of probiotics (i.e. yoghurt and fermented milks). Indeed, as 
already discussed, a global exploration of probiotic products on the market revealed that 
probiotic strains exhibit little or no survival in final goods, showing cell loads lower than that 
they are labeled  (Corona-Hernandez et al., 2013; Raeisi et al., 2013; Chen et al., 2014). Most 
of the probiotic food products are categorized as functional foods and comprise between 60 
and 70% of the whole functional food market (Tripathi and Giri, 2014). A recent global 
industrial analysis predicted that the acceptance of probiotic products among the population is 
continuously increasing to account about 34 billions € in 2018 and that milk and milk 
derivatives sectors, mainly with yoghurt and fermented milks, are undoubtedly leading this 
share of market (Global Industial Analysis, 2013). In the optic of the growing consumption of 
probiotics, the development of non-dairy probiotic foods such as fruit juices that are lactose-
free, soy-free and vegan-compliant, is becoming of paramount importance for the health-
centric consumers that can suffer from lactose intolerance, are following a specific diet or that 
simply dislike milk and its derivatives (Gawkowski and Chikindas, 2013). The application of 
microencapsulation is driving the research development of new categories of probiotic food 
products. At this purpose, I recently reviewed scientific works dealing with the application of 
microencapsulated probiotics in different food matrices discovering that the most investigated 
categories are, in growing order, the ones of milk derivatives, fruit and vegetable based 
products, meat based products and finally the one of bakery products (De Prisco and 
Mauriello, 2016). This Chapter reports the inclusion of encapsulated probiotics in three 
different food matrices for their functionalization. These different food systems such as 
cheese, almond milk syrup and blueberry juice, have also been included in this research to test 
in real food systems the efficiency of some of the microcapsules we designed to protect 
probiotics under specific harsh conditions, namely thermal stress (Mozzarella cheese), osmotic 
stress (almond milk syrup) and stress from combination of low pH and presence of organic 
acids (blueberry juice). 
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6.3 First case study. Probiotication of Water- Buffalo Mozzarella cheese with 
microencapsulated Lactobaci l lus  plantarum  LMG P-21021 
 
Milk derivatives as yoghurt and fermented milks have been widely used as delivery systems for 
probiotic cultures. Yet despite also cheese represents a suitable vehicle for delivering of 
probiotics in human intestine, both for its matrix that offer a high protection to living cells 
and for its compliance with worldwide long-term diet (De Prisco and Mauriello, 2016). If on 
one side cheese offer a suitable environment for the long term probiotic survival, for example 
because of their higher pH (4.8-5.6) than that of fermented milks (pH 3.7-4.5) or their reduced 
permeability to oxygen, on the other side their production poses some challenges to probiotic 
viability for the effect of technological factors, presence of natural antimicrobials, natural 
microbiota of some cheeses. As also recently reviewed by Feuch and Kwak (2013), the use of 
microencapsulation contributes to the development of many different types of cheese 
including Cheddar and low-fat Cheddar, White Iranian brined cheese, Kasar, Feta cheese and 
others (Feuch and Kwak 2013; De Prisco and Mauriello, 2016). Few studies instead have 
considered the inclusion of probiotics in “pasta filata” cheese, where the most relevant hurdle 
is certainly represented by the high temperature reached during curd stretching (Ortakci et al., 
2012; Minervini et al., 2012; Rodríguez-Huezo et al., 2014). This cheese typology, obtained by 
cow (Fior di Latte cheese) or water-buffalo (Mozzarella cheese) milk is manufactured through 
chemical acidification of the curd or biological acidification obtained by using natural whey 
starter cultures or commercial starter cultures. Then, the acidified curd is undergone to 
stretching procedure through the use hot water and finally temperature of stretched and 
molded curd is cooled down by its immersion in cold water. Fior di Latte and Water- Buffalo 
Mozzarella cheese have a long traditional use in Italy and especially in the South of Italy, 
where they are fully integrated in the diet (Mauriello et al., 2002). Obviously, in the production 
of a probiotic “pasta filata” cheese, the addition of probiotics prior curd stretching cannot be 
by-passed and, in this optic, microencapsulation can be a powerful tool for sustaining 
probiotic viability against high temperature applied. Here following the manufacturing of 
probiotic Water-Buffalo Mozzarella Cheese in collaboration with a local cheese factory (La 
Tramontina, Cava dei Tirreni - Salerno) obtained with the use of microencapsulated probiotic 
lactobacilli is reported.   
 
6.2.1 Methodological plan  
 
6.2.1.1 Selection of heat resistant probiotic strain 
 
Six probiotic strains such as Lactobacillus plantarum LMG P-2102, Lactobacillus paracasei LMG P-
21021, Lactobacillus rhamnosus DSM 16605, Lactobacillus acidophilus LMG P-21381 from 
Probiotical collection, Lactobacillus reuteri DSM 17938 (previously isolated from Reuterin®) and 
Lactobacillus plantarum ATCC: SD 5209 (previously isolated from Equilibria®) were included in 
this study. They were preliminary tested for the ability to resist under thermal stress condition. 
At this purpose, all the strains were grown in MRS broth (Oxoid) at 37°C in aerobic 
conditions and counted on MRS Agar at the same condition of incubation. To select the most 
heat-resistant strain and submit it to microencapsulation process for further inclusion in 
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Mozzarella cheese, all probiotic strains were exposed to heat treatment of 65°C for 5 min. 
Overnight liquid cultures of each probiotic strain were prepared, then they were centrifuged at 
5000 g for 10 min for the obtainment of cell pellets. After their washing with Ringer, cell 
pellets were resuspendend in Ringer to restore the cell concentration of initial cultures to be 
further inoculated in ratio 1:10 into preheated (65°C) UHT skimmed milk. Thermal 
treatments were carried out at 65°C x 5 min in a hot water bath (SWB-20, Major Science). At 
the end of each treatment, samples were decimally serially diluted in Ringer solution and 
subsequently counted on MRS agar for the determination of cell viability calculated as log 
CFU/ml reduction by subtracting cell load after treatment from the cell load before heat 
treatment. Results showed that Lactobacillus plantarum LMG P-2102 was the most heat resistant 
and as such was used in subsequent experiments. 
 
6.2.1.2 Microencapsulation of probiotic strain 
 
Lactobacillus plantarum LMG P-2102 probiotic strain selected on the basis of heat resistance 
under subsection 6.2.1.2 above was encapsulated in chitosan coated alginate core-shell 
microcapsules (CAM) since, from preliminary in vitro investigation reported in Chapter 3, this 
microcapsule system was selected as the best in protecting living cells under thermal stress.  
Encapsulation of Lactobacillus plantarum LMG P-2102 was performed by vibrating technology 
according to what reported in details in Chapter 3 for preparation of cell cultures, 
encapsulating matrices, capsule preparation, coating procedure and determination of 
microcapsule cell load. 
 
6.2.1.3 Mozzarella cheese manufacturing with free and encapsulated Lb. plantarumLMG P-2102 strain 
 
For these trials, encapsulated Lb. plantarumwas directly added to towed curds, previously 
obtained by fresh buffalo milk, and provided by La Tramontina. A total amount of 30 Kg of 
curds was divided into three portions and cut into small pieces (around 5 cm3 each). Then free 
cell suspension or microcapsules of Lb. plantarum(both with a total cell load of about 1012 
CFU) were added to two portions of the curd to assure a cell load of about 108 CFU/g in the 
curd prior to the stretching procedure. For an optimal homogenization of free and 
encapsulated cells, the inoculated curds were continuously and manually stirred and grounded 
for 15 min. Aliquots (5 g) of each curd samples (C1: no probiotic inoculation; C2: inoculated 
with free cells of Lb. plantarumand C3: inoculated with encapsulated Lb. plantarumcells) were 
collected for bacterial enumeration (prior to stretching). C1, C2 and C3 were separately 
stretched in an excess amount of hot water at 90°C for about 7 min and then they were 
molded in an automatic machinery to obtain standardized Mozzarella cheese with a diameter 
of 8 cm. The temperature of the curds at the end of stretching procedure ranged always 
between 60-61°C.  Finally, Mozzarella cheese samples were placed in a stainless steel mold and 
immersed in cold brine (10°C) containing 50 g/kg of NaCl for 2 h. 
Mozzarella cheese aliquots were referred as M1, M2 and M3 for the samples obtained from 
C1, C2 and C3, respectively.  The temperature of M1, M2 and M3 measured in 10 samples 
decreased to about 35°C in 30 min, 24°C after 1 h, and to 14 °C by the 2 h. After that, five 
aliquots of 5 g/each of M1, M2 and M3 were sampled for bacterial enumerations. They were 
performed by decimal serial dilutions of M1 and M2 in Ringer while M3 was decimally serially 
diluted in 0.2 M sodium citrate to favor the cell release from the capsules. The presence of 
	76	
probiotic Lb. plantarumwas evaluated by comparing the results of viable counts of not-
inoculated samples (used as control) with the viable counts of samples inoculated with free 
and encapsulated Lb. plantarumand by microscopic observation of typical colonies.  
 
6.2.1.4 Statistical analysis 
 
Two independent productions of M1, M2 and M3 were carried out and five aliquots of each 
sample (C1, C2, C3, M1, M2 and M3) were used for viable counts. Results are expressed as 
averaged values of experimental replicas and a t-test analysis (Microsoft Excel for Mac version 
11.5) was performed to ascertain significant differences between averages. Significance was 
declared at P<0.05.  
 
6.2.2    Results and discussion 
 
6.2.2.1 Thermal resistance of probiotic strains 
 
A preliminary screening based on thermo-resistance properties of six different probiotics was 
performed in order to select the most resistant strain to be used in Mozzarella cheese making. 
This selection was carried out in order to obtain the best performing couple 
probiotic/microcapsules system for further experiments. After the treatment at 65°C for 5 
min Lb. plantarumLMG P-2102 population showed the highest level of survival, accounting a 
reduction of 3.40±0.15 log CFU/ml, with respect to other probiotic strains tested (data not 
shown).  
 
6.2.2.2 Survival of free end encapsulated Lactobacillus plantarum during Mozzarella cheese 
manufacturing 
 
Free and encapsulated probiotic cells of Lb. plantarumwere used for functionalization of 
Mozzarella cheese. The addition of probiotics to “pasta filata” cheese accounts few 
applications (Ortakci et al., 2012; Minervini et al., 2012; Rodríguez-Huezo et al., 2014). Ortakci 
et al. (2012) and Rodríguez-Huezo et al. (2014) made use of encapsulation to efficaciously 
produce “pasta filata” cheese such as Water- Buffalo Mozzarella and Mexican Oaxaca cheese, 
respectively. Differently, Minervini et al. (2012) selected some probiotic strains that gave a 
positive response to previous treatment of thermic pre-adaptation to produce probiotic Fior 
di Latte Mozzarella cheese. From our previous investigations we selected the chitosan coated 
alginate core-shell system as the best one for thermal protection of probiotic Lb. reuteri cells. 
Furthermore, we considered the dimension of core-shell microcapsule system, attested around 
300 µm, suitable for the inclusion into Mozzarella cheese. Higher viable counts recorded for 
Mozzarella cheese samples with microencapsulated probiotic cells (M3) with respect to plain 
(not inoculated) Mozzarella (M1) and Mozzarella with free probiotic (M2) suggested higher 
survival level of microencapsulated strain. Results are reported in Tab. 6.2.1. 
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Tab. 6.2.1 Viable counts of not inoculated curd and Mozzarella, curds with free and 
encapsulated probiotic cells and resulting probiotic Mozzarella cheese with free and 
encapsulated L. plantarum 
 
 
 
 
 
 
 
Differences between mean values were attested by t-test and different letters among 
samples in the same column indicate significant differences. Significance was 
declared at P < 0.05.  
 
 
Furthermore Fig. 6.2.1 showed that microcapsules were homogeneously “entrapped” in the 
curds.  
 
 
 
Fig. 6.2.1 Stretched curd and Mozzarella cheese inoculated with core-shell 
microcapsules of Lactobacillus plantarum LMG P-2102 
 
 
 
6.3   Second case study. Probiotication of almond milk syrup with microencapsulated 
Lactobaci l lus  plantarum  LMG P-21021 and Lactobaci l lus reuter i  DSM 17938 
 
Almond milk syrup is a product that comes directly from the almond milk, added with sucrose 
to obtain syrup that can be stored longer at room temperature. We assisted, within a private 
project, a small company of Neapolitan area producer of almond milk syrup for the 
preparation of the HACCP plan for the hazards analysis during the production and 
distribution of this product and to define the relative control measures. Almond milk syrup is 
characterized by a high percentage of sucrose (60%). For this reason we thought that this 
product could serve as real food system to test the viability of encapsulated probiotic under 
osmotic pressure. Thus, almond milk syrup was functionalized by the addition of two strains 
of probiotic lactic acid bacteria, Lactobacillus reuteri DSM 17938 and Lactobacillus plantarum LMG 
P-21021, that were encapsulated in chitosan coated alginate matrix (AM) and core-shell 
(CAM) microcapsules and the capability of microcapsules to enhance probiotic resistance 
Samples Curds Mozzarella cheese 
                                 Log UFC/g 
Not inoculated 6.80 ±0.2a 5.10 ±0.3a 
Free Lb. plantarum 8.10 ±0.22b 5.90 ±0.3b 
Encapsulated  Lb. plantarum  8.15 ±0.20b 7.20 ±0.2c 
a	 b	
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under osmotic stress conditions was evaluated. As side effect we contributed to the possible 
development of a hedonistic probiotic food such as the almond milk based-beverage.   
 
 
 
6.3.1 Methodological plan 
6.3.1.1 Encapsulation of probiotic strains 
Microencapsulation of Lactobacillus reuteri DSM 17938 and Lactobacillus plantarum LMG P-21021 
and further determination of microcapsule cell load was performed according to the 
procedure described in Chapter 4 for the production of AM and CAM.  
 
6.3.1.2 Evaluation of probiotic viability in almond milk syrup 
To test the probiotic strain survival under osmotic stress condition, Lactobacillus reuteri and 
Lactobacillus plantarum cells in free (pellets from fresh cultures) and microencapsulated form 
were inoculated in the ratio 1/10 in almond milk syrup. Samples were stored at 20°C to 
simulate the real product storage conditions. All samples were analyzed for the viable counts 
immediately after the inoculum (T0) and weekly for a period of 1 month. Samples of almond 
milk syrup with added probiotic microorganisms in free and microencapsulated form were 
also monitored for pH values.  
 
6.3.1.3 Statistical analysis 
 
Three independent experiments were carried out and viable counts were determinate in 
duplicate. Results are expressed as average values ± standard deviations.  
 
6.3.2 Results and Discussion 
6.3.2.1 Free and microencapsulated probiotic cell viability and in almond milk syrup 
Lactobacillus reuteri DSM 17938 and Lactobacillus plantarum LMG P-21021 cells were inoculated 
in almond milk syrup in free and microencapsulated form in order to evaluate the resistance of 
the strain under conditions of osmotic stress and the protection conferred by two different 
microcapsules systems. As reported in Fig. 6.3.1, free probiotic Lb. plantarumsurvived better in 
the almond milk syrup than Lb. reuteri since no survival of Lb. reuteri cells was observed 15 
days of inoculum in almond milk syrup. Differently, Lb. plantarumwas still alive in the product 
with an average load of 4.3 log cycle after 35 days of inoculum. The resistance of both strains 
was enhanced by the microencapsulation (Fig. 6.3.1), however core-shell microcapsules 
conferred a higher level of protection than matrix microcapsules. Indeed, while Lb. reuteri cells 
in matrix microcapsules were no more detected after the timepoint at 20 days from the 
inoculum, they were still alive in almond milk syrup at the end of observation period. 
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A slow penetration of sucrose inside core-shell microcapsules due to the external alginate layer 
might explain the higher survival of probiotics when protected by this microcapsule system. 
Results from D’Orazio et al., 2015 confirmed our findings. Indeed they demonstrated that 
chitosan coated alginate microcapsules efficiently protect probiotic Lb. plantarumPBS067 cells 
from osmotic pressur given by a solution solution of 30% isoglucose or glucose-fructose 
syrup. The inoculum of both Lb. plantarumand Lb. reuteri in free and encapsulated probiotic 
lactobacilli did not led to a reduction of the pH that remained stable at a value of 5.7±0.1 
throughout the analysis period. In general, to the extent of our knowledge, very few papers 
addressed the exposure of microencapsulated probiotics to osmotic stress conditions.  
 
 
6.4 Third case study. Probiotication of blueberry juice with microencapsulated 
Lactobaci l lus reuter i  DSM 17938 
 
Development of fruit and vegetable-based probiotic foods is closely related to the increasing 
demand of products with low cholesterol content and free from animal derivatives and milk 
allergens (Céspedes et al., 2013). In this optic, fruit- and vegetable-based beverages are an 
attractive choice because of i) consumer preference towards convenience, healthy diet and 
natural ingredients; ii) naturally-occurring health-promoting components including vitamins 
and antioxidants; iii) possibility to meet consumer demands for container contents, size, shape, 
and appearance; iv) opportunity to incorporate desirable nutrients and bioactive compounds; 
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v) their taste profiles that are pleasing to all the age groups; ii) they are perceived as being 
healthy and refreshing (Prado et al. 2008; Sun-Waterhouse 2011; Wootton-Beard and Ryan 
2011). Despite the above-mentioned considerations and recent food trends related to 
vegetarianism and to soy allergy and lactose intolerance, the availability of 100% probiotic 
fruit- and vegetable-based beverages is still limited (Gawkowski and Chikindas, 2013) and this 
encourages researchers to investigated this food category for functionalization with probiotics 
(Ferreira et al. 2005; Pereira et al., 2011; Costa et al., 2013). On the other hand, low pH of fruit 
juices, typically ranging between 2.5 and 3.7, combined with the effect of phenolic acids 
(benzoic acid) and lactones, available in high amounts in some fruit juices (e.g. cranberry 
juice), could be responsible of a prominent loss of probiotics viability (Vinderola et al., 2002; 
Sheehan et al., 2007).  
What is following described as the case of functionalization of blueberry juice by the addition 
of probiotic lactobacilli is a part of a wider research finalized at the development of new 
vegetable-based probiotic carriers.  In the above mentioned study we evaluated i) the ability of 
six probiotic strains (selected among homo- and heterofermentative lactobacilli) to grow and 
to ferment six fruit-based matrices (i.e. pineapple, apple, orange, blueberry, grapefruit and 
exotic fruit juices); ii) their resistance during the storage of fermented fruit juices at 4 and 20°C 
to determine the recommended storage condition and iii) the sensorial analysis, in 
collaboration with Prof. Di Monaco (Dept. of Agricultural Sciences, University of Naples), by 
Napping and modified Flash Profile (Liu et al., 2016) of three fermented fruit juices previously 
selected for the sensory analysis. We did not include in the sensorial test all the fruit juices that 
did not show any sensorial modifications after the addition of the probiotic strains during a 
preliminary informal sensorial analysis and that exhibited poor probiotic growth and survival 
as mentioned earlier. Since Lactobacillus reuteri DSM 17938 showed the weakest ability to 
ferment and to survive in blueberry juice, it was encapsulated in two different microcapsule 
systems namely alginate matrix and chitosan-coated alginate matrix microcapsules in order to 
increase its resistance to low pH and blueberry juice components (e.g. organic acids), assessing 
the protective effect given by the alginate and chitosan toward probiotics.  
 
6.4.1 Methodological plan 
6.4.1.1 Microencapsulation of Lb. reuteri DSM 17038  
Lactobacillus reuteri DSM 17938 was previously selected for this study because of its native weak 
ability to grow and to survive in blueberry juice. With the aim to enhance its resistance in the 
above mentioned food matrix, it was encapsulated in alginate and chitosan-alginate matrix 
microcapsules by vibrational nozzle technology. Cell culturing, preparation of these 
microcapsules, their counting and conservation was performed as widely described in Chapter 
3.  
 
6.4.1.2 Inoculum of free and microencapsulated Lb. reuteri DSM 17038 cells in fruit juice 
Aseptic and ambient-stable biological blueberry juice (commercial label) having a pH of 2.9± 
0.1 was used for its functionalization with probiotic microorganisms. At this purpose, Lb. 
reuteri cells were added in blueberry juice in free and encapsulated form. Prior to addition to 
fruit juice, free cells for the inoculum were obtained by the overnight cultures that were 
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centrifuged at 5500 g for 10 min., separated from MRS supernatant and finally resuspended 
using fruit juice to restore the cell concentration of the initial cell culture. Also microcapsules 
were let to spontaneously sediment and, after discarding of Ringer solution, were resuspend 
using fruit juice to restore the initial cell concentration of microcapsule samples. Free cells and 
cells in alginate and chitosan-coated alginate microcapsules were inoculated in fruit juice to 
reach a cell concentration of 7.05± 0.10 Log CFU/ml. Inoculated juices were incubated at 
37°C for 20 hours to evaluate a possible cell growth when in encapsulated form and they were 
then stored at both 4°C for 20 days for shelf life evaluation. At specific stages during the 
experiments, microcapsules were observed with optical microscope in bright field (Y-FL 
Nikon) with a magnification of 40X to verify the integrity of the structures and to assess the 
possible presence of cells released from microcapsules. 
 
6.4.1.3 Statistical analysis  
 
Three independent productions of probiotic fruit juices were carried out and viable counts 
were determined in duplicate. Results are expressed as average values of experimental replicas 
and a t-test analysis (Microsoft Excel for Mac version 11.5) was performed to ascertain 
significant differences between averages. Significance was declared at P<0.05.  
 
6.4.2 Results and discussion 
Results about the growth and viability of free and encapsulated Lb. reuteri in blueberry juices 
are reported in Fig. 6.4.1. As already evaluated, free Lb. reuteri did not grow in fruit juices and 
exhibited the weakest viability with the respect to the microencapsulated counterparts.  
In line with several papers dealing with the use of microencapsulation technique to protect 
probiotic in fruit-based matrix (De Prisco and Mauriello 2016), results obtained by inoculating 
the probiotic strain in encapsulated form indicated a higher cell survival (Fig. 6.4.1). However 
different resistance profiles were observed between Lb. reuteri encapsulated in alginate and in 
chitosan alginate matrix. Accordingly, in first analysis a weak but significant (P<0.05) increase 
in the cell load was detected suggesting a weak ability of the strain to growth in blueberry juice 
when encapsulated in alginate microcapsules. Alongside, no significant reduction of the initial 
pH was observed. This increasing of cell population could be attributed to a dual effect of 
alginate able to protect bacteria from low pH characteristic of the juice and in the same time 
to permit the efflux of nutrients inside the capsules. Differently, when the capsules were 
coated with chitosan, any increasing of Lb. reuteri population was recorded, indicating a higher 
barrier effect of coated alginate matrix. By contrast, just this higher barrier effect of chitosan-
coated alginate microcapsules was likely responsible of the higher viability of Lb. reuteri cells 
along the storage in fruit juice (Fig. 6.4.1). The greater permeability of alginate microcapsules 
to fruit juice matrix is also suggested by the observation of the microcapsules after 7 days 
from the inoculum in blueberry juice. Indeed Fig. 6.4.2 shows that alginate capsules appeared 
more coloured than chitosan coated microcapsules for the effect of the blueberry matrix.  
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Fig. 6.4.1 Viable counts of Lb. reuteri cells in free form and encapsulated in alginate and chitosan coated 
alginate matrix microcapsules during growth (t=20h) in blueberry juice at 37°C and further storage for 20 
days at 4°C. Results are expressed as average values from three experiments carried out in duplicate ± 
standard deviations. Differences between mean values were attested by t-test and different letters among the 
same sample indicate significant differences at a level of P < 0.05 
 
 
 
 
 
As suggested by Truelstup-Hansen et al. (2002) microcapsules having a size below 100 µm 
could limit negative sensory impact in foods. Matrix morphology was selected for this 
experiments because of the small size (around 110 µm) of this microcapsule system with 
respect to core-shell morphology, to attempt to avoid the perception of microcapsules during 
the consumption of a liquid food product.  
 
 
6.5 Conclusion  
 
Probiotication of different food matrices, including fruit and vegetable-based beverages, baked 
and thermal treated products and other food categories as well as the use of probiotic bacteria 
as starter culture is aimed at broadening the availability of probiotic foods, in order to spread 
Free	cells	 Cells	in	alginate		 Cells	in	chitosan	alginate	
Fig. 6.4.2 Alginate (a) and 
chitosan coated alginate 
capsules of Lb. reuteri after 
7 days of inoculum in 
blueberry juice 
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the conscious and unconscious consumption of these beneficial microbes. The frame 
presented in this Chapter strongly encourages the research and the industrial development of 
foods enriched with encapsulated probiotics, since microencapsulation showed to be able to 
sustain probiotic viability against hurdles encountered during foods production and during 
their storage. In this optic, in order to better understand the behavior and potentiality of the 
different encapsulating systems, the study of solute diffusion kinetics into the capsules and the 
determination of the acceptance of food products functionalized with probiotic microcapsules 
should be better addressed.  
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Chapter 7                                                                                   Microencapsulation of starter cultures 
 
CHAPTER 7 
 
Behaviour of microencapsulated starter culture  
during yoghurt manufacturing 
 
 
7.1     Introduction 
Microencapsulation is a widely known technology to enhance bacterial viability and 
functionality. It is used for preservation of probiotic viability during food processing in order 
to ensure the generally recommended dose of at least 107 CFU/g or ml of food along the 
whole shelf life of the product (Corona-Hernandez et al. 2013). Microencapsulated 
probiotics have been reported to resist gastrointestinal (GI) conditions, allowing them to 
reach the lower gut and deliver their health-related functionalities (Cook et al. 2012). 
Microencapsulation may also improve cell fermentation performance. Either in its early form 
of immobilization and in the evolved microencapsulation, the use of these technologies has 
been widely explored in the past to protect cells from external contamination and to achieve 
an easier cell separation from fermentative media (Rathore et al. 2012). The use of 
immobilized/encapsulated cells in batch fermentation proved to enhance the production and 
recovery of metabolites (e.g. ethanol, lactic acid, riboflavin), and cells could also be 
effectively recycled (Westman et al. 2012). Similarly, when applied in the dairy sector the 
immobilization of lactic acid bacteria led to higher cell density, protection from oxygen and 
phage contamination and better cell survival during freeze-drying of starter cultures 
(Champagne et al. 1994; Mirzaei et al. 2012). However, some aspects of bacterial 
microencapsulation such as the metabolism of cells and their behaviour in leading food 
fermentation are still not fully investigated. When encapsulated, cells are exposed to new 
physico-chemical conditions created by the capsules themselves, mostly given by the closer 
cell-cell and cell-metabolites contact and by the lower diffusion rate of nutrients and gases 
(i.e. oxygen) into the capsules. The resulting microenvironment may lead to an alteration of 
cell metabolism, likely influencing some specific metabolic traits (Doleyres et al. 2004; Junter 
et al. 2002). For instance, a metabolic shift from homo- to heterolactic fermentation has 
been reported in immobilized lactobacilli during repeated batch cultivation (Krishnan et al. 
2001; Thomas and Turner, 1981), an increased cell tolerance to stress factors (Doleyres et al. 
2004; Krisch et al. 1997; Trauth et al. 2001) or an activation of the primary metabolic 
function of immobilized yeasts (Junter et al. 2002). Recently, the use of encapsulated 
microorganisms in food fermentation is regaining attention (Bilenler et al. 2017; Gallo et al. 
2014) in the wake of evidences about the protective effect of immobilization procedure 
widely reported in the past (Champagne et al. 1994; Kearney et al. 1990) and that some 
strains have better fermentation performances when in encapsulated form (Nedović et al. 
2015).  The wine and brewing sectors have promptly caught the potential of 
encapsulated/immobilized yeasts. Indeed, Nedović et al. (2015) recently highlighted the 
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advantages of such application, including higher volumetric cell density as well as aroma-
related metabolites and the increased cell ability to withstand the toxicity of fermentation 
environment. In this framework, it is logical to explore the encapsulation of well-know 
probiotic cultures to i) seek their use in fermentation as starter cultures and ii) to strength 
probiotic culture against food-related stress factors and further digestion (Corbo et al. 2013; 
Krunić et al. 2015). Because of the impact of new microenvironment on microbes the study 
of cell metabolites patterns such as those related to aroma formation might be a preliminary 
step toward the elucidation on the possible effect of microenvironment on the physiology of 
entrapped bacterial cells.  
In this work a mix of Streptococcus thermophilus and a probiotic strain of Lactobacillus delbrueckii 
was encapsulated in two different systems, matrix and core-shell capsules, made by alginate 
and chitosan. Starter cultures in free (non-encapsulated) and in both microencapsulated forms 
were used for production of set-yoghurt with the purposes of investigating the effect of the 
capsules on cell growth and primary metabolic functions (acidification and proteolysis) and 
evaluating the protective effect of microcapsules on bacterial cells during yoghurt storage and 
simulated digestion. Finally, volatile organic compounds (VOCs) of milk fermented by free 
and encapsulated bacteria were compared.   
 
7.2 Materials and Methods 
7.2.1 Microorganisms and culture conditions 
The probiotic Lactobacillus delbrueckii subsp. bulgaricus strain was isolated from the commercial 
food supplement YOVIS® (Sigma-Tau) on acidified (pH 5.6) de Man Rogosa Sharp (MRS, 
OXOID Ltd., Basingstoke, Hampshire, England) and identified by sequencing of 16S rDNA 
tract according to Blaiotta et al. (2004). The strain was stored at -20°C in MRS broth added 
with glycerol and routinely cultured in acidified MRS broth for 24 h at 42°C under 
microaerophilic conditions (AnoxomatTM-Mart® Microbiology, Drachten the Netherlands). 
Overnight cultures (8.10±0.10 Log CFU/ml) were pelleted by centrifugation at 6500 rpm for 
10 min, washed twice in quarter strength Ringer solution (Oxoid, below indicated with Ringer) 
and finally resuspended in half the volume of Nilac skimmed milk (NIZO, Ede, the 
Netherlands). Suspensions of Lactobacillus delbrueckii subsp. bulgaricus cells in skimmed milk 
were aliquoted in sterile vials and maintained at -45°C. Streptococcus thermophilus strain C44, 
supplied by CSK Food Enrichment (Ede, The Netherlands), was available in frozen pellets for 
direct vat inoculation and routinely and cultured overnight in M17 at 37°C under aerobic 
conditions. 
 
7.2.2 Microencapsulation of starter culture 
 
Strains were grown as previously described and then washed twice in Ringer. Resulting pellets 
were diluted in Ringer to obtain cell suspensions having an OD600 of 2.2 and 2.0 for 
Lactobacillus delbrueckii and Streptococcus thermophilus, respectively, corresponding to a cell density 
of 8.20±0.20 Log CFU/ml for both strains, as preliminarily assessed. Suspensions were mixed 
and a single pellet was obtained by centrifugation, suspended in an equal volume of 1.6% 
alginate solution and used to produce matrix microcapsules and core-shell microcapsules by 
vibrational nozzle technology implemented on (Encapsulator B-395 Pro BÜCHI 
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Labortechnik, Flawil, Switzerland). Detailed explanation of this technology is reported in De 
Prisco et al. (2015). Matrix microcapsules were produced by a single extrusion (80 µm nozzle) 
of alginate-cell suspension fed at a rate of 3 ml/min with the syringe pump. Values of 
membrane vibration frequency and electrical field were 1900 Hz and 1200 V, respectively. For 
production of core-shell microcapsules, a simultaneous-double extrusion was carried out 
through a concentric nozzle system, measuring 80 and 200 µm for core and shell extrusion, 
respectively. Cells were entrapped only into the core obtained with 1.6% alginate solution. 
Instead, shell was produced with a 1.5% alginate solution fed through the pressure bottle 
system at 400 mbar. Values of membrane vibration frequency and electrical field were of 1900 
Hz and 2500 V, respectively. In both processes, droplets were collected in a 0.5 M CaCl2 
solution bath for polymerization of alginate that causes microcapsule formation. After 
sedimentation and discarding of the supernatant, microcapsules were washed twice in Ringer 
and then coated with 0.8% chitosan solution as previously described (De Prisco et al. 2015). 
They were let to sediment, washed again in Ringer for removal of all chitosan solution and 
finally suspended in double of the volume (w/v) of Ringer to be stored at 4°C. Chitosan 
coated matrix and core-shell microcapsules are named AM and CAM, respectively. If not 
differently specified, all chemicals used were purchased from Sigma Aldrich. 
 
7.2.3 Enumeration of microencapsulated cells 
Samples containing microencapsulated cells were plate counted in original form (intact 
microcapsules) or after microcapsule disruption.  They were decimally serially diluted in 
Ringer or 0.2 M sodium citrate to conserve intact or to promote disruption of microcapsules, 
respectively. Sodium citrate was used to degrade calcium alginate network and promote cell 
release (Gombotz and Wee, 2012). For counting of Lactobacillus delbrueckii cells, dilutions were 
pour-plated on MRS agar (pH 5.6) and incubated at 42°C for 48 h under microaerophilic 
conditions. Streptococcus thermophilus cells were counted by spread plate technique on M17 agar 
incubated aerobically at 37°C for 24 h. 
 
7.2.4 Set yoghurt preparation by free and encapsulated starter culture 
Nilac skimmed milk powder was reconstituted at 10% (w/v) in milli-Q water at 50°C, 
pasteurized in batches of 400 ml at 90°C for 6 min and rapidly cooled at 42°C. Milk batches 
were inoculated with free cells from unfrozen stocks (15-20 min at room temperature) and 
with both microcapsule types to reach an initial concentration of starter culture of 6.45±0.08 
Log CFU/ml with a 1:1 ratio of the two microorganisms.  
Milk pH (InoLab pH720, WTW, Weilheim, Germany) and bacterial growth were hourly 
monitored and fermentation stopped by fast refrigeration at 4°C when pH value of 4.6±0.1 or 
a deadline of 10 hours were reached. Samples were stored at 4°C for 28 days. 
 
7.2.5 Evaluation of proteolysis 
Proteolysis was each hour monitored during milk fermentation using o-phthaldialdehyde 
(OPA) method (Mauriello et al. 1998). Briefly, 5 ml of sample were added of 2.5 ml of 0.75 M 
trichloroacetic acid, gently mixed, incubated for 10 min at room temperature and then paper 
filtered (Whatman Grade #2). One ml of OPA solution (25 ml of 0.1 M sodium tetraborate, 
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2.5 ml of sodium-dodecyl sulphate 20%, 0.04 g of OPA dissolved in 1 ml of methanol, 100 µl 
of β-mercaptoethanol), used within 2 h after its preparation, was added to 50 µl of filtered-
fraction, mixed directly in an UV-transparent cuvette and incubated for 2 min at room 
temperature prior to absorbance determination at 340 nm. The absorbance of released free 
amino groups was read against L-serine standard curve (0.0- 0.4 mM). Not-inoculated 
skimmed milk was used as blank. 
 
7.2.6 Analysis of VOCs by headspace Solid Phase Micro Extraction (SPME) and gas 
chromatography/mass spectrometry (GC/MS) 
 
Fermentation was performed in GC vials under the same conditions described above. GC 
vials (10 ml, 46x22.5 mm) were sealed with 20 mm silicon/PTFE septa and magnetic caps 
(Grace, Albany, OR, USA) to avoid loss of volatile fraction components. At the beginning and 
at the end of the fermentation period, vials were stored at -20°C and thawed immediately 
before GC/MS investigation. Analysis of volatile compounds was performed according to the 
procedure of Hettinga et al. (2008) for milk and milk derivatives and modified by 
Settachaimongkon et al. (2014) for yoghurt. Volatiles were extracted from the headspace of 
vials by their absorption on a 75 µm Carboxen™ PDMS-SPME fiber (Supelco, Bellefonte, 
PA, USA) operated by auto-sampling (TriPlus™-Autosampler, Thermo Scientific, Austin, TX, 
USA) for 5 min. at 60°C. Volatiles were thermally desorbed for 15 min from the SPME fiber 
in the GC injection port and then analyzed by GC/MS operated with Trace GC Ultra coupled 
to DSQ II mass spectrometer (Thermo Scientific, Austin, TX, USA). Volatile separation was 
performed with a Stabilwax® -DA-Crossband® -Carbowax® -polyethylene-glycol column (30 m 
length, 0.32 mm internal diameter, 1µm film thickness from Restek, Bellefonte, PA, USA) and 
helium, constantly fed at 1.5 mL/min, was used as mobile phase. Initial temperature of the 
oven was held at 40°C for 3 min, then it increased with a ramp of 15°C/min up to a final 
temperature of 220°C for 1 min. Mass spectrometer operated in the electron impact mode at 
70 eV, ion source at 225°C and ionization had a voltage within a mass scan range of 33-250 
m/z. For peak identification, volatile’s spectra were analyzed by ADMIS software with the 
NIST/EPA/NIH database and a specific library for milk and milk derivatives provided by 
Hettinga et al. (2009). Peak integration with specific retention time and m/z was carried out 
with XCalibur software (Thermo Scientific, TX, USA). Concentration was expressed as log10 
of absolute peak area of each compound.  
 
7.2.7 Evaluation of cell viability during yoghurt storage and simulated gastrointestinal (GI) transit 
The bacterial viability during 28 days of yoghurt storage was weekly evaluated by enumeration 
of free and microencapsulated Lactobacillus delbrueckii and Streptococcus thermophilus cells. At the 
end of this period, yoghurt samples were digested to test the ability of the strains to survive. 
Counting of bacteria at the final time-point of yoghurt storage (t=28 days) was considered the 
initial bacterial population level in the test of survival under GI condition. The protocol for 
simulated gastrointestinal digestion was adapted from Vizoso Pinto et al. (2006).  Briefly, five 
grams of each sample were incubated in ratio 1:1 with saliva simulating solution (SSS; 5 g/l 
NaCl, 2.2 g/l KCl, 0.22 g/l CaCl2 and 1.2 g/l NaHCO3, 100 mg/l lysozyme, pH 6.9) at 37°C 
for 5 min. Then, gastric simulating solution (GSS; 5 g/l NaCl, 2.2 g/l KCl, 0.22 g/l CaCl2 and 
1.2 g/l NaHCO3, 3g/l pepsin, pH 2.5) was added to samples in1:4 ratio (referred to sample 
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volume) followed by incubation at 37°C for 120 min and manually stirring during 20 min. In 
the third phase, intestinal simulating solution (ISS; 6.4 g/l NaHCO3, 0.239 g/l KCl, 1.28 g/l 
NaCl, 0.5% bile salts and 0.1% pancreatin, pH 7.0) was added to samples in ratio 1:5 to obtain 
a final 1:10 dilution of yoghurt samples that were incubated at 37°C for 1.5 and 3.0 hours. At 
these two final time points the viable counts of L. delbrueckii and S. thermophilus were 
determined in Log CFU/ ml of sample. 
7.2.8 Morphology of microcapsules 
Microcapsule morphology was determined by microscopy and changes were monitored during 
milk fermentation and simulated gastrointestinal digestion. Observations were made by using 
an optical microscopy (Axioskop Zeiss, Göttingen Germany) coupled to a digital camera 
(Axiocam HCR, Göttingen, Germany). 
 
7.2.9 Statistical analysis 
Three independent set-yoghurt productions were made in duplicate. A t-test analysis 
(Microsoft Excel for Mac version 11.5) was performed to ascertain significant differences 
between averages; significance was declared at P<0.05.  
 
7.3    Results  
7.3.1 Microcapsules morphology and cell load 
The two types of microcapsules (AM and CAM) differed in structure and diameter. Optical 
microscope images of microcapsules after chitosan coating are presented in Figure 7.1. AM 
are depicted in Figure 7.1a: they had a diameter of 110 ± 10 µm and the cells entrapped in this 
system were dispersed throughout the entire capsule and cells at the surface were directly 
exposed to the external environment. Instead, CAM microcapsules had a diameter of about 
300 µm and cell loaded core was homogeneously covered by the alginate outer layer (Fig. 
7.1b), which protects cells from the environment. Bacterial load was calculated before and 
after disruption of microcapsules and results are reported in Table 7.1. Microcapsules after 
fermentation are depicted in Figures 7.1c and 1d, showing that both type of capsules retain 
their morphology during milk fermentation. 
 
7.3.2 Cell growth and acidification kinetics during milk fermentation 
Fermentative ability and growth kinetics of free starter culture in milk was compared with that 
of starter culture in microencapsulated form. Results are shown in Figure 7.2. Free starter 
culture was able to ferment milk until pH 4.6±0.1 in 6 hours and the number of cells 
increased about 2.1 log cycles within this time (Fig. 7. 2a). Cells encapsulated in AM required 
longer time to acidify milk prolonging the fermentation up to 10 hours (Fig. 7. 2b). Within this 
time cell population increased 2.3 log cycles reaching the same bacterial load of yoghurt 
prepared with free cells (Fig. 7. 2b). Encapsulation of starter culture in CAM delayed milk 
acidification more markedly. As shown in Figure 7.2c, after 10 hours pH had still a value of 
5.2, which is not enough to obtain protein coagulation. However, an overall increase of 2.1 log 
cycles was registered for the cell population in these capsules. 
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Fig. 7.1 Matrix (AM, panel a and c) and core-shell (CAM, panel b and d) capsules after the inoculum in milk 
(a and b, 40X magnification) and after 6 hours of fermentation (c and d, 10X magnification) 
 
 
 
 
Table 7.1 Bacterial load (Log CFU/ml) of intact and disrupted matrix (AM) and core shell (CAM) 
microcapsules 
Mean results of three independent trials ± standard deviation 
 
 
7.3.3 Cell leaking from microcapsules during milk fermentation 
Cell load of samples during milk fermentation, measured on intact and disrupted AM and 
CAM, are reported in Figure 7.3.  Results show that the number of CFU/ml remains constant 
for 2 and 6 h for intact AM and CAM, respectively, and that a dramatic increase of the value 
was registered during the last 2-3 h of fermentation. On the other side, results of disrupted 
microcapsules show a similar growth kinetic in both AM and CAM (Fig. 7. 3). The gap 
between values of disrupted and intact microcapsules at each time indicates the magnitude of 
population remaining entrapped into the capsules during the milk fermentation. 
 
 
 
 
AM   CAM  
L. delbruekii S. thermophilus L. delbrueckii S. thermophilus 
intact 7.20±0.10 7.15±0.15  5.50±0.10 5.40±0.10 
disrupted 9.05±0.05 9.00±0.05  8.10±0.20 8.20±0.15 
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Fig. 7.2 Growth and pH kinetics during milk fermentation by yoghurt starter cultures in free form (a) and 
entrapped in matrix, AM (b) and core-shell, CAM (c) microcapsules. Bacterial loads are the sum of values 
separately acquired for Lactobacillus delbrueckii and Streptococcus thermophilus. Results are mean values 
of three different replicas of experiments carried out in duplicate, bars represent standard deviations 
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Fig. 7.3 Bacterial loads enumerated on intact and disrupted matrix (AM) and core-shell microcapsules 
(CAM) during milk fermentation 
 
7.3.4 Evaluation of proteolysis  
As shown in Figure 7.4 proteolysis was recorded in all samples during fermentation but with 
different kinetics between free and encapsulated bacteria. Higher concentrations of free amino 
groups were detected in samples fermented by free starter culture at each time points. After 
six hours of fermentation the optimal pH value (4.6±0.1) was obtained and the concentration 
of free amino groups was about 0.23 mM for free L. delbrueckii and S. thermophilus. As observed 
for acidification profiles also the proteolytic activity was delayed when the bacteria are 
encapsulated both MM and CAM. Similar concentrations (0.24 mM) of free amino groups to 
the ones observed for free cells were reached by L. delbrueckii and S. thermophilus in MM only 
after 10 hours of fermentation. At the same time-point, in the yoghurt fermented by starter 
culture in CAM a lower degree of released free amino groups of 0.20 mM was recorded. 
 
 
Fig. 7.4 Proteolytic activity of free and encapsulated S. thermophilus and L. delbrueckii in matrix (AM) and 
core-shell (CAM) microcapsules during skimmed milk fermentation at 42°C. Values are averaged from three 
independent trials carried out in duplicate ± standard deviations 
 
 
3.50 
4.00 
4.50 
5.00 
5.50 
6.00 
6.50 
7.00 
7.50 
8.00 
8.50 
9.00 
0 1 2 3 4 5 6 7 8 9 10 
L
og
 C
FU
/m
l 
Time (h) 
 Intact AM 
Disrupted AM 
Intact CAM 
Disrupted CAM 
0.00 
0.05 
0.10 
0.15 
0.20 
0.25 
0.30 
0 1 2 3 4 5 6 7 10 
Fr
ee
 a
m
in
o 
gr
ou
ps
 (m
M
 L
-s
er
in
e)
 
Time (h) 
Free starter culture 
Starter culture in AM 
 Starter culture in CAM 
	 92	
7.3.5 Volatile metabolites patterning 
The comparative analysis of volatiles was done between the yoghurt obtained by conventional 
free culture and the one obtained with MM microcapsules as the acidification was not 
sufficient when milk was fermented by CAM. Results of table 7. 2 showed a pool of 28 
volatile compounds (i.e. carbonyl and sulphur compounds, alcohols and organic acids) both in 
milk just after the inoculum and in yoghurt samples, with exception of 2,3 pentanedione and 
pentanoic acid, which were not detected in unfermented milk. Data analysis showed that: i) 6 
compounds were found in unfermented milk and their concentration remained unaffected 
during milk fermentation; ii) 10 compounds significantly increased (P<0.05) but equally in free 
and encapsulated cells (P>0.05); iii) for 9 compounds the concentration was different in all 
samples (P<0.05); iv) 2 compounds remained unaffected during milk fermentation with free 
cells (P>0.05) but significantly increased in yoghurt containing encapsulated cells (P<0.05); v) 
1 compound remained unaffected during milk fermentation with encapsulated cells (P>0.05) 
but significantly increased in yoghurt containing free cells (P<0.05). The 13 compounds, 
whose concentration is affected by microencapsulation of cells, are highlighted in table 7. 2. 
 
7.3.6 Starter cultures survivability during yoghurt storage and simulated digestion 
Viability of starter cultures in free and microencapsulated form was monitored during 28 days-
long storage of yoghurt at refrigerated condition. Free population of S. thermophilus and L. 
delbrueckii decreased from 8.40 and 8.65 Log CFU/ml to 3.00 and 6.70 Log CFU/ml, 
respectively, at the end of storage period. By contrast, microencapsulated starter culture 
showed a higher survivability since S. thermophilus and L. delbrueckii population were detected at 
6.00 and 7.70 Log CFU/ml, respectively. Yoghurt samples were exposed to simulated 
digestion in order to evaluate viability after the exposure to salivary (SSS), gastric (GSS) and 
intestinal environments (ISS). Results reported in Figure 7.5 show that microencapsulated 
bacteria survived better than free cells to the digestive condition. At the first time-point (i.e. 
after 10 min in SSS, 2 h in GSS and 1.5 h in ISS), no survivors were found in both free S. 
thermophilus and L. delbrueckii population while the microencapsulated counterparts showed 
about 100% of survival. After additional 1.5 h in ISS, S. thermophilus and L. delbrueckii 
population survived at about 60% and 1.8%, respectively. 
Along with bacterial survival during exposure to GI conditions we also monitored the 
performance of microcapsules in releasing cells. After exposure to salivary and gastric 
conditions, microcapsules did not lose their structure and still retain their original morphology. 
Differently, as shown in Figure 7.6 in intestinal simulating environment chitosan-alginate gel 
underwent a gradual swelling permitting a gradual release of cells.  
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Table 7.2 Concentration, expressed in log10 of absolute peak area, of each compound detected by 
GC/MS analysis of unfermented milk and yoghurt obtained with free and encapsulated starter culture in 
matrix (AM) microcapsules. 
 
Compound RT (min) Unfermented milk Free cells 
Encapsulated 
cells 
acetaldehyde 2.20 5.45A 7.74B 7.62B 
dimethyl sulfide 2.50 6.11A 6.15A 6.32A 
acetone 3.23 7.40A 7.51A 7.84B 
1-heptanol 3.90 5.42A 5.37A 5.14A 
2-butanone 4.41 6.43A 6.68A 6.74A 
ethanol 4.97 4.54A 6.16B 5.73C 
diacetyl 5.45 5.89A 6.87B 6.73B 
2-pentanone 5.80 5.23A 6.95B 6.78B 
2-hexanol, 2-ethyl 6.80 5.63A 7.75B 7.08B 
hexanal 6.87 5.3A 6.26B 5.16C 
2,3-pentanedion 7.04 0 A 6.35B 6.54B 
1-hexanol 7.80 4.86A 5.55B 4.81A 
1-penten-3-ol 7.90 5.00 A 4.66 B 5.50 C 
1-pentanol 8.95 4.20A 5.60B 5.41C 
3-buten-1-olo, 3-methyl 8.97 3.65A 5.53B 5.64B 
acetoin 9.41 6.47A 8.32B 8.12B 
2-propanol, 2-methyl 10.00 4.75A 6.58B 5.97C 
2-nonanone 10.17 4.55A 7.91B 7.99B 
2,4-dimethylheptane 10.66 6.48A 6.25A 6.23A 
acetic acid 10.83 6.33A 6.32A 7.99B 
benzaldehyde 12.04 5.58A 5.59A 5.49A 
3-octanone 12.30 3.80A 5.57B 5.17C 
butanoic acid 12.36 5.97A 7.56B 7.58B 
2-methyl-butanoic acid 12.50 4.45A 5.74A 5.67A 
3-methyl-butanoic acid 12.60 4.50A 5.42B 5.54C 
pentanoic acid 13.28 0A 5.55B 4.42C 
dimethyl sulfone 14.78 6.2A 5.86B 6.11C 
octanoic acid 15.66 5.56A 6.5B 6.48B 	
Different superscript means significant (P<0.05) differences between mean values of concentration of 
the same compound in different samples. 
Highlighted in grey compounds which concentrations are significantly different (P<0.05) between free 
and encapsulated cells 
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Fig.7. 5 Viable counts of free and encapsulated untreated L. delbrueckii and S. thermophilus and after 
incubation in saliva simulated solution (SSS) for 10 min, gastric simulated solution (GSS) for 2 h and 
intestinal simulated solution (ISS) for 1.5 h (A) or 3 h (B). The error bars represent standard deviations. AM: 
matrix microcapsules 
 
 
 
Fig. 7.6 Images (40X) of matrix (AM) microcapsules in yoghurt after exposure to saliva simulated 
solution (SSS) for 10 min, gastric simulated solution (GSS) for 2 h and intestinal simulated solution (ISS) 
for 1.5 h (a) or 3 h (b).  Arrows indicate points of swelling and resulting cell leakage 
 
 
7.4 Discussion 
In this study an advanced methodology to encapsulate living cells was used. The narrow size 
and shape distribution, the mouldable thickness of encapsulating matrices along with the 
smallest achievable microcapsule sizing, aim to guarantee uniform performances (e.g. 
metabolites exchange, protection toward cells) of a microencapsulated population. Because of 
the development of novel encapsulating systems, additional investigation is required over the 
acquired knowledge for the first immobilization systems. In a previous work (De Prisco et al. 
2015) vibrational nozzle technology was used to produce matrix microcapsules entrapping 
Lactobacillus reuteri DSM 17938. Accordingly, in this work we were able to produce both matrix 
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and core shell microcapsules showing excellent performances in terms of entrapment 
efficiency, shape, size homogeneity and stability. Due to the different conditions of the 
microencapsulation process and resulting difference in microcapsule morphology, the cell 
average load for microcapsule was about 5 times more in CAM cells than in MM.  
The aspect of cell leaking from microcapsules used during a food fermentation process is 
poorly investigated and discussed in literature (Corbo et al., 2016). Results on cell leaking from 
microcapsules showed that in both microcapsule types this phenomenon occurred. Data of 
Figure 7.3 showed an increase of CFU/ml, probably due to the leaking of cells from the 
microcapsules. However, in MM it is noticeable just after 3 hours, while in the CAM it starts 
after 6 hours (Fig. 7. 3). Theoretically, the number of colonies would have to remain 
unchanged along the time because we assume that each colony rise from one microcapsule 
(De Prisco et al. 2015). Interestingly, our results showed that despite different kinetics during 
milk fermentation for the two types of intact microcapsules, cell load values were very similar 
when analysed after their disruption (Fig. 7. 3). 
Microencapsulation of starter culture prolonged the time required for milk acidification and, 
according to the microcapsule type, it occurred with different kinetics (Fig. 7. 2). The slower 
acidification operated by encapsulated cells compared to the free one is most likely due to the 
mass transfer resistance that engaged both the diffusion of nutrients inside the capsules and 
the release of cell metabolites. This phenomenon also has been observed during milk 
fermentation by immobilized Lactococcus lactis and it has been ascribed to the barrier effect 
given by the capsules as well as to the cell layer formed on the capsule surface during cell 
replication (Zhou et al. 1998). Similar findings were reported by Prevost et al. (1985), who 
aimed to improve acidification performance of starter culture used for the continuous pre-
acidification of milk for yoghurt manufacture by entrapping populations of L. delbrueckii and S. 
thermophilus in separated capsules. Many conflicting results about increased, unchanged or 
reduced growth rate of immobilized bacteria used for fermentations have been found (Junter 
et al. 2002). Decreased or enhanced cell growth were attributed to mass transfer limitation and 
to the protective effect of the immobilization, respectively (Junter et al. 2002). These 
conflicting results could be reasonably attributed to the microorganism involved, to the 
performance and the design of the encapsulating system, as well. Our findings indicate that 
microcapsule performances strongly depend on capsule morphology, dimension, 
microorganisms involved and media in which fermentation process is carried out. Using MM 
capsules, the growing of cells on the outer layer lead to the formation of micro-colonies onto 
capsule surface (visible in the Panel c of Figure 7.1) from which lactic acid and other 
metabolites can be easily released. On the other hand the CAM system alginate outer layer 
likely delayed the diffusion of cell metabolites in the external environment. Another 
hypothesis for explanation of delayed growth and acidification kinetics is related to the 
possible accumulation of lactic acid in the capsules that can lead to both retarded medium 
acidification and cell growing, for the effect of the intra-capsular reduced pH. Champagne et 
al. (1994) proposed the use of microprobes to investigate the capsular microenvironment but 
no authors made use of this tool thus far. Considering the similar cell load obtained in MM 
and CAM at the end of fermentation along with the different acidification kinetics, our 
findings suggest that size and structure of microcapsules affected more markedly the diffusion 
of cell metabolites outside the capsules rather than the inflowing of nutrients. However, more 
specific investigations should be performed to confirm our hypothesis. Further hypothesis 
that should not be neglected is the possible decline of proto-cooperation between Streptococcus 
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thermophilus and Lactobacillus delbrueckii subsp. bulgaricus. Recently, Arioli et al. (2016) confirmed 
that urease activity of Streptococcus thermophilus enhanced glycolysis and homolactic fermentation 
as well as the grow rate of Lactobacillus bulgaricus. Hence, the physical barrier of alginate 
network could reduce the stimulus effect of ammonia on the metabolism of Lactobacillus 
bulgaricus cells. 
According to our data, proteolysis operated by encapsulated bacteria was significantly slower 
than that of free cells (Fig. 7. 4). The nature of LAB proteinase individuated in a cell-envelope 
proteinase system (Savijoki et al. 2006) can reasonably explain the delayed protein breakdown 
as consequence of the physical separation created by alginate layer of cell-wall proteinase and 
milk proteins. The lower proteolysis of samples containing CAM compared to that containing 
MM is an additional confirmation of this hypothesis. Proteolytic activity of starter culture has 
a key role in the formation of flavour compounds and in the rheological features of fermented 
foods. This is especially true in fermented foods like yoghurt in which the natural microbiota 
is almost completely eliminated by milk pasteurization. On the other hand, amino acids and 
small peptides obtained by proteolysis of caseins are needed for the regular growth of typical 
fastidious microorganisms like LAB. Several authors showed positive correlation between 
proteolytic activity and growth rate in LAB strains (Dandoy et al., 2011; Galia et al., 2016; 
Mauriello et al. 1998) and this could be a further reason explaining the delayed growth of 
encapsulated microorganisms with respect to the free one. From another point of view, use of 
immobilized starter cultures was recommended for the manufacturing of fresh milk-based 
products (e.g. yoghurt, quark and mozzarella cheese), in which proteolytic phenomena during 
storage are undesired (Campagne et al. 1994). However, effects arise from encapsulation might 
be different:  Unver et al. (2015) found that entrapment in calcium-alginate improved 
production and release of extracellular alkaline proteases in Cryptococcus victoriae. Despite the 
increasing number of papers dealing with the use of encapsulated LAB in food fermentation a 
proper comparison of the findings is hampered by the lack of data about the proteolytic ability 
of encapsulated microorganisms.  Proteolysis of caseins is strictly related to the formation of 
many volatile compounds implicated in the aromatic notes of fermented milk. However, 
metabolism of lactose, citrate, lipids and other milk native molecules as well as some 
metabolic intermediates like pyruvate, is implicated in the aroma formation. In this work, 
volatile profiles of yoghurt produced by free and encapsulated cells have been characterized in 
order to elucidate the possible influence of microencapsulation on relevant metabolic traits of 
starter cultures. As microencapsulation creates a hardly predictable microenvironment, where 
closer cell-cell and cell-metabolites contact is created and nutrients efflux is also altered, an 
effect on cell metabolism can be expected. Accordingly, the concentration of 12 out of all 28 
compounds detected by GC/MS analysis is significantly different between free and 
encapsulated cells (Table 7. 2). The number of metabolites is lower than that reported in the 
literature (Cheng 2010; Ott et al. 1997; Routray and Mishra 2011), but our results are probably 
caused by the use of skimmed milk. Our results are in agreement with that of other authors 
that analysed VOCs of yoghurt obtained from skimmed milk (Settachaimongkon et al. 2014). 
We found that acetone slightly raised only during fermentation with encapsulated cells. Even 
though acetone originates usually from milk, it could also be produced by the yoghurt bacteria 
(Carcoba et al. 2000; Georgala et al. 1995) and encapsulation seems to stimulate the 
biosynthesis of this aromatic compound. Interestingly, we found that encapsulated cells 
produced both acetic acid and ethanol, while free cells only ethanol in a higher quantity than 
the encapsulated cells. The production of these substances is associated to the heterolactic 
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fermentation and their concentrations are inversely correlated. It is known that different pH 
levels or availability of glucose can cause a shift from homo- to heterolactic fermentation in 
homofermentative LAB with consequent acetate and other different metabolites production 
(Borch et al., 1991; Torino et al., 2001) and microenvironment into the capsule can create 
these conditions. However, some authors reported that ethanol could be produced in yoghurt 
also by the amino acids breakdown (Cheng 2010) and the reduced proteolysis in yoghurt with 
encapsulated starter cultures might explain the resulting lower level of ethanol (Table 7.2). It is 
interesting to underline that Kwak (1995) found a positive correlation between ethanol and 
off-flavour in yogurt during the storage of 15 days at l0°C. All other substances detected in 
our study are known volatile flavour compounds identified in plain yoghurt that can affect the 
aromatic features of the final product (Cheng 2010). As our results showed that 
microencapsulation affects the cell metabolism, it could be proposed as method to balance the 
aroma compounds during a food fermentation process. 
Matrix chitosan-alginate microcapsules here tested successfully protect both L. delbrueckii and 
S. thermophilus cells during storage in yoghurt. Protective effect of alginate-based microcapsules 
is well documented (De Prisco et al. 2015; Rodriguez et al. 2011; Sousa et al. 2012). Although 
the protective effect of capsules in acidic environment could be attributed to the barrier effect 
of calcium-alginate, a more in depth investigation is needed to explain the enhanced cell 
viability at molecular level. Accurate mimicking of GI conditions is essential for a rigorous 
prediction not only of cell survival against human GI environment but also of the 
microcapsule behaviour since the composition of simulating solutions can influence capsule 
swelling and cell release. Besides the widely reported efficacy of microencapsulation in 
reducing cell sensitivity to GI transit (Cook et al. 2012; Martín et al. 2015), this work 
demonstrated that a probiotic strain normally included in pharmaceutical formulations could 
lose its prerequisite of resistance to gastro-intestinal barriers for the effect of food matrix. In 
this scenario, the use of microencapsulation might also be considered as a strategy to broaden 
the number of probiotic strains used in foods.  
 
7.5 Conclusion 
Microencapsulation of the probiotic yoghurt starter culture influenced its technological 
performances in retarding milk acidification and proteolysis and its growth in milk. This effect 
was more pronounced when bacteria were encapsulated in core-shell type microcapsules 
(CAM) because of the higher “barrier effect” exerted by the matrix microcapsules (MM), 
suggesting the key role of microcapsule morphology in determining the behaviour of a cell 
population. Our results also suggested that encapsulation can induce some modification in 
metabolic pathways linked to the production of volatile compounds suggesting the use of 
microencapsulation as a tool for routing food fermentations besides its advantageous effect in 
cell protection.  
 
 
Notes: 
• This chapter reports the content of paper entitled “Behavior of microencapsulated starter 
cultures during yoghurt manufacturing” by De Prisco A, van Valenberg H, Fogliano V, 
Mauriello G. Submitted	to	Food	and	Bioprocess	technology.	
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Experiments have been carried out during a period of seven months as guest PhD student at 
Food Quality and Design group (Dairy division) of Wageningen University (Netherlands).  
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Chapter 8                                                                                   Proteomics on encapsulated bacteria                                                                                             
 
CHAPTER 8 
 
Proteomics tool for the investigation of encapsulated probiotic  
Lactobac i l lus  reuter i  DSM 17938 physiology under simulated gastro-
intestinal conditions1 
 
8.1 Introduction 
Most of the common commercial probiotic strains belongs to Lactic Acid Bacteria (LAB) 
group and in particular to Lactobacillus genus. Lactobacilli and naturally present as 
autochthonous bacteria of many food matrices, play a key role in fermentations of dairy and 
vegetable foods and they are also associated to human and animals intestinal microbioma 
(Lebeer at al., 2008). These environments are obviously characterized by specific stress factors 
and in addition, a synergic effect among many detrimental factors can take pace influencing 
bacterial behaviour and performances (Belfiore et al., 2013; Wu et al., 2016). LAB and 
probiotic strains in particular, developed a plethora of mechanisms at bases of general and 
specific stress response allowing bacteria adaptation in many different harsh environments 
(Mills et al., 2011; Hussain et al., 2013). Stress response related pathways are associated to the 
induction of a large number of genes and to the synthesis of several proteins leading specific 
or cross-resistance to stress. In this scenario, proteomics tools allow the comprehension of the 
adaptive stress response through the study of protein expression patterns and changes induced 
by the different environment as well as of physiological conditions. Proteomic approach has 
been successfully applied to study microbial dynamics in foods (Soggiu et al., 2016), bacterial 
adaptation mechanisms to gastric or bile salt related stress (Lee et al., 2008; Alćantara and 
Zúñigua, 2012), starvation (Hussain et al., 2006) and many other conditions implying bacterial 
adaptive and resistance phenomena (Di Pasqua et al., 2013; Hussain et al., 2013; De Angelis et 
al., 2016). Several proteins known as heat shock proteins such as DnaK, DnaJ, GroES, 
GroEL and ClpB are common to Lactobacillus species and have been found involved in the 
response of a variety of stresses, namely thermic (heat and cold), osmotic, oxidative and acid 
stress (De Angelis and Gobbetti, 2004). Currently, a consistent literature is dedicated to the 
exploitation of encapsulation as strategy for the improvement of bacterial robustness under 
technological and human stress conditions. In particular great attention is given to the use of 
microencapsulation to strengthen probiotics in gastrointestinal (GI) environment (Cook et al., 
2012). However, the entire body of works dealing with this topic is at now limited to the 
development of suitable encapsulation systems for targeted delivery of probiotics in the GI 
tract and to the assessment of the improved bacterial survival Ding et al., 2009; Nazzaro et al., 
2009; Rodriguez et al., 2011; Heidebach et al., 2012; Ramos et al., 2016). The most reasonable 
hypothesis is that microcapsules act as barrier against the detrimental agents (e.g. enzymes, bile 
salts) and explain a buffering capacity against gastric pH with the resulting higher cell survival. 
Besides the increased bacterial viability, no evidence about the possible cellular origins of the 																																																								
1 Experiments described in this Chapter are currently ongoing in collaboration with the Laboratory of Microbial 
Proteomics of the Department of Veterinaty Medicine, University of Milan. 
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high resistance of encapsulated strains are available as well as about what happen to the cell 
physiology and probiotic metabolic features. Interestingly, proteomics allowed the 
comprehension of microbial physiology in immobilized/encapsulated strains, in particular for 
what concern the different growth rate and metabolites production during fermentations 
(Junter et al., 2002; 2004). Yet despite, this approach has only been carried out on few 
microbial species such as Saccharomyces cerevisiae or Pseudomonas fluorescens and, in the field of 
probiotics, it is still far from its potentiality.  To the extent of our knowledge, only one paper 
addresses the use of proteomics (by Lab-on-a-chip capillary electrophoresis) to investigate the 
behaviour an encapsulated probiotic strain during addition to carrot juice and subsequent 
incubation in gastric and pancreatic juice (Nazzaro et al., 2009). This study clearly showed 
different protein profiles in free and encapsulated strains even though proteins with different 
level of expression were not identified.  The present investigation aims at exploring for the 
first time on molecular level the behaviour of chitosan-alginate encapsulated Lactobacillus reuteri 
DSM cell response through proteomic approach based on 2DE coupled to MALDI-TOF 
mass spectrometry. In particular, proteome profiles of free and encapsulated Lactobacillus reuteri 
cells after incubation in gastric and intestinal simulated conditions are compared for the 
individuation of differential expressed protein and their identification.  
 
8.2 Materials and Methods 
8.2.1 Bacterial strain and culture conditions 
  Lactobacillus reuteri DSM 17938 isolated from Reuterin™ (Noos S.r.l.; BioGaia AB, Stockholm, 
Sweden) is the probiotic strain used in this set of experiment. Information about its grown 
and culture conditions are reported in Chapter 3 and 4 of this thesis.  
 
8.2.2 Lactobacillus reuteri cells microencapsulation in alginate-based capsules 
Lactobacillus reuteri cells were encapsulated in chitosan coated alginate core-shell microcapsules 
by vibrating technology according to the procedure described in Chapter 4. Briefly, cultures of 
Lactobacillus reuteri in the early stationary phase were harvested by centrifugation at 5200 g for 
15 min. Cell pellets were washed twice in sterile 0.01 M phosphate buffer solution (PBS, pH 
7.4) and harvested again by centrifugation to be finally suspended in a volume of 1.6% alginate 
that was equal to the initial volume of cell cultures to obtain a final cell load of 8.70± 0.20 or 
the same volume of PBS to be stored overnight at 4°C and used in the following experiments. 
Core-shell microcapsules were obtained by a double extrusion with the concentric-nozzle 
system. Cell-alginate suspension was extruded through the inner nozzle (80 µm) to obtain the 
cell-loading core of the capsules while the cell free alginate suspension (1.8%) was 
simultaneously extruded through the external nozzle (200 µm) to produce the shell of 
microcapsules. Optimal values for the encapsulation of Lactobacillus reuteri cells in alginate core-
shell microcapsules were previously individuate and are reported in Chapter 4. Hardening of 
droplets after extrusion was allowed by their incubation in a 0.5 M CaCl2 solution for 20 min.  
After the removing of CaCl2 solution, all microcapsules pellets were washed twice with PBS. 
Then, they were further coated with a 0.8% chitosan solution by gentle stirring at 200 rpm for 
30 min, let to sediment, rinsed twice and finally resuspended in the double of their volume 
(v/W) of PBS to be stored overnight at 4°C until their use. Three independent experiments of 
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microencapsulation were carried out and resulting probiotic microcapsules were treated as 
following described.  
 
8.2.3 Simulated gastrointestinal passage of free and encapsulated bacterial culture 
Gastrointestinal conditions were simulated as already reported in Chapters 5 and 6 according 
to the protocol by Vizoso-Pinto et al. (2006). Briefly, 25 grams of microcapsules or a free cell 
pellet from 25 ml of Lactobacillus reuteri culture were incubated in ratio 1:4 (referred to the 
volume of samples) in gastric simulating solution (GSS; 5 g/l NaCl, 2.2 g/l KCl, 0.22 g/l 
CaCl2 and 1.2 g/l NaHCO3, 3g/l pepsin, pH 2.5) and incubated at 37°C for 2.0 hours under 
manually agitation each 20 min. Then, the intestinal simulating solution (ISS; 6.4 g/l NaHCO3, 
0.239 g/l KCl, 1.28 g/l NaCl, 0.5% bile salts and 0.1% pancreatin, pH 7.0) was added in ratio 
1:5 to obtain a final 1:10 dilution of the samples that were incubated in ISS at 37°C for 3.0 
hours. Viable counts were performed on samples before GI treatment (untreated) and after 
their incubation in GSS and ISS. For encapsulated L. reuteri, cell load was determined after 
disruption of microcapsules obtained by decimal serial dilutions of the samples in 0.2 M 
sodium citrate solution (pH 8.0) while samples of free cells were decimally serially diluted in 
quarter strength Ringer solution (Oxoid). They were further plate counted on MRS agar and 
incubated 37 °C for 48 h in aerobic conditions. Results are expressed as Log CFU/ml of g for 
free and encapsulated cells, respectively. Samples were referred as indicated in Tab. 8.1. 
Samples of untreated free (L0) and encapsulated cells (M0), after 2.0h of incubation in GSS 
(Lg and Mg) and after the whole treatment under GI condition (Lg+i and Mg+i) were 
centrifuged at 5500g for the discarding of GI simulated solutions while cell pellets were 
washed and centrifuged again for following analysis. Three independent replicas of the 
experiment were carried out. 
 
Tab 8.1 Abbreviations for samples of free and encapsulated Lactobacillus reuteri cells before (untreated) and 
after incubation in simulated gastric (GSS) and intestinal (ISS) solution for 2.0 and 3.0h, respectively 
 
 Untreated After incubation in GSS After incubation in 
GSS+ISS 
Free cells L0 Lg Lg+i 
Encapsulated cells M0 Mg Mg+i 
 
 
8.2.4 Microcapsule dissolution  
The total volume (25 g) of recovered microcapsules approximately containing 1x1010 cells was 
suspended in ratio 1:5 in 0.2 M sodium citrate solution. The suspension was held at room 
temperature for 30 min at constant agitation (150 rpm) to favour the chitosan-alginate matrix 
dissolution and to obtain a cell suspension free from capsules residues. Thereafter, samples 
were centrifuged at 5200 g for 10 min and again resuspended in the same volume of sodium 
citrate, agitated as above described and finally centrifuged for the recovery of cell pellets. Free 
cell samples after GI simulated passage were treated in the same way.  
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8.2.5 Preparation and quantification of bacterial protein extracts  
About 30 mg of cell pellet from all samples (L0, M0, Lg, Mg, Lg+i and Mg+i) were suspended 
in 300 µl of lysis buffer made by 7 M urea (Sigma), 2 M thiourea (Invitrogen) and 2% CHAPS 
(Sigma) and 0.1 mm Zirconium Silica beads (Biospec products Inc, USA) added in ratio 1:1 
(w/v) to the cell pellets.  Thereafter, samples were processed along 6 alternated cycles of 1 
min in bead beater (Bertin Technologies), 5 min in ice incubation and centrifugation (14000 
rpm) for 5 min at 2°C. After all cycles were completed, samples were finally centrifuged 
(14000 rpm) for 30 min at 2°C. Supernatants were collected to be treated for protein 
purification. Thus, protein extracts were precipitated in Protein Bind tubes (Eppendorf) 
following a procedure adapted from Wesse and Fugge (1984) by a first addition of 100% 
MeOH in ratio 1:2 to the protein supernatant, a subsequent addition, after sample agitation, of 
Chloroform in ratio 1:1 to the sample and a further addition of MilliQ water in ratio 1:6 to the 
samples and centrifugation (13000 rpm) for 1 min at room temperature.  After removing and 
discarding the upper layer, 100% MeOH was added again in ratio 1:6 with the initial volume 
of samples that were firstly agitated on vortex and then centrifuged (13000 rpm) for 2 min at 
room temperature. Finally, for the recovery of purified protein pellets, supernatants were 
discarded and protein pellets were air dried. 
Afterwards pellets were resuspended in half volume of lysis buffer with respect to the initial 
volume of the protein extracts and finally stored at -20°C up to following analysis. Protein 
concentration was determined by Bradford assay. An aliquot of 2 µl of purified protein 
extracts were let incubated at room temperature for 5 min in 800 µl of MilliQ water and 200 µl 
of Protein Assay Stain (Biorad). Optical density was measured at 595 nm using a 
spectrophotometer (Gene Quant 100, GE Healthcare) and protein concentration was 
determined against Bovine Serum Albumin (BSA, Thermo Scientific) used as standard. The 
total protein extraction and purification was performed for the samples obtained from the 
three replicas of the experiments of GI simulated transit, both for free and encapsulated cells. 
The protein solutions were finally stored at -20°C and used in subsequent analyses. 
 
8.2.6 2D-PAGE 
2D Elecrophoresis was performed as described by Piras et al. (2015). The first-dimension 
isoelectric focusing (IEF) of proteins was run by using immobilized pH gradient (IPG) 
polyacrilamide gel strips (GE Healthcare, 7 cm, pH 4.0-7.0) and Protean IEF Cell (Bio Rad). 
Prior to IEF, 100 µg of purified proteins from each sample were dissolved in a solution of 30 
mM DTT, 0.5% w/v Ampholine (pH 3.5-10.0), 1% w/v bromophenol blue and lysis buffer to 
a final volume of 126 µl. Samples were carefully distributed onto IPG strips that were actively 
rehydrated at 50 V and 20°C for 18 h. For protein focusing, the voltage was gradually 
increased according to the following protocol; 100 V (4 h), 250 V (2 h), 4000 V (5 h), 4000 V 
until the cumulative voltage reached 60 kVh, then it was decreased to 250 V. A limit of 50 µA 
per gel strip was set. Water imbibed paper wicks were previously placed between cathode, 
anode and gel strips for preventing their burning. After IEF, proteins on each strip were 
reduced for 15 min in 5 ml of Equilibration buffer (6 M Urea, 2% w/v SDS, 50 mM Tris-HCl 
buffer and 20% v/v Glycerol in MilliQ water, pH 8.8) with 1% w/v DTT, and then, after a 
gentle removing of previous solution, they were alkylated in 5 ml of Equilibration buffer with 
2.5% w/v of Iodoacetamide for 15 min in dark incubation. Each IPG strip was washed in 1X 
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running buffer (1% w/v SDS, 250 mM Tris-HCl, 1920 mM Glycine in MilliQ water, pH 8.8) 
and loaded onto 12% w/v polyacrylamide resolving gel (10 ml; 4 ml of 30% Degassed 
Acrylamide/Bis, 3.4 ml of MilliQ water, 2.5 ml of 1.5M Tris-HCl, 0.1 ml of 10% SDS 
solution, 5 µl of Temed and 50 µl of ammonium persulfate solution) along with the protein 
ladder (Precision Plus Protein Al Blue Standard, Biorad). IPG strips were sealed on top of the 
SDS-PAGE gel using 0.5% agarose. Second dimension was carried out in Mini-Protean Tetra 
system (Bio Rad).  
SDS-PAGE was run in Tris-glycine-SDS buffer system (25mM Tris, 192mM glycine and 0.1% 
SDS) at 8 mA per gel for 15 min until the bromophenol blue entered the resolving gel and 
than 16 mA per gel were applied until the dye front reached the bottom edge of the gel. Gels 
were washed three times in 100 ml of deionised water for 5 min under gentle agitation and 
then left in overnight incubation in 100 ml of preheated Brilliant Blue Coomassie G-250 
solution (60 mg/L Brilliant Blue Coomassie, 3ml/L HCl) for staining.  
 
8.2.7 Image analysis 
2-DE protein patterns were developed as digitalized images using a flatbed scanner 
(ImageScanner III, GE Healthcare, Uppsala). Before scanning, gels were washed for 20 s in 
70% v/v ethanol and then for 2 min in 100 ml of deionised water. Variations in protein 
expression revealed between free and encapsulated L. reuteri cells after simulated 
gastrointestinal passage were analysed using the Progenesis SameSpots software (Nonlinear 
Dynamics, UK), Version 4.6. The module for 2DE gel analysis was used for images aligning, 
background removal and detection, normalization and matching of the spots.  
Since only two out of the three replicas of the samples have been analysed up to now, 
statistical analysis will be completed using the Progenesis SameSpots Stats module on the log-
normalized volumes for all spots once all the replicas will be available. Stats module performs 
automatically a One-way ANOVA on each spot to evaluate the P-value between different 
groups. P-values under 0.05 will be considered statistically significant.  
 
8.2.8 Protein identification by MALDI-TOF MS 
Proteins with significant different (P<0.05) levels of expression will be identified by Matrix 
Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) 
after spots reviewing and selection for manually excision from 2 DE gels. 
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8.3 Results 
8.3.1 Viability of free and encapsulated Lactobacillus reuteri after GI simulated passage 
The behaviour of free and microencapsulated Lactobacillus reuteri DSM 17938 cells in coping 
with the stress from GI environment is described in Fig. 8.1.  
 
Fig. 8.1 Viable counts and survival percentages of free and microencapsulated L. reuteri 
cells before (untreated) and after incubation in gastric (GSS) and gastric plus intestinal 
simulated solutions (GSS+ISS). Data are expressed as mean values of three independent 
replicas of the experiment and standard deviations were always <0.1.  Different letters 
labelling bar graphs of the sample categories indicate that mean values are significantly 
different (P≤0.05) as determined by t-test. 
 
 
Lactobacillus reuteri had different performances of survival under gastrointestinal simulated 
conditions when treated in free and microencapsulated form. When treated in free form, L. 
reuteri population showed a notable resistance both in GSS and in the entire GI passage. 
However, after its incubation in GSS, a (P≤0.05) significant reduction of the 70% of the 
population was recorded against a reduction of only 10% in microencapsulated population. 
The survival level of free and microencapsulated Lactobacillus reuteri population dropped to the 
19 and 60% after the subsequent incubation in ISS, respectively. Interestingly, this finding 
indicated an overall higher resistance of microencapsulated cells after incubation in GSS and 
ISS but a higher resistance of free population in its passage from gastric to intestinal 
incubation, as demonstrated by a reduction of about the 10% of population against a 
reduction of the 30% of microencapsulated population.  
 
8.3.2 Protein patterns of free and encapsulated Lactobacillus reuteri in response to GI simulated passage 
 
Proteomics analysis of Lactobacillus reuteri treated in free and encapsulated form under GI 
conditions was performed in order to investigate at molecular level the stress-response of the 
probiotic strain when conveyed to intestinal tract in free and microencapsulated form. Protein 
analysis by 2D Elecrophoresis of untreated microencapsulated cells (M0) and of 
microencapsulated cells after incubation gastric simulated solutions (Mg) was partially 
unsuccessful by the probable residue of microcapsules that interfered with IEF of the samples 
(data not showed). Consequently, 2DE analysis of untreated Lactobacillus reuteri in free form 
(L0), here cosidered as control, and Lactobacillus reuteri after the complete GI passage in free 
(Lg+i) and microencapsulated form (Mg+i) were performed and compared. Only two out of 
the three replicas of the experiments have been analysed until now and thus, a statistical 
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analysis of the protein patterns in the 
three samples has not been already 
accomplished. Representative 2 DE gel 
profiles of samples L0, Lg+i and Mg+i 
are represented in Figs. 8.2 a, b and c. 
Even though a statistical analysis has 
not been already performed for a 
complete spot comparison and 
determination of significant differences 
among protein patterns, some 
differences in the presence of some 
spots and their relative expression levels 
are appreciable in Fig. 8.2. This is also 
confirmed by a preliminary and partial 
analysis carried out with Progenesis 
SameSpots that indicates possible 
difference in the relative 
presence/absence and in different 
expression levels of several proteins 
among the three samples (Fig. 8.3). 
Accordingly, panel a of Fig. 8.3 shows 
the expression of a high molecular 
weight protein (and the ones next to it) 
in samples L0 and that it was down-
regulated in both free and encapsulated 
cells after exposure to GI conditions. 
Differently, panel b of Fig. 8.3 shows an 
example of an overexpressed protein in 
samples Mg+i with respect to L0 and 
Lg+i. Opposite situation is depicted in 
panel c that shows the overexpression 
of a protein in the treated free cell with 
the respect to the control and to the 
microencapsulated counterparts.  
 
 
 
 
 
 
 
 
 
 
 
 
Fig 8.2 Brilliant Blue Comassie-stained 2DE gels of 
total cell proteins extracted from free untreated L. 
reuteri DSM17938 (L0, panel a) and treated under 
gastrointestinal simulated passage in free (Lg+i, panel 
b) and encapsulated form (Mg+i, panel c). The figure 
shows one representative gel for each sample. 
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Fig. 8.3 Spot identification by Progenesis SameSpots image analysis in protein profiles of untreated free 
Lactobacillus reuteri DSM17938 cells (L0) and of free (Lg+i, panel b) and encapsulated L. reuteri (Mg+i, 
panel c) after incubation in gastrointestinal simulated conditions. 2DE protein pattern of L0 was used as 
reference gel.  
 
 
 
8.4  Discussion 
Driven by consistent growth in the body of knowledge dealing with  the use of 
microencapsulation to endure probiotic bacteria, this group of experiments aim for the first 
time at the exploitation of the molecular bases of the increased microencapsulated probiotic 
viability as well as of cell physiology under gastrointestinal conditions. At this purpose, a well-
known probiotic strain has been treated in simulated gastric and intestinal conditions in free and 
encapsulated form for the analysis and comparison of protein patterns by Two Dimensional 
Gel Elecrophoresis. In accomplishment with the gastrointestinal resistance as important 
prerequisite for the selection of probiotics, free cells of Lactobacillus reuteri DSM 17938 exhibited 
a notable level of viability when tested against human barriers such as low pH, digestive 
enzymes and bile salts (Fig. 8.1). Nevertheless, the viability of L. reuteri population was further 
improved by the microencapsulation as demonstrated by the higher level of survived cells 
recovered after the GI passage (Fig. 8.1). However, in order to fulfil their beneficial action, 
probiotics should be able to sense the environment of the GI tract and to adhere to the 
intestinal mucosa (Siciliano and Mazzeo, 2012). In this perspective, in spite of the large 
application of microencapsulation on probiotics, what happen to the physiology of probiotic 
bacteria after to instauration of new microenvironment given by the capsules is still fully 
unexplored. The most probable reasons at the bases of microcapsule preservation ability are 
recognized in their barrier and buffering effect that play an essential role to limit the contact of 
L0 Lg+i Mg+i 
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probiotic cells with the stress factors (Cook et al., 2013; Nualkaekul et al., 2013). In addition, 
with this set of experiments we aim to investigate whether the enhanced cell survival can be also 
attributed to other important factors namely, the new physic-chemical environment within the 
capsules where the cells and their metabolites are closely related and whether they can influence 
cell physiology having a role in cell stress resistance. At this purpose, the use of proteomics tool 
is increasing providing important information about the changes of protein expression patterns 
in bacteria induced by specific and physiological and environmental conditions. Our preliminary 
results indicated that some proteins were up- or down- regulated in microencapsulated 
Lactobacillus reuteri during simulated gastrointestinal transit (Fig.8.3). Unfortunately, the 
investigation of microencapsulated cells recovered at the beginning (M0) and after GSS 
exposure (Mg) has been hindered by probable alginate and chitosan residues that interfered with 
IEF phase. Differently, the analysis of microencapsulated samples after gastric and intestinal 
incubation was allowed by the dissolving action of the intestinal reproduced conditions on 
alginate-chitosan complex, as also reported in Chapter 7, necessary to permit cell release of 
probiotics in the target site. Future identification will reveal which functional protein categories 
(e.g. proteins involved in signal transduction, transcription and translation and general stress; 
cell-envelope proteins) might be involved in the different stress response of encapsulated 
bacteria as well as how microencapsulation can influence probiotic related pathways. In the 
same time, this research will also provide relevant information on the global protein profile of a 
probiotic Lactobacillus reuteri strain following the subsequent exposure to gastric and intestinal 
conditions since, to the extent of our knowledge, only the response to low pH (Lee et al., 
2008a) and bile salts (Lee et al., 2008b; Yanina Bustos et al., 2015) have been separately 
investigated through proteomic analysis. In spite of the potential application of proteomics 
tools on microencapsulated microorganisms, few investigations have been carried out in this 
field and they generally not concern probiotics. Accordingly, Westman et al. (2012) studied the 
proteomic profile of Saccharomyces cerevisiae by 2-D DIGE and quantitative nLCMS/MS, shed a 
light on the mechanisms sustaining the increased thermoresistance and ethanol production and 
the decreased biomass yields of alginate-encapsulated yeasts compared to the free cells. These 
phenomena were mainly attributed to stricter anaerobic and nutrient starvation conditions of 
the encapsulated cells leading to an up-regulation of proteins related to trehalose and glycogen 
(membrane protectors) synthesis and utilization, alcohol dehydrogenases and many stress-
related proteins along with the down-regulation of the proteins linked to protein synthesis. An 
evidence of different protein profiles expressed by a probiotic strain of Lactobacillus acidophilus 
added to carrot juice after GI simulated passage has been reported by Nazzaro et al., (2008) but 
no data about protein identification are available. Also the bacterial cross-talk by quorum sensing 
(QS) has been found implied in regulation of cell behaviour (Di Cagno et al., 2011). 
Interestingly, Gao et al. (2016) has recently discovered an improved stress resistance of 
Escherichia coli cells when encapsulated in chitosan-alginate matrices, mediated by an up-
regulation of luxS/AI-2 system. With their findings, they demonstrated the encapsulated cells 
had a stronger quorum sensing capacity since they were aggregated and confined in microcapsules 
promoting cell-cell-signal interactions and QS related molecules accumulation and reducing cell-
cell communication distance (Gao et al., 2016). These findings provide reasonable evidences to 
let us consider a deep influence of new environment within the capsules on cell physiology.  
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8.4  Conclusion 
The topic of the present work is the exploitation of the physiology of microencapsulated cells 
by proteomics approach. Even though the experiments are still ongoing, preliminary results 
showed different levels of expression of some proteins indicating differential stress response 
in microencapsulated bacteria with respect to their free counterparts. Future findings could 
open a new area of research looking forward the elucidation of the influence of microcapsules 
on probiotic cell behaviour in many different stress conditions. For example, the reason 
behind the higher probiotic viability during long-term storage or the increased bacteriocin 
production from certain probiotic cells could be fully addressed. At this purpose, the 
refinement of the procedure of microcapsules dissolving is of paramount importance for the 
recovery of cell pellets suitable for genomic and post-genomic analysis. In this perspective, a 
comprehensive study of encapsulated microorganisms behaviour at cellular level will provide 
essential information about the metabolic state and long-term behaviour over the general 
information of their increased viability. Furthermore, it also could drive the development of 
new encapsulating systems thought on the base of the interaction between the encapsulating 
matrices and target probiotics.  
 
Notes: 
Experiments described in this Chapter are currently ongoing in collaboration with Dr. Paola 
Roncada, of Istituto Spallanzani and Dr. Alessio Soggiu, Dr. Cristian Piras and Dr. Isabella 
Alloggio of the Laboratory of Microbial Proteomics- Department of Veterinary Medicine, 
University of Milan.  
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Chapter 9                                                                                                            General discussion 
 
 
CHAPTER 9 
 
General discussion 
Microencapsulation technology has become an effective strategy for enhancing  the resistance 
and functional features of microorganisms. A consistent body of knowledge providing 
evidence on the versatility of this technology has accumulated over the years. Successful 
application of the technology both at laboratory-scale and industrial process has enabled its  
adaption for the encapsulation of many classes of bacteria, rnging from those used as starter 
cultures and biocatalysts (Rokka and Rantamäki, 2010; Westman et al., 2012; Adbel-Rahman et 
al., 2013), to probiotics, which are considered an important promotor of human health 
(Douglas and Sanders, 2008; Del Piano et al., 2011; Mills et al., 2011). Over the years, research 
has shown that microencapsulation of cells used as starter cultures or biocatalyst improves 
their fermentative characteristics, including their metabolite production, robustness and 
operational stability of the fermentation system. Furthermore, from an industrial point of 
view, cell encapsulation has become one of the most useful methods for increasing cell 
concentrations in fermentors, enabling their re-utilization and continuous fermentation at high 
dilution rates (Adbel-Rahman et al., 2013). Among other applications, microencapsulation was 
proved to be a successful tool in the sector of probiotic microorganisms for the enhancement 
of their ability to reach the intestine in higher amounts and for the improvement of their 
robustness during their production and utilization as food ingredient or supplement. 
Probiotics are defined as “live microorganism, which, when administered in adequate 
amounts, are able to confer a beneficial physiological effect on the host” (Expert Committee 
FAO/WHO, 2001). Their health benefits are worldwide recognized and include anti-
mutagenic, anti-carcinogenic and anti-infection properties, immune system stimulation, 
reduction of serum cholesterol and lactose intolerance and nutritional enhancement raising a 
high interest from probiotic industry in broadening their use in foods (Dong et al., 2013). 
However, while probiotic food products comprise between 60 and 70% of the whole 
functional food market (Tripathi and Giri, 2014), the probiotic food sector is almost 
exclusively leads from represented by fermented and non-fermented dairy products (De Prisco 
and Mauriello, 2016). ). Nevertheless, the health benefits attribured to probiotics has created 
impetus to extend their application in other categories of foods. In this optic, 
microencapsulation is used as valid strategy for the improvement of probiotic viability against 
technological and food-related hurdles.  In this thesis, the potential of microencapsulation 
technology to improve probiotic viability against technological and food-related hurdles was 
investigated.  In building the rationale for the studies reported in this thesis, a review on the 
application of microencapsulation was conducted until Septenber 2015. The review revealed a 
notable number of new probiotic food carriers developed at research level (Fig. 9.1).  In 
addition, the review provided useful data on the distribution of new probiotic products in 
different food categories obtained by the addition of encapsulated probiotics.  
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As previously discussed in this thesis, despite the relevant improvements toward the useful 
application of microencapsulation technology to probiotic microorganisms, some challenges 
still need to be addressed for full industrial adoption of cell microcapsules. In these regards, 
although some enterprises are involved in the production of probiotic microcapsules and 
many patents have been issued (Probiocap®; Duaolac®; Intelicaps®) to the extent of our 
knowledge, no products carrying microencapsulated probiotic bacteria is currently present on 
the market. 
 
 
 
 
Prior to conducting studies reported in this thesis, we did not have any experience with 
procedure of encapsulation of living cells by vibrating nozzle technology implemented on the 
device Encapsulator B-395 Pro (BÜCHI Labortechnik). Our previous experiences with  
encapsulation was derived from spray-drying and emulsion technologies for which we 
registered poor viability of some lactobacilli strains (by spray-drying) and  recovered of 
microparticles which were non homogeneous in shape and dimension distribution together 
aswell as low entrapment efficiency (emulsion). By introducing this recently developed 
extrusion-based technology we achieved promising results in terms of encapsulation 
efficiency, microorganism viability and morphological and functional properties of 
microcapsules. These aspects were first addressed in Chapter 2 of this thesis, providing the 
impact of the encapsulation procedure on cell viability and the effect of encapsulating 
parameters on the quality of resulting microcapsule population. In detail, cells of Lactobacillus 
reuteri DSM 17938, used as probiotic “model”, were successfully encapsulated, showing a 
matrix type morphology with a homogeneous spherical shape and diameter. The optimization 
of the encapsulating parameters is considered fundamental for the recovering of 
microcapsules with the best properties for food application. Indeed, even though some 
general indications about the use of the Encapsulator are provided by the manufacturer (Buchi 
Lab.), only an accurate study of encapsulating parameters allows us to obtain microcapsules 
with the desired final morphological properties. Our opinion was recently confirmed by 
Yeung et al. (2016), who reported that encapsulation of strains of Lactococcus lactis by adopting 
the manufacturer’s standard operating conditions led to the production of non-spherical 
capsules with an irregular dimension, with a diameter ranging from 7 to 480 µm. Beside 
morphology, experiments reported in Chapter 2 showed an efficient protective feature of 
microcapsules on cells during freeze-drying and storage; and cells exhibited a high survival 
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capacity as measured by preliminary experiments of GI simulated passage. These results 
confirm previous findings, in which of the twelve different microorganisms (including yeasts 
and bifidobacteria) being encapsulated by vibrating technology, none of them exhibited 
significant loss of viability. Up to now, at least twelve different microorganisms (including 
yeasts and bifidobacteria) have been efficiently encapsulated by vibrating technology and none 
of them exhibited significant loss of viability. Finally, based on the extensive literature and our 
personal experience, the recovery of high cell viability and the obtainment of microcapsule 
population with good morphological and functional features are of paramount importance in 
the field of living cell encapsulation. In this optic, we can consider that the vibrating nozzle 
technology met all these requirements since it yielded spherical microcapsules with a narrow 
size distribution and a notable cell viability raising the 100%.   
Following observation of good properties of basic alginate matrix microcapsules, the latters 
were tailored as described in Chapter 3, through the inclusion of xanthan gum in the their 
formulation and the evolvement in the core-shell morphology. It has to be underlined that, 
even though the term core-shell is very often referred to matrix microcapsules to which a 
second layer is applied during a further coating step, the formulation of the real core-shell 
microcapsule morphology is poorly reported. Alginate blended with xanthan resulted in 
microcapsules with a likely higher porosity as suggested by our results. Indeed, although a 
morphological analysis of the alginate-xanthan microcapsules (AX) is required to confirm our 
hypothesis, we found a weaker ability to protect cells during thermal treatments than 
microcapsule obtained by only alginate (AM), suggesting that AX were more permeable to hot 
milk. The inclusion of xanthan also led to the obtainment of core-shell microcapsules with 
non-perfectly moulded core, as demonstrated by the presence of some cells present in the 
alginate layer. On the other side, the presence of xanthan prolonged Lactobacillus reuteri cell 
viability during the storage suggesting its advantageous prebiotic effect toward this probiotic 
strain. Further studies can be carried out to confirm this effect and to exploit alternative use of 
xanthan gum for Lactobacillus reuteri cell protection. Chitosan coated alginate core shell 
microcapsules behaved as the best microcapsule system in terms of cell protection during 
thermal treatments, confirming the hypothesis that bigger the capsules size the higher the 
protection exerted. Yet despite, we believe that through this core-shell microcapsule system 
the protective effect and particle the size are rightly since these microcapsules had an 
acceptable diameter of about 310 µm. Even though we developed a promising microcapsule 
system able to exert a thermal protection by using only two relatively cheap encapsulating 
agents (i.e. alginate and chitosan), we conclude that the exploration of hydrophobic coating 
agents (e.g. stearic acid) should be addressed to optimize the protection features of the 
capsules.  
The gastro-protective effect of probiotic strains can be considered the most important 
achievement of microencapsulation to the extent that this technique has been regarded as the 
future of probiotic human delivery (Vidhyalakshmi et al., 2009; Hernández et al., 2010; Del 
Piano et al., 2012). Although the gastrointestinal resistance is one of the most important 
requirements for probiotic selection, it cannot be assumed that all commercial probiotic 
strains show this feature. Indeed, the storage time or the interaction with food matrices can 
affect the bacterial stress resistance. As already discussed, microencapsulation showed to 
increase the stability of probiotics during inclusion and storage in food as well as during 
simulated transit through the GI tract. With the results reported in Chapter 5 we confirmed this 
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evidence but we also demonstrate that microencapsulation can confer the GI resistance to 
new isolated and potentially probiotic strains selected for interesting and important 
technological features. Also in this set of experiment, chitosan coated alginate core-shell 
microcapsules exhibited the best protective performances. In our opinion, more attention has 
to be given to an accurate simulation of gastrointestinal environment in its composition and 
physiology. In this regard, a better simulation of human digestive tract including the intestinal 
microbiota can be achieved through the use of computer-controlled human GI models (e.g. 
Simulator of the Human Intestinal Microbial Ecosystem, SHIME) in order to project this 
research at a higher level of investigation.  
The formulation of unconventional probiotic foods could represent an attractive form of 
consumption for humans resulting in an increased assumption of these beneficial microbes. 
Similarly, the disposability of a variety of probiotic foods already compliant with local food 
habits can support consumers in unconsciously growing consumption of probiotics. In this 
framework we use three different food matrices such as Water-Buffalo Mozzarella cheese, 
almond milk syrup and blueberry juice to test their “probiotication”, as described in Chapter 6. 
Through the accurate selection of the most suitable microcapsule system for each of the food 
system tested, we obtaining promising result about their potential functionalization with 
probiotic cells. Future research has to address i) the monitoring of cell stability along capsule 
production and storage and their utilization during the entire food production and ii) the 
sensorial analysis of product enriched with probiotic microcapsules.  
Since most of the investigations are focused on the addition of microencapsulated probiotic to 
foods in a dose (106-107 CFU/ ml or g) required to assure the probiotic effect, these bacteria 
are generally not required to grow in a food matrix. As in consequence, the impact of 
microcapsules and the new microenvironment on primary cell metabolism is few investigated. 
Because we believe that probiotic bacteria can also be included in the production of fermented 
food products, we carried out the experiments described in Chapter 7. We encapsulated a 
mixed yoghurt starter culture prepared with a probiotic strain of Lactobacillus delbrueckii to test 
its ability to ferment milk and to produce volatile compounds when in encapsulated form. 
This set of experiments was also thought to investigate the permeability of chitosan-coated 
matrix and core-shell microcapsules in exchanging nutrients and metabolites with external 
environment. As expected we found that, because of the larger diameter and the presence of 
the alginate shell, core-shell microcapsules limited the efflux of nutrients/metabolites with 
higher extent than the matrix microcapsules. However, interestingly, a similar grow rate was 
found both in matrix and in core-shell microcapsules. So, in this sense we can indicate the 
core-shell system more suitable for fermentations processes where a high cell density 
alongside the separation of cells from fermentative media wants to be achieved. It can be 
assumed that the entrapment in matrix microcapsules let the starter culture to behave as slow-
acidifying cultures requiring longer time to ferment milk. On the other hand encapsulated 
strains were protected during the storage, prolonging yoghurt shelf life, and during yoghurt 
simulated transit where free cells of L. delbrueckii showed poor resistance even if probiotic. 
Another interesting finding is the evidence that, although the volatile patterns of yoghurt 
fermented by free and encapsulated strains were similar for what concerned some of the most 
important yoghurt aroma compounds, they differ for ethanol, acetone and other compounds 
content. This was likely imputable to the new conditions of the microenvironment suggesting 
the microencapsulation as a tool to influence aroma formation during fermentation process.   
	 114	
The great potential of probiotic cells is recognized and appreciated in an extremely wide range 
of areas related to human health. Nevertheless, for optimum action of these probiotic cells, it 
is essential that they are provided with appropriate conditions for growth and metabolism, and 
that they are protected from hash environmental conditions. As previously discussed, the 
potential of suitable microcapsules to protect probiotics is uncontroversial but the only 
outcome that has so far been realised following many years of intensive research, is the 
protection of viability of probiotic. Apart from a few pieces of evidence about the ability of 
probiotics to produce bacteriocins after their microencapsulation, information on metabolism 
of encapsulated probiotic cells is hardly available. Similarly, to the best of our knowledge, 
evidence at a molecular level about stress-response of encapsulated probiotics have not yet 
been adduced. In this context therefore, experiments described in Chapter 9 of this thesis 
produced at very preliminary level results which showed different levels of expression of some 
proteins. The identification of these proteins will be performed in order to fully understand 
which probiotic- and stress response-related proteins are potentially influenced by the 
microenvironment created by the capsule. Finally, the present research aims at introduce a 
new approach based on the application of proteomic tool to study the behaviour of 
microencapsulated probiotics, with the view of understanding  physiology of encapsulated 
probiotic cells.  
  
 
 
Recommendations  
In the future, new food sources of probiotics will likely play a significant role in the human 
health. However, to fully realize the potential application of encapsulated probiotics for the 
broadening and quality improvement of probiotic food product, a range of multidisciplinary 
actions should be pursued as part of a cooperative model to address the following points: 
• evaluation and optimisation of drying processes to allow the marketing of dried 
microcapsules; 
• understanding the relationship between capsule material, dimension and their 
nutrient/metabolite diffusion kinetic which is essential to allow their use in food 
matrixes with specific processing and storage conditions; 
• comprehension, at molecular level, of the effect exerted by the capsule 
microenvironment on cell physiology in the different processing and utilization 
conditions;  
• advancement of sensorial impact of probiotic capsules in real food systems;  
• development of a clear and comprehensive shared guidelines and legislative standards 
at international level that would lead towards the full deployment microencapsulated 
probiotics and to boost their introduction in the food market. 
But to fully realize the potential of microencapsulation in contributing at the development of 
new food formula there is the need to create a solid bridge between academia and both small 
and large enterprise to ensure a fruitful exchange of scientific and technological knowledge.  
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Competitiveness 2007-2013, project title : “Encapsulation of active ingredients for improving 
the quality and food safety”.  This was followed by the PhD research project at the 
Microbiology division of the Dept. of Agricultural Sciences at University of Naples, Federico 
II. During the three years of her PhD she visited for three times the Ugandan University of 
Gulu where she met Duncan Ongen, Dean of Faculty of Agriculture and Environment and 
co-tutor of her PhD thesis. During the longer stay she supported her PhD tutor, Prof. 
Gianluigi Mauriello in the start up of a laboratory for molecular microbiology at Gulu 
University and in training for students and future trainers in molecular microbiology 
techniques. She also attended a training School in Strasbourg University on 
Microencapsulation organized by Strasbourg University and Bioencapsulation Research 
Group.  
She conducted part of this research in at the Department of Agrotechnology and Food 
Sciences, Food Quality and Design Group of Wageningen University, the Netherlands.  
Outcomes of this PhD project have been presented in this thesis, entitled “Effect of 
microencapsulation on functional and technological features of probiotic and starter cultures” 
 
I want with all my heart and my sincerity express my thanks for my PhD period.  
Thanks to my parents, my colleagues, my friend and colleague Diamante, thanks to my tutor, 
thanks for many opportunities to challenge myself, for the new friends I met, for travelling, 
for working in the best field ever, the research.  
 
 
I will never forget these three years, the most incredible ones of my life.  
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Publications  
 
• De Prisco A., van Valemberg H.J.F., Fogliano V., Mauriello G. Behaviour of 
microencapsulated starter culture during yoghurt manufacturing. In submission to Applied 
Microbiology and Biotechnology. 
 
• Mauriello G., De Prisco A., Di Prisco G., La Storia A., Caprio E. Microbial 
characterization of bee pollen from the Vesuvius area collected by using three different traps. 
Submitted to PLOS ONE.  
 
• De Prisco A. and Mauriello G. (2016). Probiotication of foods: a focus on 
microencapsulation tool. Trends in Food Science and Technology, 48, 27-39. 
 
• De Prisco A., Maresca D., Ongeng D., Mauriello G. (2015). Microencapsulation by 
vibrating technology of the probiotic strain Lactobacillus reuteri DSM 17938 to enhance its 
survival in foods and in gastrointestinal environment. LWT - Food Science and Technology, 
61, 452-462.  
 
• Maresca D., De Prisco A., La Storia A., Cirillo T., Esposito F., Mauriello G. (2015). 
Microencapsulation of nisin in alginate beads by vibrating technology: preliminary 
investigation. LWT - Food Science and Technology, 66, 436-443.  
 
• Vitaglione P., Troise A.D., De Prisco A., Mauriello G., Gokmen V. and Fogliano V. 
(2015) Use of microencapsulated ingredients in bakery products: technological and nutritional 
aspects. In Leonard M.C. Sagis Ed. Microcapsules and Microspheres for food Application. 
Elsevier, p-301-311. 
 
• Mauriello, G., Maresca, D., Malmo C., De Prisco, A. (2013). Microencapsulation for 
functional foods: a focus on the Vibrating technology. New Food, 16 (5), 15-20. 
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Scientific Curriculum 	
Current occupation 
PhD	candidate																																																																																																			March	2014-	February	2017	in	Food	and	Agricultural	Sciences	at	University	of	Naples,	Federico	II.	Dept.	of	Agricultural	Sciences,	Portici	(Na).	Division	of	Microbiology.	Research	topic:	Study	of	the	effects	of	microencapsulation	on	technological	and	functional	feature	of	probiotic	and	starter	cultures	
Work experience 
• Research	fellow	
Development	of	novel	encapsulated	 ingredients,	 in	particular	
antimicrobial	substances	(bacteriocins,	essential	oil).	
In	vitro	and	in	vivo	performance	of	encapsulated	bioactives.	Activities	within	 the	program	PON	Research	 and	Competitiveness	2007-2013.	 Project	 title	 “Encapsulation	 of	 active	 ingredients	 for	improving	the	quality	and	food	safety”.																																																																University	 of	 Naples,	 Federico	 II.	 Dept.	 of	 Agricultural	 Sciences,	Portici	(Na).	Division	of	Microbiology.	
		 January-October	2013	
				 	 	
• Quality	assurance		 	 January	2009-October	2012	Quality	assurance	and	quality	system	management	according	to	the	standard	UNI	EN	ISO	9001:2008	and	IFS	GSFS.		
Production	and	packing	in	modified	atmosphere	of	meat	derivatives.	
Jomi	S.p.a.	,Via	delle	Industrie,	95,	80067-Bellizzi	(Sa)	and	Via	Roma,	
50-	Langhirano	(Pr),	Italy.		
	
• Quality	control		 								August-	October	2006	Quality	control	and	HACCP.		
Production	of	tomato	derivatives.	
Europa	Conserve	,Sant’Antonio	Abate,	80059	(Na),	Italy.	
	
 
Education and training 23-26	February	2015	
BRG	7th	Training	School	on	Microencapsulation	
organized	 by	 Strasbourg	 University	 andmBioencapsulation	
		 	
	 136	
Publications  
• De	Prisco	A.,	van	Valenberg	HJF,	Fogliano	V,	Mauriello	G.	Behaviour	of	microencapsulated	starter	 culture	 during	 yoghurt	 manufacturing.	 Submitted	 to	 Food	 and	 Bioprocess	technology.	
• Mauriello	G.,	De	Prisco	A.,	Di	Prisco	G.,	La	Storia	A.,	Caprio	E.	Microbial	characterization	of	bee	 pollen	 from	 the	 Vesuvius	 area	 collected	 by	 using	 three	 different	 traps.	 Submitted	 to	PLOS	ONE.		
• De	Prisco	A.	and	Mauriello	G.	(2016).	Probiotication	of	foods:	a	focus	on	microencapsulation	tool.	Trends	in	Food	Science	and	Technology,	48,	27-39.	
• De	Prisco	A.,	Maresca	D.,	Ongeng	D.,	Mauriello	G.	 (2015).	Microencapsulation	by	 vibrating	technology	of	the	probiotic	strain	Lactobacillus	reuteri	DSM	17938	to	enhance	its	survival	in	foods	 and	 in	 gastrointestinal	 environment.	 LWT	 -	 Food	 Science	 and	 Technology,	 61,	 452-
Research	Group,	held	in	Strasbourg	University	
- Overview	and	physiochemical	methods	for	encapsulation;	
- Practices	in	microcapsules	characterization;	
- Current	 research	on	 living	 cells	 and	 functional	 ingredients	encapsulation;	
- Laboratory	scale	demonstrations;	
- Physical	methods	and	technologies	for	encapsulation;	
- Pilote	scale	demonstrations;	
- Scaling:	from	LAB	to	industrial	production.		University	of	Strasbourg,	France.		July	2012	
Master	degree	in	Food	Science	and	Nutrition,	with	honours			with	a	thesis	on	the	study	of	the	encapsulation	of	oregano	essential	oil	 component	 (carvacrol)	 and	 its	 antimicrobial	 effect	 on	 food	pathogens	 and	 spoilers.	 Title:	 “Encapsulation	 of	 natural	antimicrobial	substances:	the	case	of	carvacrol”.		University	 of	 Naples,	 Federico	 II.	 Dept.	 of	 Agricultural	 Sciences,	Portici	(Na).	Division	of	Microbiology.		July	2009	
Bachelor	degree	in	Food	Science	and	Technology	with	a	thesis	on	the	mechanisms	related	to	programmed	cell	death	in	bacteria,	with	particular	attention	to	two	food	pathogens	(E.	coli	and	B.	subtilis).	Title:	“Apoptosis	in	bacterial	cells”.		University	 of	 Naples,	 Federico	 II.	 Dept.	 of	 Agricultural	 Sciences,	Portici	(Na).	Division	of	Microbiology.		
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462.	
• Maresca	 D.,	 De	 Prisco	 A.,	 La	 Storia	 A.,	 Cirillo	 T.,	 Esposito	 F.,	 Mauriello	 G.	 (2015).	Microencapsulation	 of	 nisin	 in	 alginate	 beads	 by	 vibrating	 technology:	 preliminary	investigation.	LWT	-	Food	Science	and	Technology,	66,	436-443.	
• Vitaglione	P.,	Troise	A.D.,	De	Prisco	A.,	Mauriello	G.,	Gokmen	V.	and	Fogliano	V.	(2015)	Use	of	microencapsulated	ingredients	in	bakery	products:	technological	and	nutritional	aspects.	In	Leonard	M.C.	 Sagis	 Ed.	 Microcapsules	 and	Microspheres	 for	 food	 Application.	 Elsevier,	 p-301-311.		
• Mauriello,	G.,	Maresca,	D.,	Malmo	C.,	De	Prisco,	A.	(2013).	Microencapsulation	for	functional	foods:	a	focus	on	the	Vibrating	technology.	New	Food,	16	(5),	15-20.		
		
	
Conference participation and contributions 
	
• De	 Prisco	 A.	 Mauriello	 G	 and	 Hein	 J.F.	 van	 Valenberg	 (2016).	 Behaviour	 of	 a	microencapsulated	 starter	 culture	 during	 preparation,	 storage	 and	 simulated	gastrointestinal	 transit	 of	 set	 yoghurt.	 Food	 Micro	 2016,	 University	 College	 of	 Dublin.	Abstract	and	poster	n°779.		
• De	Prisco	A.	Mauriello	G	and	Ongeng	D.	(2016).	Survival	of	Latobacillus	reuteri	DSM	17938	microencapsulated	 by	 vibrating	 technology	 in	 three	 different	 microcapsules	 after	 heat	treatments.	Food	Micro	2016,	University	College	of	Dublin.	Abstract	and	poster	n°780.		
• Mauriello,	 G.,	 Maresca,	 D.,	 De	 Prisco,	 A.,	 La	 Storia,	 A.	 (2013)	 Preservation	 of	 nisin	 by	microencapsulation	 through	 vibrating	 technology.	 International	 Congress	 Spoilers	 in	Food.	Quimper	France,	1-3	July.	Poster	pp.	136		
• De	 Prisco,	 A.,	 Maresca,	 D.,	 Mauriello,	 G.	 (2013)	 Application	 of	 vibrating	 technology	 for		microencapsulation	of	bacterial	cells	and	nisin.	“New	frontiers	in	living	cell	encapsulation”.	Università	 degli	 studi	 di	 Perugia	 8-10	 Settembre	 2013.	 Abstract	 pp.	 24	 and	 oral	presentation.			
Research and educational experience  Guest	 at	 Proteomics	 Laboratory	 at	 Veterinary	 Medicine,	University	of	Milan	(Università	degli	Studi	di	Milano)	Investigation	 of	 protein	 expression	 in	 free	 and	 encapsulated	
Lactobacillus	 reuteri	 cells	 under	 simulated	 gastro-intestinal	transit.		
	 December	2016	
PhD	 guest	 at	 Wageningen	 UR	 (Netherlands)-	 Group	 of	 Food	Quality	and	Design,	Dairy	division.		Investigation	 of	 behaviour	 of	 microencapsulated	 probiotic	
February	–	August	2016	
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starter	 culture	 during	 yoghurt	 manufacturing,	 with	 special	attention	 to	 acidification	 and	 growth	 kinetics,	 proteolysis	 and	aroma-related	volatiles	production.			Guest	at	Gulu	University,	Faculty	of	Agriculture,	Uganda	within	Gulu-Nap	Project	of	University	of	Naples,	Federico	II.	Set-up	 of	 molecular	 biology	 laboratory	 and	 training	 to	 future	trainers	on	molecular	biology	techniques	and	experiments	(e.g.	bacterial	 DNA	 extraction,	 PCR	 of	 bacterial	 genes,	electrophoresis).	
	 																						August	2015	
 
Membership 
• SIMTREA,	Italian	Society	of	Agri-Food	and	Environmental	Microbiology.				 		 January	2015	
• Bioencapsulation	Research	Group		 		 January	2015			
 		
 
